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Abstract
Cell-fate decisions are governed by the integration of multiple stimuli. Th cell
differentiation is a well-studied example of cell-fate decision: mature Th cells
emerge from the thymus in a naive state and, upon encounter with their cognate
antigen, differentiate into a specialised subtype depending on the polarising
cytokines present in their environment. The most common and first described
Th cell subtypes, Th1 and Th2 cells, differentiate in response to IFN-γ/STAT1
and IL-12/STAT4 (Th1) versus IL-4/STAT6 (Th2) signals, respectively, and start
expressing the master transcription factors T-bet or GATA-3. T-bet in Th1 cells
drives the expression of the effector cytokine IFN-γ that leads to the activation
of macrophages, whereas GATA-3 in Th2 cells controls the expression of IL-4,
IL-13 and IL-5, leading, among other things, to antibody class switching in B
cells. Recent discoveries concerning the plasticity of Th cell subtypes as well as
the existence of stable hybrid phenotypes, specifically T-bet+GATA-3+ hybrid
Th1/2 phenotypes, have put Th cell fate decision under a different light. Those new
findings stimulated the detailed study of the differentiation process under different
assumptions than the hitherto valid paradigm of single master transcription factor
expression deciding between alternative cell fates using complex cytokine signals
as inputs in this work.
Here, we developed a data-based approach for inferring the molecular network
underlying the differentiation of Th1, Th2 and hybrid Th1/2 lymphocytes. We
performed systematic titrations of the polarising cytokines IFN-γ, IL-12 and IL-4 in
all possible combinations during primary differentiation of ex vivo isolated naive
Th cells and, using flow cytometry, quantified signal transduction in the form
of STAT1, STAT4 and STAT6 phosphorylation as well as target-gene expression
(T-bet, GATA-3, STAT1, STAT4 and STAT6 expression). Visual inspection of the
thus generated dataset indicated the presence of a multitude of cytokine-specific
regulatory mechanisms; however, the size and complexity of the dataset made a
systematic analysis necessary to identify those mechanisms. To extract the network
topology, we used linear regression analysis, retrieving known regulatory mechan-
isms and predicting numerous novel ones. The predicted network topology was
verified experimentally and used to develop a mechanistic mathematical model of
cytokine signal integration that reproduces independent data and confirms the
significance of all predicted interactions.
This approach inferred a highly connected regulatory network. Previously un-
described functions of STAT signal transducers mediate network rewiring during
differentiation: self-reinforcing feedback within the Th1 and Th2 regulatory path-
ways, self-limiting feedback within the Th1 pathway, and strong mutual inhibition
2between the two pathways were predicted to be mediated by the phosphorylated
STATs, and selected new interactions were confirmed by experiments using gene-
deficient cells. Importantly, while mutual-inhibition motifs are often considered
canonical digital switches, the inferred Th-cell network acts as a rheostat, gen-
erating a continuum of differentiated states along the Th1-Th2 axis. This work
explains the observed Th1-Th2 cell fate continuum mechanistically and provides a
quantitative framework for the data-based inference of cellular signal integration
networks.
Zusammenfassung
Differenzierungsentscheidungen von Zellen werden durch die Integration meh-
rerer Stimuli bestimmt. Die Differenzierung von Helfer-T-Zellen (Th-Zellen) ist
hierfu¨r ein gut untersuchtes Beispiel: reife Th-Zellen treten in einem naiven Zu-
stand aus dem Thymus aus und entwickeln sich beim Kontakt mit einem fu¨r sie
spezifischen Antigen zu einem spezialisierten Subtyp, der von den in ihrer Umge-
bung vorhandenen Zytokinen abha¨ngt. Die ha¨ufigsten und zuerst beschriebenen
Th-Zell-Subtypen, Th1- und Th2-Zellen, differenzieren sich in Antwort auf IFN-γ /
STAT1- und IL-12 / STAT4-Signale (Th1) bzw. IL-4 / STAT6-Signale (Th2) und ex-
primieren dann die Mastertranskriptionsfaktoren T-bet bzw. GATA-3. T-bet in Th1-
Zellen treibt die Expression des Effektorzytokins IFN-γ, das zur Aktivierung von
Makrophagen fu¨hrt, wa¨hrend GATA-3 in Th2-Zellen die Expression der Zytokine
IL-4, IL-13 und IL-5 steuert, die u. a. zum antiko¨rper-Klassenwechsel in B-Zellen
fu¨hren. Neuere Entdeckungen bezu¨glich der Plastizita¨t von Th-Zell-Subtypen
sowie die Existenz von stabilen Hybridpha¨notypen, insbesondere T-bet+GATA-3+
Hybrid-Th1/2-Pha¨notypen, haben die Schicksalscharakterisierung von Th-Zellen
in ein anderes Licht gesetzt. Diese neuen Ergebnisse motivierten die detaillierte
Untersuchung vom Differenzierungsprozessen von Th-Zellen in Anwesenheit
komplexer Zytokinsignale in dieser Arbeit.
Dazu haben wir einen Ansatz fu¨r die datenbasierte Inferenz der molekula-
ren Netzwerke entwickelt, die der Differenzierung von Th1-, Th2- und hybriden
Th1/2-Lymphozyten zugrunde liegen. Wir haben systematisch die polarisierenden
Zytokine IFN-γ, IL-12 und IL-4 in allen mo¨glichen Kombinationen wa¨hrend der
prima¨ren Differenzierung ex vivo isolierter Th-Zellen titriert und mittels Durchflus-
szytometrie Signaltransduktion (STAT1-, STAT4- und STAT6-Phosphorylierung)
und Zielgenexpression (T-bet, GATA-3, STAT1, STAT4 und STAT6) quantifiziert.
Die visuelle Auswertung des erzeugten Datensatzes legte die Existenz einer Viel-
zahl von Zytokin-spezifischen Regulationsmechanismen nahe. Der Umfang und
die Komplexita¨t der Daten machten jedoch eine systematische Analyse notwendig,
um diese Mechanismen genau zu identifizieren. Lineare Regressionsanalyse wurde
verwendet, um die Netzwerktopologie zu extrahieren. Dabei haben wir bekannte
Regulationsmechanismen wiedergefunden sowie zahlreiche neue Interaktionen
vorausgesagt. Die prognostizierte Netzwerktopologie wurde anschließend expe-
rimentell verifiziert und verwendet, um ein mechanistisches, mathematisches
Modell der Zytokinsignalintegration zu entwickeln, das unabha¨ngige Daten re-
produziert und die Relevanz aller vorhergesagten Interaktionen besta¨tigt.
Diese Methode hat ein hochgradig venetztes regulatorisches Netzwerk infe-
riert. Bisher nicht beschriebene Funktionen von STAT-Signalwandlern vermitteln
2die Neuverkabelung (rewiring) des Netzwerkes wa¨hrend der Differenzierung:
Selbstversta¨rkende Ru¨ckkopplung innerhalb der Th1- und Th2-Regulationswege,
selbstlimitierende Ru¨ckkopplung innerhalb des Th1-Signalweges und starke ge-
genseitige Inhibierung zwischen den beiden Signalwegen, die durch die phospho-
rylierten STATs getrieben werden, wurden vorhergesagt, und ausgewa¨hlte neue
Interaktionen wurden in gezielten genetischen Experimenten besta¨tigt. Wa¨hrend
gegenseitige Inhibitionsmotive oft als kanonische digitale Schalter interpretiert
werden, funktioniert das Th-Zell-Netwerk als ein Rheostat, der Variationen der
Zytokinsignale in graduelle Expressionsa¨nderungen der Mastertranskriptions-
faktoren GATA-3 und T-bet u¨bersetzt. Unsere Arbeit erkla¨rt mechanistisch das
beobachtete Kontinuum von Th-Zelldifferenzierungszusta¨nden entlang der Th1-
Th2-Achse und beschreibt eine quantitative Methode fu¨r die datenbasierte Inferenz
zellula¨rer Netzwerke der Signalintegration.
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Chapter 1
Introduction
1.1 The immune system and T helper cells
Organisms are under constant threat of infection by a multitude of pathogens1. All
forms of life possess a defence system against pathogens, called immune system2,
that uses various mechanisms based on the same principle: the recognition and
tolerance of self versus the recognition and attack of non-self. Pathogenic cells,
like bacteria, yeast or helminth cells, can be identified by immune cells through
detection of generic patterns present directly on pathogens, like bacterial lipo-
polysaccharides (LPS) or nucleic acids3,4. Infected or cancer host cells can be
identified by the presence of foreign or modified antigen on the constitutively
expressed major histocompatibility complex (MHC) molecules on their surface;
healthy cells present self-antigen on their MHC molecules that induce tolerance
by the immune system5. Furthermore, some healthy specialised immune cells,
called antigen-presenting cells (APCs) can display foreign antigen on their surface
to signal the presence of a pathogen to other members of the immune system6.
Vertebrates possess a highly diversified immune system that is divided into
two major branches7. The first barrier against pathogens, called the innate immune
system, is strongly conserved amongst species and is a non-specific system that
fights pathogens in a generic way, although different cell types act against different
types of threat to the organism: type 1 immunity is active against most infections
caused by small eukaryotic cells and is characterised by a high phagocytic activity,
while type 2 immunity is active mainly against helminth and characterised by high
antibody titers8. As its name suggests, innate immunity is already present and
functional at birth; it has no memory, which means that its response will be the
same if a pathogen is seen for the first time or has already infected the organism
before. This system is able to control most of the infections directly at the interface
between the organism and its environment through different simple mechanisms.
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The second barrier, adaptive immunity, is present only in vertebrates9 and is
active if the innate immune response fails to contain an infection. The adaptive
immune system fights pathogens in a specific manner: upon encounter with
pathogenic antigen, a massive expansion of adaptive immune cells targeting the
invading pathogen takes place (thus adapting the immune response to the detected
threat). Fighting infection is a time-sensitive process which can be described as
a contest between the pathogen multiplying in the host and the host destroying
the pathogen; thus, a fast immune response is crucial for the survival of the host.
Building an adaptive immune response takes times; However, so-called memory
cells remain after the elimination of an infection by the adaptive immune system.
These memory cells expand the pool of cells reacting to a specific antigen, thus
increasing the efficiency of the adaptive immune response drastically10.
1.1.1 The first line of defence: overview of the innate immune
system
The innate immune system is the dominant immune response in plants and
fungi but is also crucial for higher organisms. In order to fight a broad range
of infections, from viruses to helminths, several mechanisms play a part in the
mammalian innate defence: some are non-cellular, like the complement system,
some, like anatomical barriers, are made by non-immune cells, and some require
specialised cells. As a first line of defence, the innate immune system is responsible
for preventing the entry of pathogens into the organism; failing that, for the
clearing of the invading pathogens, and finally, if necessary, for the activation of
the adaptive immune response. The principal players and functions of the innate
immune system are:
Epithelial cells from the skin and mucosa secrete mucus and toxins that prevent
the entry of pathogens into the body11.
Inflammation aims at establishing a physical barrier around injured cells; those
cells release chemical factors, like histamine, that promote vasodilatation
and attract phagocytes to clear the pathogens12.
The complement system is a protein cascade that leads to the opsonising or cyto-
lysis of pathogens and triggers inflammation13,14; it complements the action
of antibodies.
Professional immune cells all develop from the same hematopoietic progenitor
cell, but differentiate into different cell types that have different roles2:
• Mast cells release inflammatory factors and chemokines to attract other
immune cells15.
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• Phagocytes (macrophages, neutrophils and dendritic cells) engulf patho-
gens and unhealthy host cells and present pathogenic antigens on their
MHC molecules so that other immune cells, specifically T cells, can be
activated16.
• Basophils and eosinophils secrete toxins against parasites and bac-
teria17.
• Natural killer (NK) cells attack unhealthy host cells (recognising the
‘missing self’ condition, for example in cancer or virus-infected cells)18.
1.1.2 A specific response to pathogens: the adaptive immune sys-
tem
Sometimes pathogens expand faster than the innate immune response can control.
When this is the case, a strong and specific immune response against the pathogen
in question is needed; this is provided by the adaptive immune system. Adaptive
immunity has a cellular and a humoral component. The effector immune cells,
called lymphocytes, are divided into two main cell types: B and T cells. T cells
mediate the cellular response, while B cells secrete immunoglobulins (Igs, also
called antibodies) and take part in the humoral response. Both cell types originate
from a common progenitor in the bone marrow that differentiates and matures in
the thymus (for T cells) or in the bone marrow and spleen (for B cells)19.
Both B and T cells recognise antigens through special proteins made of several
chains that vary between clonal populations. T cells bind antigens via a T cell
receptor (TCR) and B cells via a membrane-bound immunoglobulin (Ig) that forms
the B cell receptor (BCR). Those receptors must have a very high affinity for one
antigen to achieve the specificity of the adaptive immune response. This specificity
is achieved by recombinations in the TCR and Ig gene loci; the T and B cells
are mature once those recombination processes are finished20,21. In B cells, the
immunoglobulin gene undergoes further mutations after an antigen encounter,
called somatic hypermutations, which allow B cells to increase the affinity of their
Igs for their cognate antigen at each encounter22. Once the maturation process
is terminated, both T and B cells are considered naive as long as they have not
encountered their cognate antigen, and have to be activated in order to become
fully functional. This happens in a similar fashion for both cell types.
B cell maturation and function
B cells get activated when their BCR binds a free antigen and the cell receives a
co-stimulus at the same time; the antigen is then engulfed, digested and presented
as a peptide on a MHC class-II molecule at the cell surface. The peptide can then be
recognised by T helper cells with the same antigenic specificity, which will secrete
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cytokines allowing the B cell to mature into either an antibody-secreting plasma
cell and to multiply or, for a small subset, into a memory cell23. Memory cells and
long-lived plasma cells can survive for a long time24, and react fast to a secondary
infection thanks to their specific antibody epitope: no maturation process is needed
and the antigen encounter is followed by a quick clonal expansion. Plasma cells
derived from naive progenitors or memory cells secrete immunoglobulins with the
same specificity as their BCR; those Igs act against pathogen in various fashions,
the principal ones being:
Agglutination or precipitation is the process in which immunoglobulins bind
several pathogenic antigens and join pathogenic cells (agglutination) or
antigens (precipitation), thus facilitating their elimination by phagocytes;
Complement activation is the process that triggers the complement protein cas-
cade;
Neutralisation is the process in which the binding of pathogenic antigens leads
to a reduction in pathogen activity.
T cell maturation and function
T cells are key mediators of the cellular adaptive immune response. Progenitor T
cells formed in the bone marrow migrate to the thymus where they expand and
undergo maturation into T helper cells that express the cluster of differentiation
(CD)4 marker or cytotoxic T cells that express the CD8 marker. The fate of T cells
is determined, among other things, by the class of the MHC molecule they bind
to during selection: cells interacting with MHC class-I molecules become CD8 T
cells, while cells interacting with MHC class-II molecules become CD4 T cells25.
The main role of cytotoxic T cells is to secrete cytotoxins leading to apoptosis of
injured or infected cells. Perforin, one of the secreted cytotoxins, forms pores in
the membrane of the target cell, allowing another kind of cytotoxin, granzymes, to
enter the cell and activate the caspase cascade that causes apoptosis of the target
cell26. The main role of T helper cells is to secrete cytokines activating other parts
of the immune response against the pathogen carrying their cognate antigen27,28.
Mature helper and cytotoxic T cells exiting the thymus are naive and have
to be activated by antigens to become functional. Unlike B cells, T cells do not
recognise free antigen; it has to be digested to peptides and presented on MHC
molecules by antigen presenting cells (e.g., dendritic cells, macrophages, B cells,
or non-professional antigen-presenting cells stimulated by interferon (IFN)-γ)28,29.
Presented pathogenic peptides are bound by the TCR, which signals through
the NFAT (Nuclear factor of activated T-cells) and MAPK (Mitogen-activated
protein kinase) pathways, leading to the transcription of genes like Tbx21 and
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Gata3 encoding the so-called master transcription factors (MTFs) T-box expressed
in T cells (T-bet) and GATA-3, as well as cytokine genes. The cytokine milieu
during activation determines which genes are upregulated during this activation
process, and thus the lineage into which the cells differentiate.
Immunological memory
The adaptive immune system has two hallmarks: the first one is the specificity of
each cell for a defined antigen, and the second is that the system recalls pathogens
it has already encountered. This is achieved by the presence of long-lived T and B
memory cells that arise during the primary infection and survive in the absence of
antigen30,31,24. These memory cells are already mature, having acquired a cytokine
profile during differentiation for T cells and undergone class switching for B
cells, making their response faster upon antigen re-encounter. Furthermore, the
presence of memory cells increases the number of cells with a given antigenic
specificity10, thus making the expansion process much more efficient.
It is unclear why a primarily activated T cell will survive and enter the memory
pool while most of its counterparts undergo apoptosis after the infection is cleared.
However, interleukin (IL)-7 signalling play a crucial role by inducing the expres-
sion of B-cell lymphoma (Bcl)-2, an anti-apoptotic factor, in both CD4 and CD8 T
cells32,33, while the latter also need IL-15 and TCR signalling for the homeostatic
proliferation of memory cells34,35. CD8 memory cells can be found in constant
numbers in the spleen, while their CD4 counterparts reside in the bone marrow in
the vicinity of IL-7-producing stroma cells36.
1.1.3 Co-ordinating the global immune response: T helper cells
T helper cells are the main constituents of the CD4 population; their role is to
activate other immune cells by secreting cytokines targeting the appropriate im-
mune cell population to fight the pathogen. Hence, the mediators of their effector
functions are those cytokines that signal to other cells (e.g., B cells, macrophages
or neutrophils). Although innate immune cells act in defence against pathogens
in the absence of T cell help, their response can be enhanced by the latter in case
of an infection progressing despite their autonomous activity. In order to elicit
a response adapted to the current threat to the organism, different Th cell types
expressing different cytokines that target different effector populations arise in
response to different pathogens37,28.
CD4 T cells exiting the thymus are naive (with the exception of natural regulat-
ory T (nTreg) cells38) and differentiate into one of several subtypes upon antigen
encounter, depending on the cytokine milieu39. Differentiation into a specific
subset is driven by polarising cytokines that signal mostly via Signal transducers
14 1. Introduction
and activators of transcription (STAT) proteins40, leading to the up-regulation
of master transcription factors that drive effector cytokine expression. MTFs are
defined by the fact that their expression is both necessary and sufficient to specify
a Th cell lineage. MTF expression is sustained throughout the T helper cell’s life
and maintains the cell’s phenotype in the memory phase. Commonly accepted
subtypes are T helper type (Th)1, Th2, Th17, T follicular helper (Tfh) and induced
regulatory T (iTreg) cells41 (Figure 1.1).
Effector cytokine expression and secretion is regulated at several levels42:
epigenetic changes take place during differentiation that lead to expression or
silencing of cytokine genes43,44,45; transcription is enhanced or repressed by tran-
scription factors, and post-translational mechanisms regulate mRNA stability or
protein secretion. Most of the cytokine regulation is carried out by lineage specific
master transcription factors. Cytokines signal in an endocrine manner: receptors
on the membrane of target cells relay the cytokine signals intracellularly, often via
the STAT protein family. The polarising cytokines, master transcription factors
and signature cytokines of the main Th cell types are listed below.
Th1 cells are characterised by a high T-bet expression46. The main Th1 cytokine
is IFN-γ and contributes to the response against intracellular pathogens by
signalling to macrophages. Their differentiation is driven by IFN-γ/STAT1
and IL-12/STAT4.
Th2 cells show a high GATA-3 expression47. They secrete mainly IL-4, a cytokine
that enhances the antigen-presenting capacity of B cells and fights extracel-
lular parasites, but also IL-5 and IL-1348. Their differentiation is driven by
IL-4/STAT6.
Th17 cells express the transcription factor RAR-related orphan receptor (ROR)γt49.
They produce, among others, IL-17A, which activate fibroblasts, epi- and
endothelial cells as well as stromal cells and recruit neutrophils. Th17 cells
also produce IL-17F, IL-21 and IL-2250,51. Their differentiation is driven by
Transforming growth factor (TGF)-β/SMAD2/3 and IL-6/STAT352.
Treg cells are characterised by a high Forkhead box (Fox)P3 expression53,54 and
are responsible for immune tolerance and tuning of the immune response by
repressing other immune cells55; they can arise already in the thymus (nTreg
cells) or during an immune response (iTreg cells)56. Their differentiation is
driven by TGF-β/SMAD2/357.
Tfh cells are dependent on Bcl-658,59 and are critical for B cell activation and
germinal centre formation by producing IL-4 and IL-21. Their differentiation
is driven by IL-6/STAT3 and IL-21/STAT1/360.
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Adapted from Schulz E.G., Mariani L., Radbruch A. and Ho¨fer T.
Sequential polarisation and imprinting of type 1 T helper lymphocytes by interferon-χ and
interleukin-12.
Immunity 30(5), 673-683, May (2009).
Figure 1.1: Subtypes of CD4+ T cells
Stability and plasticity of Th cell lineages
Antagonistic relationships between the different Th cell lineages have often been
observed. The master transcription factor of Treg cells, Foxp3, is known to
repress the master transcription factor of Th17 cell, RORχt61; conversely, the
Th17-polarising cytokine IL-6 represses Foxp3 expression62. Foxp3 expression
is also repressed by both T-bet and GATA-3 in Th1 and Th2 cells63, while IFN-χ
signalling in Th1 cells and IL-4 signalling in Th2 cells inhibit Th17 differenti-
ation64,65. The Th1 and Th2 gene networks contain several mutually repressive
mechanisms discussed in detail below. Those discoveries lead to the belief that T
helper cells make a clear lineage decision during primary activation and cannot
be reprogrammed to express factors belonging to distinct lineages, even though
co-expression of IFN-χ and IL-4 was observed early after the description of the
Th1 and Th2 lineages66,67.
In recent years, many discoveries have been made concerning T cell plasticity68,
showing that differentiated cells can be reprogrammed to co-express factors from
different lineages and challenging the hitherto accepted paradigm of a unique,
lineage-defining transcription factor expression69. Virus-specific Th2 cells can
up-regulate both T-bet and IFN-χ without losing their Th2 characteristics upon
viral infection70; similarly, both Th1 and Th17 cells are able to express IL-4 upon
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helminth infections71. The Th17 phenotype shows particularly high plasticity, as
it can acquire Th1 and Th2 features72,73,74,71,75 as well as be combined to Treg cell
characteristics76,77,78. The finding that many mutually repressive factors can be
stably co-expressed in a single cell still needs to be investigated. The fact that the
cells are plastic (i.e., able to adopt some phenotypic characteristic not belonging to
their lineage after differentiation) does not mean that they are not stable; indeed,
with the exception of Treg cells being converted to pathogenic Th17 cells79, all
other lineages retain the expression of their original master transcription factors
and cytokines, although not necessarily in the same amount. This plasticity allows
for a better tuning of the immune response and is, in most cases, beneficial.
1.1.4 Th1, Th2 and hybrid Th1/2 cells: co-existence, mutual in-
hibition and auto-activation
Th1 and Th2 cells are the most abundant subtypes of T helper cells and were the
first described T helper phenotypes80. Th1 and Th2 cells have distinct activation
histories, gene expression profiles and functions. As such, the molecular network
underlying their differentiation and maintenance are well-studied, It has long
been postulated that the Th1 and Th2 programs were mutually exclusive81,68,
mainly because most studies of Th cells focused on one type of stimulus during
differentiation. Furthermore, mutually inhibitory mechanisms between Th1- and
Th2-specific factors have been described. However, it has recently been shown
that stable cells with a mixed Th1/Th2 phenotype70,82, expressing both T-bet and
GATA-3 as well as Th1 and Th2 cytokines, can be generated both in vivo and in vitro.
This type of cell can be obtained through viral infection of mice after the transfer of
virus-specific Th2 cells70, cells that then start up-regulating T-bet and co-produce
IL-4 and IFN-γ while maintaining their GATA-3 expression. T-bet+GATA-3+ cells
can also be found in mice after parasite infection with H. polygyrus82. In vitro,
T-bet+GATA-3+ cells are obtained when naive cells are activated in the presence
of the polarising cytokines IFN-γ, IL-12 and IL-482,83,84. Furthermore, it was shown
that a continuum of hybrid states existed between high T-bet expressing Th1
cells and high GATA-3 expressing Th2 cells, depending on the concentration and
combination of cytokines present during primary differentiation83,84.
Th1 cells
Th1 cells mediate type-1 immunity and are defined by the expression of the master
transcription factor T-bet46. The secretion of IFN-γ as well as high amounts of
Tumor necrosis factor (TNF)-α stimulate macrophage, while the expression of the
chemokine receptors CXCR3 and CCR585,86 leads them to sites of bacterial and
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Figure 1.2: Canonical signalling pathways of the cytokines IL-4, IL-12 and IFN-γ.
viral infections where their respective ligands CXCL9 and CXCL1087, and MIP-1α,
MIP-1β and RANTES88 are expressed89,90.
The gene network underlying Th1 differentiation and maintenance is not fully
known, although several mechanisms are well-described. It involves several
positive feedback loops on T-bet and cytokine genes that induce and maintain
the Th1 phenotype and the expression of T-bet. Differentiation of naive cells into
Th1 cells occurs when naive Th cells are in an IL-4-free environment and in the
presence of IL-1291,92 and IFN-γ 93,94 and happens in several steps. First, IFN-γ,
produced by other neighbouring cells or, in the absence of IL-4, stochastically
by the naive Th cells upon TCR stimulus, will induce the Tbx21 gene via STAT1
signalling; T-bet will then up-regulate the expression of both IFN-γ 46 and IL-
12Rβ2, which is part of the IL-12 receptor95. This renders the cells responsive to
IL-12 signalling. Then, external IL-12 can further up-regulate T-bet and IFN-γ in
IL-12 responsive cells via STAT4 signalling96, leading to full Th1 differentiation.
Thus, even though T-bet is sufficient to drive IFN-γ expression, Th1 differentiation
also relies on both STAT1 and STAT4. Furthermore, T-bet co-operates with several
other transcription factors to regulate IFN-γ expression via epigenetic changes at
the Ifng locus, among which Eomesodermin97, Runt-related transcription factor
(Runx)398,97, H2.0-like homeobox protein (Hlx)99 and E26 transformation-specific
(Ets) transcription factors100,101.
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There are thus several cytokine-dependent positive feedback loops on T-bet
expression: via IFN-γ signalling, which up-regulates T-bet via STAT1, as well
as via IL-12 signalling through the up-regulation of the IL-12 receptor. A more
direct feedback loop on T-bet might be achieved through the transcription factor
Onecut2, which might be up-regulated by T-bet and might, in turn, enhance T-bet
transcription102, as well as directly by T-bet itself through auto-activation95,103.
Th2 cells
Th2 cells mediate type-2 immunity and are defined by the high expression of the
transcription factor GATA-347. They secrete the signature cytokines IL-4, IL-13
and IL-5 which are involved in class switching of B cells to IgG1 and IgE104,105 as
well as alternative activation of macrophages106. The expression of the chemokine
receptor CCR486 leads them to sites of type-2 inflammation107.
The Th2 differentiation network also involves positive feedback loops on
GATA-3, allowing its long-term expression. Th2 cells arise when IL-4 is present
and IFN-γ and IL-12 are absent during primary activation of naive Th cells; IL-4
signalling occurs via STAT6 and up-regulates GATA-3 expression108,109. GATA-3
in turn stimulates the expression of IL-4 by the Th2 cell itself110,111 in concert
with IL-2-activated STAT5108,112,113, as well as its own expression. Other tran-
scription factors are Th2-specific and involved in cytokine regulation; c-Maf and
JunB promote IL-4 expression114,115,116. Th2 differentiation could also be induced
independently of IL-4 through T Cell Factor 1 (TCF-1), which is induced by TCR
signalling and activates GATA-359. Thus, as is the case for T-bet in Th1 cells,
GATA-3 depends on several other transcription factors to orchestrate full Th2
differentiation, most importantly STAT6.
In this way, GATA-3 expression is amplified in various fashions: it trans-
activates its gene, thereby directly maintaining its own expression117,118, and in-
duces IL-4 expression which in turn enhances GATA-3 expression via STAT6108,109,110,111.
Another feedback loop could be via Dec2 during Th2 differentiation: Dec2 is in-
duced by GATA-3 and induces IL-4, IL-5 and IL-1348,119,120.
Mutual inhibition of the Th1 and Th2 pathways
The full range of interactions between the two gene networks is still unclear. GATA-
3 is known to down-regulate STAT4121 and IL-12Rβ2122, which are important parts
of the Th1 gene network, and to silence the T-bet locus123. Furthermore, GATA-3
has also been reported to silence the IFN-γ locus124,123 and to block IFN-γ induction
by Runx3 and Eomes97. c-Maf and TCF-1 are also thought to down-regulates IFN-
γ in Th2 cells114,59. The transcription factor Ikaros also silences T-bet and IFN-γ in
Th2 cells125,126.
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Conversly, T-bet has been reported to bind GATA-3 and repress its transcrip-
tion factor activity (thereby possibly also its auto-activation)127. STAT4 has also
been shown to suppress GATA-3 expression, although, as the study predates
the discovery of T-bet, it is not clear if the effect is T-bet-mediated or direct122.
IFN-γ signalling has been linked to a reduced IL-4 expression128,129. Another Th1
transcription factor, Runx3, could cooperate with T-bet to silence IL-4 (as well as
enhance IFN-γ), and also interacts with GATA-3 to attenuate the Th2 phenotype
in Th1 cells130,98,131. Lymphoid enhancer-binding factor (LEF)1 is expressed in Th1
but not Th2 cells and seems to down-regulate IL-4 in Th1 cells132. Furthermore,
TCR-mediated signalling, present during both Th1 and Th2 differentiation, has
been reported to bias differentiation depending on its strength and duration: while
weak signals were associated with Th2 differentiation, stronger stimulation was
linked with Th1 differentiation133,134,135,136.
Models of Th1 and Th2 regulatory gene networks
Network inference is the reconstruction of biological networks based on large
datasets; inference is typically done using high-throughput data. State-of-the-
art methods for network inference include machine learning and pattern clas-
sification as well as probabilistic methods137,138,139. Several studies have used
high-throughput data to unravel the network underlying Th cell differentiation,
including Th1-Th2 plasticity140, Th17 differentiation141,142,143, discovery of master
regulators144, identification of genes regulated by polarising cytokines145 and in-
volved in Th1/Th2 differentiation146,147, comparison of Th cell subsets expression
profiles148, epigenetic patterns149 as well as DNA binding of GATA-3 and STAT
proteins123,150. The role of STAT6 during Th2 differentiation was studied using
RNAi and ChIP sequencing151. Network inference allows to describe network
topologies that can be used for dynamical modelling.
Dynamical mathematical modelling is a way of describing the dynamics of
real phenomena (physical systems, biological interactions, ecological problems or
economic situations, for example) by equations representing the different players
and their interactions in the modelled system. It can describe exact mechanics
and dynamics of a system. Specifically, biological modelling allows to simulate
the behaviour of biological systems in order to reproduce experimental data,
thereby confirming or excluding mechanisms leading to the observed phenotypes
or reconstructing gene regulatory networks. It can also be used to predict the
behaviour of a biological system under certain conditions, for example the knock-
out of genes in a regulatory network, to discover new mechanisms and new roles
for these mechanisms.
Several mathematical models of Th cell regulatory networks, and specifically
Th1 and Th2 networks, can be found in the literature152. Suppression of one
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phenotype by the other was present in an early model in the form of competition
for antigenic stimulation and cross-suppression by cytokines153. Later models
model the expression of the master transcription factors T-bet and GATA-3; T-bet
expression has been modelled by E. Schulz et al.96 considering IL-12Rβ2, T-bet and
IFN-γ. In this model, TCR signalling activates T-bet, which in turns promote the
expression of IFN-γ and IL-12Rβ2, the latest being repressed by TCR signalling at
the beginning of differentiation. IFN-γ then enhances T-bet expression via STAT1;
later on, IL-12 signalling via STAT4 enhances T-bet expression, but also IFN-γ
expression. The crosstalk between IL-12, IFN-γ and TNF-α has been investigated
using a Th1 cell model154. GATA-3 expression and regulation has been modelled
by T. Ho¨fer et al.155 and L. Mariani et al.156. In these models, GATA-3 is induced by
STAT6 signalling and trans-activates its own gene; interleukins are not included.
In T. Ho¨fer et al.’s model, several processing steps between mRNA and protein are
included, whereas L. Mariani et al.’s model uses only one translation step. Both
models generate a bistable behaviour for GATA-3 protein expression.
Simple models of interactions between T-bet and GATA-3 (and so the Th1
and Th2 networks) have also been published157,158; they include auto-activation
loops and mutual repression between GATA-3 and T-bet. In one model, polarising
cytokines are included as parameters157, and are not present in the other model158.
A complex model aiming at explaining the principal constituents of the regulatory
networks in terms of cytokines, cytokine receptors and transcription factors has
also been published159; however, this model is not data-based. Furthermore,
models including other Th cell phenotypes like Treg and Th17 cells have been
developed to study Th cell differentiation160,161,162,163. All of these models are
based on the assumption that T-bet and GATA-3 are mutually exclusive, so that
none of them account for co-expression of T-bet and GATA-3 or explain the signal
integration process by the cells when several distinct cytokines are present during
differentiation, even though one model accounts for Treg/Th17 plasticity163.
Following the numerous descriptions of Th cell plasticity, models studying
this process have been developed. A logical, non-data-based model predicted the
four stable Th1, Th2, Th17 and Treg states as well as transient hybrid states164.
The combination of microarray human gene data and large gene network ana-
lysis allowed the development of a gene regulatory network describing a stable
Th1/Th2 hybrid state extending beyond T-bet and GATA-3140. This model did
not, however, explain quantitative differences but only represented the genes as
active or inactive. The plasticity of the different Th subsets has been investigated
using a logical model, making predictions about possible hybrid cell types not yet
described165.
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1.2 Aim of the study
This study focuses on Th1 and Th2 cells, the most abundant T helper cell subtypes,
as well as hybrid Th1/2 cells. More precisely, we will focus on the molecular
regulation of their differentiation programs.
Dysregulations of the T helper cell immune response are involved in several hu-
man diseases. Th1 cells are linked to autoimmune diseases such as type-1 diabetes
and rheumatoid arthritis166,167 and to chronic inflammation168, while Th2 response
imbalance is involved in allergic reactions such as asthma169 or antibody-linked
autoimmune diseases such as lupus170. It is therefore important to understand the
mechanisms underlying Th cell differentiation, memory, phenotype maintenance
as well as the interactions between differentiation programs that allow a well-
tuned immune response. Furthermore, Th cells are a well-established model of
cell fate decision and lineage commitment in biology, so that understanding their
differentiation pathways and maintenance mechanisms may provide a blueprint
for understanding many other biological phenomena. Indeed, the concept of
master regulators extends beyond the immune system and is pivotal in the study
of lineage decision-making (e.g, in stem cell and cancer biology).
The goal of this project is to get an insight into the gene networks underlying
Th1, Th2 and hybrid Th1/2 cell differentiation, more precisely the regulation of
the master transcription factors T-bet and GATA-3, which govern the functional
activity of Th1 and Th2 cells, respectively. Through experimental work and data-
based mathematical modelling, the regulatory mechanisms leading to T-bet and
GATA-3 expression patterns will be analysed in order to answer the following
questions:
• Can a methodology be developed to reconstruct gene regulatory networks
based on straightforward experiments and basic knowledge of the network’s
hierarchy?
• How does a cell integrate several differentiating signals to decide its pheno-
type?
• How do the Th1 and the Th2 lineage-specific and signature genes influence
each other during differentiation?
• What determines the amplitude of the functional response in differentiated
cells?
1.3 Methodology
In this section, we present the general experimental and computational approach
we used to address the questions at the centre of this study. Detailed protocols are
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Figure 1.3: Experimental protocol. a Freshly ex vivo isolated naive CD4+ T cells were cultured for five
days with antigen presenting cells, antigen, IL-2, polarising cytokines and blocking antibodies. pSTATs,
total STATs, T-bet and GATA-3 were measured by flow cytometry on a daily basis, and the cytokine
production after restimulation was quantified on day 5. b The three main Th1 and Th2 skewing cytokines
IFN-χ, IL-12 and IL-4 were titrated in naive CD4 T cell cultures in the absence and/or presence of the
other two cytokines.
described in the Materials and Methods section. We used a combination of highly
quantitative experiments, linear regression analysis and dynamical modelling to
unravel the cytokine network underlying Th1 and Th2 differentiation.
Experimental setup
To obtain an integrated picture of signalling and gene expression during Th1 and
Th2 cell differentiation, we differentiated freshly ex vivo isolated, FACSorted naive
CD4+ LCMV-TCRtg T cells in the presence of cognate antigen stimulus (in form of
GP64(61≻80) peptide), the growth factor IL-2 and the instructive cytokines IFN-χ,
IL-12 and/or IL-4 (Figure 1.3). We call cells generated with IFN-χ and/or IL-12 and
anti-IL-4 ‘Th1’; cells generated with IFN-χ and/or IL-12 and IL-4 ‘hybrid Th1/2’
and cells generated with anti-IFN-χ, anti-IL-12 and IL-4 ‘Th2’. We measured
the phosphorylation levels of the three main signal transducers downstream
of the instructive cytokines (STAT1, STAT4 and STAT6) as well as their total
protein levels and those of the master transcription factors T-bet and GATA-3 by
flow cytometry on a daily basis up to day 5 of differentiation. To characterise
the functional phenotype of the cells after differentiation, we re-stimulated the
cells in the absence of instructive cytokines with PMA/ionomycin, mimicking a
strong antigen stimulus, and measured the production of key cytokines by flow
cytometry after intracellular cytokine staining. We thus obtained quantitative
information on signal transduction and transcription factor expression from early
to late differentiation as well as a functional read-out in differentiated cells.
To investigate how the cells respond to a broad range of mixed cytokine
stimuli, in particular how different combinations and amounts of IFN-χ, IL-12
and IL-4 influence master transcription factor expression, we titrated each one
of the three cytokines (e.g., IFN-χ) in the presence or absence of one or both
of the other cytokines (e.g., IL-12, IL-4) (Figure 1.3b). The titration steps were
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chosen empirically as to induce different levels of T-bet and/or GATA-3 upon
differentiation. This resulted in a total of twelve groups of titrations, with 48
different cytokine combinations each evaluated at five time points (a list of all
conditions used is available in Supplementary Table 7.1). Th cells do not produce
IL-12, but may produce IFN-γ or IL-12; to ensure that the amounts of polarising
cytokines in the culture medium were strictly controlled and that the results were
not confounded by IFN-γ or IL-4 produced by the Th cells themselves during
the culture, we used Ifng-/- T cells as well as blocking antibodies to IL-4 in the
Th1 conditions for the IFN-γ and IL-12 titrations. Similarly, we used Il4-/- cells
and blocking antibodies to IFN-γ in the Th2 conditions for the IL-4 titrations.
Furthermore, we used cells deficient in both IL-12 and IFN-γ as antigen-presenting
cells (no significant amount of IL-4 is produced by the APCs used in this setup).
Thus, the levels of polarising cytokines are determined externally.
The data generated with these time-resolved titration experiments was ana-
lysed to reconstruct the regulatory network through which master transcription
factors are regulated by the STATs and each other, but also through which the
STATs themselves and cytokine expression are regulated.
Computational analysis
The experimental part of this project generated a large amount of data: eight
proteins were measured at five different time points in 48 different conditions.
Although a first visual analysis of the data put several mechanisms in evidence,
it soon became clear that the number of regulatory interactions involved made
an unambiguous interpretation of the origin of the observed effects difficult. To
systematically analyse this titration data and derive a general topology of the
signalling network underlying Th1 and Th2 differentiation, we used a series of
linear regression models describing how a layer of regulators (e.g., cytokines or
pSTATs) controls a corresponding layer of regulatees (e.g., pSTATs or transcription
factors, respectively):
regulateei = α0 +
∑
j
αj · regulatorj
with all combinations of j for each i.
We thus obtained families of linear models describing the amount of each protein
quantified during the titration experiments in function of the polarising cytokines
used during the cell cultures. Model comparison using goodness of fit measures
(R2 and Akaike information criterion (AIC)) quantified the correlations between
the factors measured. Furthermore, we used the time-resolved data to gain in-
formation about the kinetics of regulation by taking the amount of regulators at
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previous time points into account to explain the amount of regulators at a given
moment, i.e., a weighted sum of the expression of the regulators over time was
used to explain the expression of the regulatee at each time point. Repetition of
this analysis for each time point and each layer considered, i.e., STAT phosphoryla-
tion by the cytokines, transcription factors expression regulation by the activated
STATs and the master transcription factors, and cytokine expression regulation by
T-bet and GATA-3 allowed us to determine the most probable complete network
of interactions at each time point.
Linear models can describe the general topology of a network, but usually
cannot capture its dynamics. Furthermore, a linear model allows only linear in-
teractions between one layer of regulators and one of regulatees, and thus cannot
describe feedback loops such as auto-activation. To further study those points
and test the network topology against time-resolved data, we designed a dy-
namical, ordinary-differential-equations (ODE)-based model derived from the
linear-regression network topology. This model was used to reproduce the kinet-
ics of phosphorylation and/or up-regulation of the transcription factors STAT1,
STAT4, STAT6, T-bet and GATA-3, to predict the response of the system to gradi-
ents of polarising cytokines, and to study the relative effect of the phosphorylated
STAT and MTF proteins on the final phenotype of the Th cells.
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Th1 and Th2 cells are the most abundant subtypes among T helper cells, which
are part of cellular adaptive immunity and are responsible for coordinating the
adaptive immune response via cytokine secretion. Th1 cells are characterised
by the expression of the master transcription factor T-bet, which is up-regulated
by IFN-γ/STAT1 and IL-12/STAT4 signalling and leads to IFN-γ secretion,
while Th2 cells are characterised by high expression of the master transcription
factor GATA-3, which is up-regulated by IL-4/STAT6 signalling and leads to
IL-4 secretion. Although the Th1 and Th2 lineages have long been thought to
exclude one another due to several mutually repressive mechanisms involving
their master transcription factors, hybrid Th1/2 cells have recently been shown
to arise and remain stable in vivo. This works aims at understanding how mixed
cytokine signals are integrated during Th cell differentiation and how they
influence master transcription factor expression and lineage decision, using
quantitative time-resolved experiments followed by computational analysis in
form of linear regression and dynamical mathematical modelling.
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Figure 1.4: Methodology.

Chapter 2
Experimental results
Th1 differentiation occurs when IFN-γ and IL-12 up-regulate T-bet expression
via STAT1 and STAT4 signalling, respectively93,94,91,92, while Th2 differentiation
requires GATA-3 up-regulation following STAT6 signalling108,109. Hybrid Th1/2
cells arise when all three signalling pathways are activated simultaneously, leading
to the up-regulation of T-bet and GATA-382,83,84. Both Th1 and Th2 differentiation
have been studied extensively under conditions which elicit one or the other
response. However, the molecular network that mediates the responses of naive T
helper cells to gradients and combinations of cytokines remains poorly understood.
This chapter describes the qualitative changes occurring during differentiation in
response to distinct cytokine amounts and combinations at three levels (Figure
2.1): the phosphorylation of the STATs, the protein expression of T-bet, GATA-
3, STAT1, STAT4 and STAT6, and the cytokine production by the differentiated
Th cells upon restimulation. We start by studying the kinetics of expression
and phosphorylation in ‘classical’ conditions, i.e., Th1, Th2 and hybrid Th1/2
with fixed cytokine concentrations, in order to determine how the polarising
cytokines used in standard in vitro setups affect the expression and activity of
various regulators. We then go on to qualitatively analyse the dose-response of
the transcription factors to the cytokines IFN-γ, IL-12 and IL-4 and their response
to different cytokine combinations.
Cytokine stimuli
IFN-γ, IL-12, IL-4
TF expression
T-bet, GATA-3
STAT1, STAT4, STAT6
STAT phosphorylation
pSTAT1, pSTAT4, pSTAT6
Cytokine production
IFN-γ , IL-4, ...
Figure 2.1: Sequential levels of response to cytokine stimuli during differentiation.
28 2. Experimental results
20 60 100
20
60
100
T-bet
GA
TA
-3
 Ifng-/-, IFN-γ titration
Ifng-/-, IL-12 titration
Il4-/-, IL-4 titration
Figure 2.2: Quantitative differences in cytokine concentrations are reflected on the MTF expression.
A continuum of T-bet-GATA-3 co-expression patterns was generated on day 4 in response to the titrated
cytokines, normalised geometric mean indices for all conditions are shown.
2.1 STAT, master transcription factor and cytokine ex-
pressions are dynamically regulated in Th1, Th2
and Th1/2 hybrid cells
Previous work has shown that Th1 versus Th2 differentiation is driven by the
cytokines IL-1291,92 and IFN-γ 93,94 versus IL-4108,109, acting through their canonical
Jak-STAT pathways (STAT1 for IFN-γ 171,172, STAT4 for IL-12173,174, and STAT6 for
IL-4175,176) to up-regulate T-bet versus GATA-3; these studies have focused on
either Th1-polarising or Th2-polarising stimuli. However, T-bet and GATA-3 were
recently shown to be co-expressed in a gradual manner in response to increasing
amounts of cytokines83,84. This co-expression was accompanied by the capacity
to express both Th1 and Th2 cytokines as well as the simultaneous activation of
STAT1, STAT4 and STAT682. Furthermore, quantification of T-bet and GATA-3
protein amounts after differentiation showed that Th cells can adopt a continuum
of T-bet and GATA-3 co-expression levels after primary differentiation, and that
most cytokine combinations actually generated hybrid Th1/2 cells with T-bet and
GATA-3 co-expression (Figure 2.2 and Reference 83). These findings raised the
question of how differences in amounts of polarising cytokines are integrated by a
T helper cell so that they are reflected in the expression of the master transcription
factors and signature cytokines.
We reasoned that for quantitative differences in cytokine amounts to be reflec-
ted on the transcription factor expression level, the strength and/or duration of
signalling downstream of the cytokines must also vary depending on the input
stimuli, which motivated us to study the relation between the amount of phos-
phorylated STAT and master transcription factor. As a matter of fact, we observed
that, for a definite cytokine stimulus, the amount of active signal transducers cor-
related to the amount of target master transcription factor (Figure 2.3): co-staining
pSTAT4 and T-bet or pSTAT6 and GATA-3 in Th1 cells differentiated for 72 hours
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Figure 2.3: Quantitative differences in MTF expression correlates to the amounts of pSTAT. T-bet and
pSTAT4, and GATA-3 and pSTAT6 were co-stained in Th1 and Th2 cells after 72 hours of differentiation.
with IL-12 and IFN-γ and in Th2 cells differentiated for 72 hours with IL-4 showed
that the cells with the highest master transcription factor expression also had the
highest corresponding pSTAT amounts. The stainings for pSTAT4 in Th2 cells and
pSTAT6 in Th1 cells can be interpreted as negative even though they are higher
than the isotype control; this is a technical artefact due to the staining protocol.
Indeed, in order to obtain a good co-staining of the master transcription factors
and the pSTAT proteins, BD Phosflow buffers were used as in a total STAT/pSTAT
co-staining (see subsection 6.1.2 on page 111), but the last washing step after
staining was omitted, causing an increase in pSTAT intensity compared to the
standard staining method using which the isotype control was calibrated.
We thus proceeded to quantify the phosphorylation and up-regulation kinetics
of the main players in the known signalling cascades involved in Th1 and Th2
differentiation: pSTAT1, pSTAT4 and pSTAT6, T-bet and GATA-3, as well as the
total STAT1, STAT4 and STAT6 proteins, in order to see if and how different
cytokine combinations affected the amount and dynamics of those transcription
factors. Given that T-bet and GATA-3 orchestrate the functional Th cell response,
we also measured the production of effector cytokines after TCR restimulation at
the end of differentiation. Kinetics and representative flow cytometry stainings in
Th1, Th2 and Th1/2 hybrid cells are shown in Figure 2.4.
The phosphorylated STATs constitute the first level of the intracellular response
we quantified. The canonical STATs downstream of the polarising cytokines, i.e.,
STAT1 downstream of IFN-γ, STAT4 downstream of IL-12 and STAT6 downstream
of IL-4, were phosphorylated with a unimodal distribution in the cell population;
the left panel of Figure 2.4a shows the phosphorylation on day 2 of culture (day 2
was chosen due to the fact that Th cells are responsive to all three cytokine at this
time point). This phosphorylation pattern allowed us to use the geometric mean
index (GMI, see subsection 6.2.1 on page 112 for a description of the normalisation
procedure) of the staining, a population average, for further quantitative analyses.
Phosphorylation lasted long with still marked amount of pSTAT4 and pSTAT6 on
30 2. Experimental results
day 5. Maximal phosphorylation levels were reached on day 3 for pSTAT1 and
pSTAT6 and on day 4 for pSTAT4 (Figure 2.4a, right panel).
The master transcription factors T-bet and GATA-3 were expressed with a
unimodal distribution within the Th1, Th2 and hybrid Th1/2 populations (Fig-
ure 2.4b, left panel), allowing the use of the geometric mean index for further
analysis. Up-regulation started already at day 2 of differentiation, before extensive
cell division occurred; the up-regulation of transcription was visible even earlier
(day 1; Supplementary Figure 7.3a,b). The combination of IL-4, IL-12 and IFN-γ
gave rise to hybrid Th1/2 cells, with co-expression of T-bet and GATA-3 in indi-
vidual cells albeit at somewhat lower levels than in Th1 and Th2 cells, respectively
(shown in purple in Figure 2.4b and from here on), rather than distinct Th1 (shown
in blue) or Th2 (shown in red) phenotypes. The simultaneous presence of Th1 and
Th2 cytokines affected the expression level of the master transcription factors, but
not the kinetics of their up-regulation.
We found that the expression levels of all three STATs were also dynamically
and differentially regulated depending on the cytokine milieu; indeed, clear differ-
ences in the expression levels could be observed already on day 1 for STAT1 and
on day 2 for STAT4 and STAT6. STAT1 and STAT4 were up-regulated in Th1 and
hybrid Th1/2 cells whereas STAT6 expression was augmented in Th2 and hybrid
Th1/2 cells (Figure 2.4c); these changes were also seen at the RNA level for STAT1
and STAT4 (Supplementary Figure 7.3c,d). The unimodal expression of those five
transcription factors allowed us to use the geometric mean index of the stainings
for the quantification of their expression.
In contrast to the uniform regulation of transcription factor expression, the
cytokine recall response showed the typical separation of the population into
responders and non-responders177,178, with a fraction of hybrid Th1/2 cells pro-
ducing both IFN-γ and IL-4 (Figure 2.4d). Therefore, we quantified cytokine
production using the fraction of producing cells and not the geometric mean.
The observed prolonged phosphorylation of the STATs as well as the changes
in their expression levels point to an underlying dynamic regulatory network
that evolves on a timescale of days, stimulating a careful kinetic analysis of the
changes occurring during differentiation. In the next sections, we thus study the
dose response of the pSTATs and transcription factors amounts to cytokines in a
time-resolved manner.
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STAT1, STAT4 and STAT6 were phosphorylated with a unimodal distribution
during up to five days in the presence of their canonical cytokines IFN-γ, IL-12
and IL-4, respectively. The expression of the master transcription factors and
the STATs was dynamically and differentially regulated during Th1, Th2 and
hybrid Th1/2 differentiation. The Th1 factors T-bet, STAT1 and STAT4 were
highly expressed in Th1 cell, intermediate in hybrid Th1/2 cells and low in Th2
cells. The Th2 factors GATA-3 and STAT6 showed the inverse behavior.
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Figure 2.4: pSTATs, MTFs and STATs are up-regulated in a unimodal and cytokine-specific manner
during primary differentiation. a pSTAT1, pSTAT4 and pSTAT6 were measured on a daily basis by flow
cytometry. Left panel: left: pSTAT1 in response to IFN-γ on day 2; middle: pSTAT4 in response to IL-12 on
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2.2 STAT activation is dose-dependent, long-lasting
and happens outside of the canonical pathways
In the previous section, we showed that STAT4 phosphorylation correlated posit-
ively with T-bet expression, and STAT6 phosphorylation with GATA-3 expression,
at the single cell level. Furthermore, a unimodal and long-lasting phosphorylation
of STAT1, STAT4 and STAT6 in response to IFN-γ, IL-12 and IL-4, respectively,
was observed. In order to understand how adverse signals, like IFN-γ and IL-4 or
IL-12 and IL-4, are integrated by the the cells during hybrid Th1/2 differentiation
as well as how quantitative differences in cytokine concentrations are translated
into graded master transcription factor expression, we asked how the presence
of multiple and particularly mixed Th1-Th2 stimuli affects the way cytokines act
on each STAT pathway. To this end, we measured the phosphorylation of the
three relevant STATs during a 5-day time course in ex vivo isolated naive murine
CD4 T cells, carrying an LCMV-specific T cell receptor, in the presence of antigen-
presenting cells loaded with cognate antigen and different mixtures of cytokines
to induce differentiation into Th1, Th2 or hybrid cells. We titrated each cytokine
(e.g., IFN-γ) in the presence and absence of one or both of the other cytokines
(e.g., IL-12, IL-4) and examined the response of each STAT to all three cytokines.
Although we focused on the dose-response of the canonical pSTAT downstream
of each cytokine in the following sections, all three pSTATs were measured and
analysed during each titration experiment; the data is not shown here to avoid
unnecessary redundancy.
We start by analysing STAT1 phosphorylation in response to an IFN-γ titration,
as IFN-γ induces the phosphorylation of STAT1171,172. To examine the response
of pSTAT1 to different doses of IFN-γ in combination with other cytokines, we
performed a 5-step titration of IFN-γ (i.e., no IFN-γ, 0.003, 0.03, 0.3 and 3 ng/ml
of IFN-γ) in the presence of 5 ng/ml IL-12, 10 ng/ml IL-4, both of them, and
none of them. Representative flow cytometry stainings for selected conditions
on day 2 and the whole normalised dataset for pSTAT1 are shown in the form of
GMI time courses in Figure 2.5. The different IFN-γ concentrations led to graded
pSTAT1 elevations in both Th1 and hybrid conditions, but did not influence the
duration of phosphorylation (Figure 2.5): no pSTAT1 was detected on day 5 in
Th1 cells, no matter what the initial IFN-γ concentration was, and little in hybrid
cells. Little effect of the two smaller concentrations could be observed, with
only a small increase compared to the condition without IFN-γ on days 3 and
4. Furthermore, IL-12 and IL-4 also influenced STAT1 phosphorylation. Indeed,
comparing the left and right columns in Figure 2.5b, we see an increase in pSTAT1
in the presence of IL-12. Interestingly, the presence of the Th2 cytokine IL-4 did
not reduce the amount of pSTAT1; on the contrary, the latter seemed to increase in
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Figure 2.5: pSTAT1 is phosphorylated gradually in response to titrated IFN-γ. a pSTAT1 stainings
on day 2 of culture with increasing amount of IFN-γ. b Time courses of STAT1 phosphorylation with
increasing amounts of IFN-γ with IL-12 (left) or without IL-12 (right), anti-IL-4 (top) or IL-4 (bottom).
the presence of IL-4 (compare top and bottom rows in Figure 2.5b and the positive
staining without addition of IFN-γ in the lower panel of Figure 2.5a). Both those
effects could also be observed by measuring pSTAT1 in response to IL-12 and IL-4
titrations.
To study how STAT4 phosphorylation was induced by IL-12173,174 and other
cytokines, we performed a 4-step titration of IL-12 (i.e., no IL-12, 0.5, 1.5 and 45
ng/ml IL-12) in the presence of 10 ng/ml IFN-γ, 10 ng/ml IL-4, both and none
of them, similarly to what was done with IFN-γ. Representative flow cytometry
stainings on day 2 and the whole dataset for pSTAT4 in form of GMI time courses
are shown in Figure 2.6. Similarly to STAT1 downstream of IFN-γ, the amount of
pSTAT4 per cell increased gradually in response to IL-12, most notably so from
day 3 on; indeed, the differences in pSTAT4 intensity were small until the peak
of phosphorylation was reached. However, the period during which STAT4 was
phosphorylated also depended on IL-12: the more IL-12, the longer pSTAT4 could
be detected by flow cytometry: no phosphorylation was measured on day 5 with
the smaller IL-12 concentrations, while its level were nearly equal to the peak
levels with the highest concentration in Th1 conditions. Comparing the left and
right columns in Figure 2.6b, we see that the pSTAT4 levels are globally lower in
the absence of IFN-γ. IL-4 seemed to have two distinct effects: it increased the
intensity at the peak phosphorylation on day 3, but decreased it on later days
(compare upper and lower panels).
STAT6 is known to be phosphorylated downstream of IL-4175,176. We studied
its response to IL-4, IL-12 and IFN-γ using the same protocol used for pSTAT1
and pSTAT4: we titrated IL-4 in 4 steps (no IL-4, 0.5, 5 and 50 ng/ml IL-4) in the
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Figure 2.6: pSTAT4 is phosphorylated gradually in response to titrated IL-12. a pSTAT4 stainings
on day 2 of culture with increasing amount of IL-12. b Time courses of STAT4 phosphorylation with
increasing amounts of IL-12 with IFN-γ (left) or without IFN-γ (right), anti-IL-4 (top) or IL-4 (bottom).
presence and absence of 5 ng/ml IL-12 and/or 10 ng/ml IFN-γ and quantified
pSTAT6 every day. Representative data from day 2 and the kinetics of pSTAT6
GMI in all the conditions are shown in Figure 2.7. STAT6 was phosphorylated
in a graded manner in response to IL-4 in all the conditions observed, with clear
differences visible from day 1 up to day 5. As is the case for pSTAT4 downstream
of IL-12, phosphorylation of pSTAT6 could still be measured on day 5 when
high IL-4 concentrations were used. The presence of IL-12 and IFN-γ did not
induce significant changes in the pSTAT6 intensities, but peak phosphorylation
was reached earlier, on day 2 rather than day 3, in the presence of IL-12 (compare
upper and lower rows of Figure 2.7b).
The amplitude of the pSTAT signals increased with the concentration of the
corresponding canonical cytokines. However, the presence of other cytokines
also affected signalling: IL-4 increased the peak levels of pSTAT1 and pSTAT4
in response to IFN-γ and IL-12, but also caused lower pSTAT4 on day 4 and 5.
IL-12 augmented the pSTAT1 levels in addition to increasing the pSTAT4 levels.
Importantly, this data indicates that cytokines additional to the canonical ones
induce and modulate STAT phosphorylation.
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Figure 2.7: pSTAT6 is phosphorylated gradually in response to titrated IL-4. a pSTAT6 stainings on
day 2 of culture with increasing amount of IL-4. b Time courses of STAT6 phosphorylation with increasing
amounts of IL-4 with IL-12 (bottom) or without IL-12 (top), IFN-γ (right) or anti-FN-γ (left).
2.3 Transcription factor expression is regulated both
positively and negatively in a dose-dependent man-
ner downstream of polarising cytokines
We focus on five of the transcription factors involved in Th cell differentiation
and function that are critical for both lineage decision and cytokine expression
regulation. The master transcription factors T-bet (expressed in Th1 cells46) and
GATA-3 (highly expressed in Th2 cells47) are both necessary and sufficient for
determining the gene expression profile of differentiated Th cells. STAT proteins, in
particular STAT1, STAT4 and STAT6, are essential parts of the signalling pathways
controlling T-bet and GATA-3 expression40. In the previous sections, we showed
that all five proteins were differentially regulated in Th1, Th2 and hybrid Th1/2
cells during primary differentiation and that the upstream pSTAT phosphorylation
was dose-dependent and influenced by cytokines within and outside of their
canonical pathways. Here, we concentrate on the effect the same cytokines exert
on the expression levels of those five transcription factors using titrations as
described previously.
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2.3.1 T-bet and GATA-3 can be regulated in a synergistic man-
ner by several cytokines and do not respond differently to
antigen concentration
Key targets of pSTAT1/pSTAT4 and pSTAT6 downstream of IFN-γ/IL-12 and IL-4
are the master transcription factors T-bet and GATA-3, respectively93,94,91,92,108,109.
The latter are up-regulated in differentiating Th cells under Th1 conditions (T-bet),
Th2 conditions (GATA-3) and hybrid Th1/2 conditions (T-bet and GATA-382,83,84)
and direct the expression of other lineage-specific genes that are essential for T
cell function, most notably cytokines and chemokine receptors. In addition to
cytokine signalling via activated STATs, TCR signalling in response to antigen is
necessary for the induction of the master transcription factors in naive cells. In the
next sections, we analyse the response of master transcription factors to antigen
stimulus and cytokine signals.
Antigen concentration does not bias Th cell differentiation
Previous studies have shown that the strength of the TCR stimulus influences
Th1 or Th2 cell fate decision133,134,135,136, but how universal these findings are is
unclear. To investigate how our system responded to titrated antigenic peptides,
we performed a 5-step titration of the lymphocytic choriomeningitis (LCMV)-
derived GP64-peptide (i.e., 0.05, 0.2, 0.8, 3.2 and 12.8 µg/ml GP64-peptide), for
which the transgenic cells used throughout this study have a specific TCR, in IFN-
γ-, IL-4-competent cells (Figure 2.8a). In order to discriminate between potentially
confounding effects of antigen signalling and cytokine signals and detect eventual
synergetic effects of antigen and cytokine signalling, the titration was performed
under several differentiating conditions: the ‘antigen only’ condition, without
addition of any cytokine or blocking antibody; the ‘Th0’ condition, in which the
three major cytokines IFN-γ, IL-12 and IL-4 were blocked, as well as ‘classical’
Th1 and Th2 conditions and hybrid Th1/2 conditions. The cytokine IFN-γ was
not added to the polarising mix, but produced by the T cell themselves. The flow
cytometry quantification of T-bet and GATA-3 after four days of differentiation is
shown in figure 2.8; similar results were obtained at day 2 and 6 of differentiation.
We observed no significant bias towards Th1 or Th2 differentiation depending
on the peptide concentration. The amount of peptide showed no specific correla-
tion with the mean per cell expression of T-bet or GATA-3 during differentiation.
Overall, the cells seemed to express higher amounts of master transcription factor
with higher antigen doses in the conditions where autogenous cytokine signalling
was involved: T-bet increased with the GP64 concentration in Th1, hybrid Th1/2
and antigen only conditions, all conditions in which Th cells produced IFN-γ; the
same was true for GATA-3 in Th2 and hybrid Th1/2 conditions in which IL-4 is
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produced by the cells (Figure 2.8b). This suggests that a higher antigen concen-
tration increases the whole activation status of the cells, thereby increasing their
cytokine production during the early days of differentiation, without specifically
influencing lineage decisions. However, higher antigen concentrations seemed to
repress the emergence of a population expressing intermediate levels of GATA-3
among the otherwise unimodal T-bet-positive Th1 cells, and to induce a small
T-bet-positive population in GATA-3-positive Th2 cells. The bimodality observed
here under Th1 and Th2 conditions in IFN-γ-, IL-4-competent cells was not seen
in experiments using Ifng-/- cells under Th2 conditions or Il4-/- cells under Th1
conditions. We thus did not consider this phenomenon further, as it is probably
due to the imperfect blockade of stochastically produced cytokines.
IFN-γ and IL-12 lead to the dose-dependent up-regulation of T-bet and repres-
sion of GATA-3, while IL-4 correlates positively with GATA-3
Having established that antigen concentration does not bias cell differentiation in
either the Th1 or Th2 direction in our system, we proceeded to study the effects
of the polarising cytokines. Previous studies83,84 and unpublished work by M.
Peine and C. Helmstetter shown in Figure 2.9 have shown that T-bet and GATA-3
can have a continuum of co-expression patterns if the Th cells are differentiated
with varying amounts of cytokines. To quantify the effect of each cytokine on each
master transcription factor, we used the same titration experiments during which
STAT phosphorylation was measured, i.e., IFN-γ, IL-12 and IL-4 were titrated
separately in the presence of one, both and none of the other two cytokines. T-bet
and GATA-3 were quantified on a daily basis during the 5-day differentiation.
We then analysed how multiple cytokine stimuli govern the expression of the
master transcription factors T-bet and GATA-3 in the differentiating (days 1-4)
and differentiated (day 5) cells. To be specific, we show here the data for day 4 of
culture as dose-response curves of master transcription factor expression versus
cytokine concentration; previous days and day 5 all gave qualitatively similar
results; day 4 represents a time-point at which differentiation is nearly completed
and the cells are still activated.
First focusing on the response of the Th1 master transcription factor T-bet
to IFN-γ (Figure 2.10a), we observed a graded up-regulation of T-bet protein in
response to IFN-γ in most conditions. However, when the Th cells were differen-
tiated in the presence of the Th1-polarising cytokine IL-12 in the absence of the
Th2-polarising cytokine IL-4 (full blue line), the addition of IFN-γ did not further
increase the expression of T-bet. Contrastingly, when IL-4 was added to the culture
(full purple line), the already up-regulated levels of T-bet rose in a dose-dependent
manner in response to IFN-γ in a steeper manner than in the absence of IL-12,
reaching nearly saturation and Th1-levels for the highest concentrations. In the
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Figure 2.8: T-bet and GATA-3 are not differentially regulated by antigen. T-bet and GATA-3 flow
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GATA-3 stainings on day 4 of culture. b Dose responses of T-bet and GATA-3 to GP6461−80 in the different
conditions on day 4 of culture.
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Figure 2.10: T-bet is strongly positively correlated to IFN-γ and IL-12. a Dose response of T-bet to
IFN-γ with IL-12 (full lines) or without IL-12 (dotted lines), in the presence of IL-4 (purple lines) or
anti-IL-4 (blue lines). b Dose response of T-bet to IL-12 with IFN-γ (full lines) or without IFN-γ (dotted
lines), in the presence of IL-4 (purple lines) or anti-IL-4 (blue lines). c Dose response of T-bet to IL-4 with
IFN-γ (full lines) or anti-IFN-γ (dotted lines), in the presence of IL-12 (purple lines) or without IL-12 (red
lines).
absence of IL-12, the addition of IL-4 did not influence T-bet levels (compare the
purple and blue dotted lines) and even high concentrations of IFN-γ were only
associated to intermediate T-bet expression. Analysing the dose-response of T-bet
to IL-12, we observed a similar dependence of T-bet to the IL-12 concentration
than to the IFN-γ concentration: IL-12 correlated positively with T-bet amounts
(Figure 2.10b). However, IL-12 was strictly needed to achieve optimal T-bet expres-
sion, both in the presence and absence of IFN-γ. The positive effect of IFN-γ could
again be observed in hybrid conditions (compare full and dotted purple lines). The
addition of IL-4 led to reduced T-bet expression and a decreased responsiveness to
IL-12 in the absence of IFN-γ (compare blue and purple dotted lines), while IFN-γ
in the absence on IL-4 had no effect on the dose-response of T-bet to IL-12. Finally,
IL-4 showed no consistent effect on T-bet independently of IFN-γ and IL-12, but
correlated negatively with the Th1 master transcription factors in the presence
of IFN-γ (full lines). Collectively, these data show that cytokine effects on T-bet
expression are strongly modulated by other cytokines.
We then analysed the response of GATA-3 to IL-4, IFN-γ and IL-12. First
focusing on the titration of IL-4 (Figure 2.11c), its main regulator during Th2
differentiation, we observed a graded up-regulation of GATA-3 in response to
increasing IL-4 concentrations. However, this effect seemed to be dampened in
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Figure 2.11: GATA-3 is strongly positively correlated to IL-4 and negatively to IFN-γ and IL-12. a
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IL-4 (purple lines) or anti-IL-4 (blue lines). b Dose response of GATA-3 to IL-12 with IFN-γ (full lines)
or without IFN-γ (dotted lines), in the presence of IL-4 (purple lines) or anti-IL-4 (blue lines). c Dose
response of GATA-3 to IL-4 with IFN-γ (full lines) or anti-IFN-γ (dotted lines), in the presence of IL-12
(purple lines) or without IL-12 (red lines).
the presence of IFN-γ; indeed, the up-regulation was stronger when IFN-γ was
added to the culture (compare full and dotted lines), while no reduction of GATA-3
expression could be observed in the absence of IL-4. Contrastingly, the addition of
IL-12 did not diminish the effect of IL-4, although it reduced the overall expression
of GATA-3 (compare red and purple lines). This negative effect of IL-12 seemed
to be overridden by high IL-4 concentrations (dotted purple line). Focusing on
the response of GATA-3 to IFN-γ (Figure 2.11a), we observed a dose-dependent
reduction of GATA-3 expression, most notably so in conditions where IL-4 was
absent (blue lines). In the presence of IL-4, the effect of IFN-γ was visible at low
concentrations and did not consistently increase with augmenting IFN-γ amounts
(purple lines). IL-12 did not influence the response to IFN-γ (compare full and
dotted lines). Finally, IL-12 also caused a gradual decrease in GATA-3 expression
(Figure 2.11b) in most conditions. In ‘optimal’ Th2 conditions (i.e., in the presence
of IL-4 and absence of IFN-γ, dotted purple line), however, IL-12 was not able
to suppress the IL-4-induced up-regulation of GATA-3; the presence of IFN-γ
restored the effect of IL-12 in the presence of IL-4 (full purple line), but had no
influence on the dose response in its absence. Thus GATA-3, like T-bet, is regulated
in a complex manner by multiple cytokine inputs.
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The data on master transcitpion factor expression corroborated previously
described mechanisms, like the up-regulation of T-bet by IFN-γ and IL-12 and
the up-regulation of GATA-3 by IL-4. Distinct negative effects of both Th1
cytokines on GATA-3 could also be observed. Importantly, however, we found
that the cytokines modulated each other’s effects. The dose response of T-bet
to IFN-γ was steeper in the presence of IL-12, and IL-4 prevented maximal
T-bet up-regulation by IL-12 in the absence of IFN-γ. Conversely, the influence
of IL-4 on GATA-3 was reduced in the presence of IL-12, and both IL-12 and
IFN-γ were needed for maximal GATA-3 repression.
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2.3.2 Total STATs expression is influenced by the concentration
of polarising cytokines
The analysis of STAT phosphorylation showed negative effects of cytokines on
STAT pathways, specifically of IL-4 on STAT4 phosphorylation at the end of
differentiation. Therefore, we asked whether this negative cross-talk resulted from
inhibition of STAT phosphorylation (i.e., mediated by SOCS proteins179,180) or
from the regulation of STAT expression. Indeed, time-resolved flow cytometry
quantification of total STAT1, STAT4 and STAT6 under Th1, Th2 and hybrid
differentiation conditions showed that all three STAT proteins were dynamically
and differentially regulated depending on the cytokine milieu (cf. Figure 2.4c):
STAT1 and STAT4 were up-regulated in Th1 and hybrid Th1/2 cells whereas
STAT6 expression was augmented in Th2 and hybrid Th1/2 cells. To determine
how cytokines influenced STAT expression, we analysed the regulation of total
STAT protein expression in response to IFN-γ, IL-12 and IL-4 by titrating each
cytokine in the presence and absence of one or both of the others daily for five
days. As in the analysis of T-bet and GATA-3 regulation, we discuss here the data
for day 4, other days showing similar results.
The effect of IFN-γ, IL-12 and IL-4 on STAT1 expression are shown in Fig-
ure 2.12; the left panels depict typical stainings for all different cytokine com-
binations and the right panels the dose response to one cytokine in different
conditions. Looking at STAT1 expression in response to IFN-γ (Figure 2.12a,b), we
observed a gradual increase in protein levels with augmenting IFN-γ concentra-
tions (Figure 2.12b). The positive correlation could be observed independently of
the presence of IL-4 (compare blue and purple lines); however, the presence of
IL-12 reduced the steepness of the dose-response (compare dotted and full lines).
The positive effect of IFN-γ is also clearly visible in the histograms of Figure 2.12c
(compare full and dotted lines). In contrast to IFN-γ, when analysing the dose-
response of STAT1 to IL-12 (Figure 2.12c,d), we observed that the signal transducer
was repressed by IL-12 (Figure 2.12d), although this down-regulation was only vis-
ible in the presence of IFN-γ (full lines). In the absence of IL-4 and IFN-γ, a slight
positive correlation could be observed (dotted blue line). Finally, IL-4 showed
no correlation with STAT1 expression (Figure 2.12e,f), but the titration confirmed
the positive effect of IFN-γ (compare full and dotted lines in Figure 2.12f) and
the negative effect of IL-12 in the presence of IFN-γ (compare full red and purple
lines). Thus, STAT1 expression was up-regulated by IFN-γ and this activation was
counteracted by IL-12.
The effect of IFN-γ, IL-12 and IL-4 on STAT4 expression are shown in Fig-
ure 2.13. The regulation of STAT4 by Th1 cytokines was qualitatively similar to
that of STAT1. STAT4 expression was correlated positively to IFN-γ in all the
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Figure 2.12: STAT1 correlates positively with IFN-γ and negatively with IL-12. a STAT1 expression in
response to different cytokine combinations with and without IFN-γ. b Dose response of STAT1 to IFN-γ
with IL-12 (full lines) or without IL-12 (dotted lines), in the presence of IL-4 (purple lines) or anti-IL-4 (blue
lines).c STAT1 expression in response to different cytokine combinations with and without IL-12. d Dose
response of STAT1 to IL-12 with IFN-γ (full lines) or without IFN-γ (dotted lines), in the presence of IL-4
(purple lines) or anti-IL-4 (blue lines). e STAT1 expression in response to different cytokine combinations
with and without IL-4. f Dose response of STAT1 to IL-4 with IFN-γ (full lines) or anti-IFN-γ (dotted
lines), in the presence of IL-12 (purple lines) or without IL-12 (red lines).
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observed conditions (Figure 2.13a, b), although its overall levels were higher in the
absence of IL-4 (Figure 2.13a, compare purple and blue lines). STAT4 correlated
negatively to IL-12, despite the fact that IL-12 induces its phosphorylation (Fig-
ure 2.13c,d). This effect was augmented in the presence of IFN-γ (compare full and
dotted lines in Figure 2.13c), but not modified by the addition of IL-4. Looking at
the dose-response of STAT4 to IL-4, we observed that IL-4 induced a decrease in
the STAT4 amount in the absence of the Th1-cytokine IFN-γ (Figure 2.13f, dotted
lines), but had no effect otherwise. IL-12 did not influence the action of IL-4 on
STAT4, but the overall decrease in STAT4 expression levels in its presence could
be observed again (compare full and dotted lines). Collectively, these data show
complex regulation of STAT4 protein levels by the cytokines, with an up-regulation
downstream of IFN-γ and repression downstream of IL-12 and IL-4. Furthermore,
IFN-γ augmented the decrease in STAT4 expression in response to IL-12.
Finally, we show the dose responses of the signal transducer STAT6 in fig-
ure 2.14. The dose response of IFN-γ showed a gradual negative effect of the latter
on STAT6 (figure 2.14b), which was left unchanged by the addition of IL-12 or
IL-4, even though the overall STAT6 levels were higher in the presence of IL-4
(compare purple and blue lines). IL-12 had no detectable effect on STAT6 expres-
sion (Figure 2.14c,d). The strongest response observed was to IL-4 (Figure 2.14e,f):
STAT6 was strongly induced in response to increasing IL-4 concentrations (Fig-
ure 2.14f), suggesting a positive feedback-loop similar to that between STAT1 and
IFN-γ. IFN-γ seemed to reduce IL-4-induced STAT6 up-regulation (compare full
and dotted lines in figure 2.14f). Thus, STAT6 protein expression was positively
regulated by IL-4 and negatively by IFN-γ.
Interestingly, many different effects of the cytokines on STAT protein expression
could be observed: while IFN-γ acted both to induce the Th1 factors STAT1
and STAT4 and to repress the Th2 factor STAT6, IL-12 acted as a Th1-brake on
the protein expression level by repressing STAT1 and STAT4 expression while
still supporting Th1 differentiation on the signalling level. The function of IL-4
was more restricted to the Th2 lineage in enhancing STAT6 expression.
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Figure 2.13: STAT4 correlates positively with IFN-γ and negatively with IL-12. a STAT4 expression in
response to different cytokine combinations with and without IFN-γ. b Dose response of STAT4 to IFN-γ
with IL-12 (full lines) or without IL-12 (dotted lines), in the presence of IL-4 (purple lines) or anti-IL-4 (blue
lines). c STAT4 expression in response to different cytokine combinations with and without IL-12. d Dose
response of STAT4 to IL-12 with IFN-γ (full lines) or without IFN-γ (dotted lines), in the presence of IL-4
(purple lines) or anti-IL-4 (blue lines). e STAT4 expression in response to different cytokine combinations
with and without IL-4. f Dose response of STAT4 to IL-4 with IFN-γ (full lines) or anti-IFN-γ (dotted
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Figure 2.14: STAT6 correlates negatively with IFN-γ and positively with IL-4. a STAT6 expression in
response to different cytokine combinations with and without IFN-γ. b Dose response of STAT6 to IFN-γ
with IL-12 (full lines) or without IL-12 (dotted lines), in the presence of IL-4 (purple lines) or anti-IL-4 (blue
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2.4 The amounts of polarising cytokines are predict-
ive for the recall response of most cytokines
Th cells exert their function by secreting subset-specific effector cytokines both
during differentiation in the course of a primary immune response and as memory
cells, during a recall response triggered by a TCR stimulus (i.e., a secondary infec-
tion). TCR stimulation (here by addition of PMA and ionomycin, which mimick a
strong TCR stimulus) of differentiated Th cells causes reactivation of the cytokine
profile acquired during differentiation without the need for additional cytokine
cues. Th1 cells secrete IFN-γ 46, whereas Th2 cells secrete IL-4, IL-10 and IL-1347,
both cell types secrete IL-2 and TNF-α, although they are preferentially expressed
by Th1 cells181; hybrid subsets stably co-produce Th1 and Th2 cytokines82,83,84.
IL-5 is also expressed by Th247 and hybrid cells; however, two weeks of consec-
utive differentiation are necessary to up-regulate IL-5 production in vitro, so that
we do not consider it in this study. Binding of the master transcription factors to
cytokine genes has been shown to result in epigenetic modifications42. To study
the relation between MTF expression and cytokine recall response, we cultured
IFN-γ- and IL-4-competent naive Th cells with a gradient of both IL-12 and IL-4
(without addition of IFN-γ, relying on the autogenous production by the cells)
and measured T-bet and GATA-3 protein on day 5 (see figure 2.9), as well as IFN-γ,
IL-4, IL-13, IL-10, TNF-α and IL-2 production after restimulation of the cells. The
results are shown in the form of heat maps of T-bet and GATA-3 expression directly
before the restimulation (also see Figure 2.9 for the flow cytometry plots and dose
responses) and of cytokine production in terms of frequency of producing cells
directly after restimulation in Figure 2.15a and b, respectively.
As observed previously, T-bet expression both increased with the IL-12 concen-
tration (x-axis) and decreased with the IL-4 concentration (y-axis) (Figure 2.15a,
upper panel), while the expression of GATA-3 increased with IL-4 and decreased
with IL-12 (Figure 2.15a, lower panel). In addition to graded T-bet and GATA-3
co-expression patterns, we observed gradients in the frequency of cytokine produ-
cers, which were most pronounced for IFN-γ, IL-4, TNF-α and IL-2 (Figure 2.15b).
The frequency of IFN-γ producers was increased by IL-12 and reduced by IL-4,
showing a pattern similar to that of T-bet expression. While TNF-α and IL-2 also
correlated positively with IL-12 and negatively with IL-4, the resulting expression
patterns looked more like an inverse image of the GATA-3 pattern than like the
T-bet pattern. Looking at Th2 cytokines, we observed inverse correlations between
the frequency of IL-4 producers and the IL-12 and IL-4 concentrations added to
the culture to those present for IFN-γ, TNF-α and IL-2: more added IL-4 led to
more IL-4 producers, while more IL-12 reduced the number of IL-4 producers.
Qualitatively, this resembled the GATA-3 expression heat map. IL-13 production,
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Figure 2.15: Cytokine expression largely reflects T-bet and GATA-3 expression. FACS-sorted naive IFN-
χ- and IL-4-competent CD4 T cells were activated with APCs and GP61≻ 80 peptide under the indicated
conditions (legend on the right). On day 5, T-bet and GATA-3 expression levels were measured before the
cells were restimulated with PMA and ionomycin in the presence of brefeldin A for 3 hours. Cytokines
were then stained intracellularly. a Heatmap of T-bet and GATA-3 intensities before restimulation. b
Heatmaps of IFN-χ, IL-4, IL-13, TNF-ϕ, IL-2 and IL-10 percentages of producing cells.
although enhanced by the presence of added IL-4 (y-axis), seemed to be strongly
repressed by Th1 polarising cytokines; indeed, the mere absence of anti-IFN-χ
nearly abrogated its expression, even if high IL-4 concentration were used (second
column). IL-10 production showed a complicated pattern: it was clearly positively
correlated to the IL-4 concentration in the absence of Th1 cytokines (left column),
but also enhanced by high IL-12 (right columns). Very little IL-10 could be detected
with low to intermediate IL-12 concentrations in the absence of IFN-χ blockade,
unless high IL-4 concentrations were used (centre part of the plot).
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Several regulatory patterns seemed to exist for cytokine expression; IFN-γ,
TNF-α and IL-2 correlated positively to IL-12 and negatively to IL-4, but while
IFN-γ mirrored T-bet expression, TNF-α and IL-2 were inverse images of
GATA-3 expression. IL-4 and IL-13 were increased by IL-4 and decreased by
IL-12; IL-4 strongly mirrored GATA-3 expression, while IL-13 showed a mixed
pattern. IL-10 production correlated to IL-4, but both this correlation and the
frequency of producers were modulated by IL-12 in a complex manner.
2.5 Conclusion
Taken together, these results about STAT phosphorylation, master transcription
factor expression, total STAT expression and cytokine production showed that
graded stimuli induce graded responses and put multiple cross-effects between
the Th1 and Th2 inducing pathways in evidence. The latter occurred at multiple
levels: on the level of STAT phosphorylation, we observed phosphorylation of
typically Th1 STATs downstream of IL-4; on the transcription factor expression
levels, we observed repression of GATA-3 downstream of IFN-γ and IL-12 and
of STAT6 downstream of IFN-γ; and finally, down-regulation of IL-13 production
in response to Th1 cytokines. However, the piecemeal inspection of the multiple
dose-response data did not yield a clear picture of the underlying regulatory
interactions. The multiple correlations observed make it difficult to determine
which factor influences which other factor, most of all if the whole dataset, and not
only day four, is studied. We thus needed a more systematic approach to unravel
the topology of the signalling network, which will be the topic of the next chapter.

Chapter 3
Linear regression analysis
In Chapter 2, we presented a series of titrations of the cytokines IFN-γ, IL-12 and IL-
4 in differentiating T helper cells during which the downstream phosphorylation
of STAT1, STAT4 and STAT6, respectively, as well as the total protein expression
of the same STATs and T-bet and GATA-3 were measured. We analysed the
dose responses of each of these nine protein species in order to gain insights
into the integration of multiple signals resulting in Th1, Th2 and hybrid Th1/2
cells differentiation, as well as the cytokine production of the differentiated cells.
Multiple correlations, both positive and negative, were put in evidence by a
qualitative analysis of the data; however, the amount of data generated required a
more systematic approach to clarify the relationships at play between the different
transcription factors. Furthermore, as the protein amounts were measured using
flow cytometry, a technology yielding quantitative results, a method providing
quantitative information about the different mechanisms observed would allow a
better analysis of the Th1/Th2 regulatory network studied.
Based on previous knowledge, we started by defining three layers of regulatees
and regulators. The first layer is composed of the cytokines regulating STAT
phosphorylation, the second of active transcription factors (i.e., the phosphorylated
STATs, T-bet and GATA-3) regulating transcription factor expression, and the last
of T-bet and GATA-3 regulating cytokine production. Although activated STATs
have been shown to be involved in cytokine regulation, the protocol used in
this study focused on cytokine expression in differentiated cells following TCR
stimulation in the absence of polarising cytokines, and thus in the absence of
relevant amounts of phosphorylated STATs. We therefore omitted the latter in
our analysis of cytokine expression. To systematically analyse the titration data
presented in Chapter 2 in order to derive the topology of the regulation network,
we used a series of linear regression models describing how a layer of regulators
54 3. Linear regression analysis
  
Stat MTF
STAT pSTAT
MTF
Cytokine
Cytokine
Figure 3.1: Mechanistic assumption for Th cell differentiation. We assumed that the cytokines mediate
STAT phosphorylation, allowing the active pSTATs to regulate the expression of the master transcription
factors and the STATs. The master transcription factors in turn regulate each other’s expression, the
expression of the STATs and cytokine production upon restimulation.
controls a corresponding layer of regulatees:
regulateei = α0 +
∑
j
αj · regulatorj
The advantages of linear regression models are that they allow a straightfor-
ward and unbiased analysis of trends in the data with very few assumptions. In
our cases, the only assumption was the hierarchy of the network presented in
Figure 3.1, which is based on reliable biological knowledge: cytokines induce STAT
phosphorylation and transcription factors regulate the transcription of genes.
To allow for rigorous model selection, we considered a family of models
composed of all possible combinations of the potential regulators of each regulatee.
Specifically, this family contains all models with single regulators, all regulator
pairs, triplets, and so on. The models describing the amounts of phosphorylated
STATs, total STATs, T-bet, GATA-3 and fraction of cytokine producers were fitted to
the normalised data derived from all the titrations performed in order to determine
the values of the regression coefficients αj . We tested for each regulator wether it
made a significant contribution to the levels of the regulatee using the F -statistic
in analysis of variance (ANOVA) calculations182. In order to compare the models
for each regulatee and determine which of the regulators were significant for its
regulation, we ranked the models by goodness of fit (measured by the coefficient of
determination, R2) and Akaike information criterion183,184(AIC). R2 ranges from 0
to 1 and indicates the fraction of the data that is explained by the model while the
AIC additionally implements a trade-off between complexity of the model and
goodness of fit, allowing to quantify the quality of each model relative to the others.
The model with the lowest AIC, the highest R2 and no non-significant parameter
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was the most likely to explain the experimental data. We further inspected the
quality of the model fits using (i) Cook’s distance, which put outliers in evidence182,
and (ii) the probability plots of the residuals as well as the residuals themselves to
ascertain their normal distribution and the absence of bias in the model182. This
analysis and the associated statistics were computed using Wolfram Mathematica
10 (see Section 6.2.2 for more details).
3.1 STAT activation is induced, but not repressed, by
both canonical and non-canonical cytokines
The first layer of regulation downstream of the polarising cytokines is the phos-
phorylation of the STATs. The visual analysis of the data presented in the previous
chapter suggested the presence of several cross-effects between cytokines on STAT
phosphorylation. Such positive effects could be due to activation of non-canonical
STATs by cytokines or to up-regulation of signalling components, whereas neg-
ative effects could be caused by the induction of negative regulators of STAT
phosphorylation (e.g., SOCS proteins179,180) or down-regulation of components of
the signalling pathway. We analysed the effect of the cytokines on the phosphoryla-
tion level systematically. As dynamic regulation of the total STAT expression is
also reflected in the amount of pSTAT that is measured, without it being a direct
effect on phosphorylation, we computed the relative pSTAT values which inform
us about the fraction of protein being phosphorylated independently of the total
amount expressed. The idea is that STAT phosphorylation is a fast process (typic-
ally happening in 10 to 20 minutes) while changes in STAT expression occur on
much larger timescales. The relative pSTAT values were obtained by co-staining
pSTATs and total STATs during the experiments and dividing the pSTAT values by
the corresponding total STAT values after normalisation:
pSTATrel,i =
pSTATi − baseline
STATi
for i = 1, 4, 6 and each experiment. The baseline was set to be equal to the lowest
normalised pSTAT value for each experiment and each day.
We began by considering all possible models of how three cytokine stimuli
could control the phosphorylation of each of the three STATs, resulting in seven
models for each pSTAT (Figure 3.2). As input variables, we chose the logarithms
of the cytokine concentration,
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Figure 3.2: Possible ways of STAT phosphorylation. The general assumption that each cytokine can
induce or repress the phosphorylation of each STAT is tested by comparing models representing all the
different cytokine combinations.
motivated by the fact that receptor occupancy saturates. We performed this
linear regression analysis separately for each day.
pSTATrel↪i = ϕ1↪ilog(IFN-χ) + ϕ2↪ilog(IL-12) + ϕ3↪ilog(IL-4)
for i = 1↪ 4↪ 6 and allowing each ϕj↪i to be equal to zero; i.e., each cytokine to have
no effect at all on the phosphorylation of each STAT. The fitting to the relative
pSTAT data (ranged between 0 and 1) allowed us to compare the regression
coefficients obtained for different days.
The ranking of the models by goodness of fit and AIC is shown in Figure 3.3
for day 1 for pSTAT1 and day 3 for pSTAT4 and pSTAT6 (the days shown here
were those with the best-fitting models, see Table 3.1 for the other time points). We
selected the best model for each pSTAT according to the value of the AIC: the model
with the lowest AIC was best able to fit the data with only significant explanatory
variables. Standard diagnostics such as the plotting of Cook’s Distance, computing
the probability plots of the residuals and residual inspection were performed to
confirm that the model fits were satisfactory (Supplementary Figure 7.4).
G E C F B D A E G C F B D A
pSTAT4
E F B G D C A
Model Model Model
pSTAT1
R2
Δ AIC
R2
Δ
 A
IC R
2
Δ
 A
IC R
2
Δ
 A
IC
pSTAT6
0.2
0.4
0.6
0.8
10
30
80
100
0.1
0.3
0.5
0.7
20
40
70
90
0.2
0.4
0.6
0.8
20
120
140
10
Figure 3.3: STAT phosphorylation can be induced by several non-canonical cytokines. The best model
is boxed and is the one with the lowest AIC, the greatest R2 and only significant regressors. Left: models
describing pSTAT1 on day 1; middle: models describing pSTAT4 on day 3; right: models describing
pSTAT6 on day 3.
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Using these linear modelling approach, we can indeed explain much of the
measured variability in the pSTAT data on most days with the combined effects
of the cytokine stimuli (Table 3.1; coefficients of determination, R2, for pSTAT1
0.32 to 0.75, for pSTAT4 0.62 to 0.75 and for pSTAT6 0.47 to 0.88). The finding that
all regression parameters are non-negative implies that cytokines only activate
(and never inhibit, in this particular setup) STAT phosphorylation (Table 3.1). This
finding implies that potential inhibitory cytokine effects are not due to crosstalk in
signal transduction.
The regression analysis identifies the known canonical signalling pathways (i.e.,
pSTAT1 activation by IFN-γ, pSTAT4 activation by IL-12 and pSTAT6 activation by
IL-4). In addition, we find weaker, non-canonical activations: phosphorylation of
STAT1 by IL-12, as well as phosphorylation of STAT1 and STAT4 by IL-4. Looking
at the kinetics of STAT1 phosphorylation, we observe a decrease in goodness
of fit from day 3 on accompanied by a reduction in the strength of the IFN-γ
effect, which corresponds to the time point where pSTAT1 amounts decreased. In
contrast, pSTAT4 levels are well explained during the whole time course; however,
the IL-12 effect becomes stronger with time, reflecting the late increase in pSTAT4.
pSTAT6 phosphorylation is only linked to IL-4, and this effect remains stable with
time. We summarised these results by averaging the regression coefficients over
days 1 to 5 for each interaction (Figure 3.4a, hitherto undescribed effects are shown
as green arrows here and later on).
The predictions of the regression modelling were verified directly by flow
cytometry; plots of the response of the pSTATs to their non-canonical cytokines on
day 3 of culture are shown in Figure 3.4b. The left panel shows the phosphorylation
of STAT1 (top) and the absence of phosphorylation of STAT6 (bottom) in response
to IL-12; STAT1 phosphorylation was increased by 45 ng/ml IL-12 2.5 times above
baseline. The middle panel shows that neither STAT4 nor STAT6 phosphorylation
were increased by IFN-γ. Finally, the right panel shows a 2-fold increase of STAT1
phosphorylation and a 2.9-fold increase of STAT4 phosphorylation in the presence
of IL-4 compared to the blockade of IL-4.
pSTAT1 pSTAT4 pSTAT6
IFN-γ IL-12 IL-4 IL-12 IL-4 IL-4
Day α1 α2 α3 R2 α2 α3 R2 α3 R2
1 0.67 0.21 0.26 0.75 0.34 0.28 0.63 0.91 0.88
2 0.6 0.4 0.7 0.7 0.63 0.17 0.7 0.88 0.85
3 0.15 0.46 0.39 0.39 0.63 0.27 0.75 0.85 0.85
4 0.2 0.26 0.34 0.34 0.69 0.15 0.69 0.91 0.81
5 0.19 0.1 0.32 0.32 0.7 0.17 0.62 0.73 0.47
Mean 0.36 0.29 0.2 0.5 0.6 0.21 0.68 0.86 0.78
Table 3.1: Best-fit parameters and R2 for pSTAT1, pSTAT4 and pSTAT6 on each day
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Figure 3.4: Observed ways of STAT phosphorylation. a Graphical representation of the best linear
models describing the effect of IL-12, IFN-γ and IL-4 on STAT1, STAT4 and STAT6 phosphorylation.
Grey arrows represent previously described interactions, green arrows hitherto undescribed mechanisms.
Numbers show the average strength of the effect the cytokines have during the 5 days of culture. b Flow
cytometry measurements of the non-canonical pSTATs downstream of IL-12 (left), IFN-γ (middle) and
IL-4 (right) on day 3 of culture.
Linear regression analysis allowed us to quantify statistically significant effects
of polarising cytokines on STAT phosphorylation. The challenge of naive T cells
with mixed Th1-Th2 cytokine stimuli revealed canonical and non-canonical
cytokine-induced STAT phosphorylation. Specifically, in addition to the well-
studied and dominating activation of STAT1 by IFN-γ, STAT4 by IL-12 and
STAT6 by IL-4, the activation of STAT1 and STAT4 by IL-4 as well as the
activation of STAT1 by IL-12 was observed. No negative regulation of STAT
phosphorylation by IFN-γ, IL-12 or IL-4 was observed.
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3.2 Transcription factor expression can be explained
by linear combinations of the weighted sums over
time of active transcription factors
Having established how the pSTATs depended on the cytokine inputs, we moved
on to the next layer of the Th1/Th2 regulatory network and analysed how tran-
scription factor expression is regulated. Complex interdependencies of the cy-
tokines in influencing the transcription factor expression observed in the data were
described in the previous chapter, which we again sought to capture by linear
regression models. Because cytokine signalling is carried out by pSTATs and the
master transcription factors and STATs are known to be their direct targets, and
because previous work has indicated that MTFs can affect each other’s expression,
we used the pSTATs and T-bet as explanatory variables (regulators) for GATA-3 ex-
pression, the pSTATs and GATA-3 for T-bet expression, and the pSTATs, T-bet and
GATA-3 for STAT1, STAT4 and STAT6 expression (Figure 3.5). Although GATA-3
and T-bet are known to enhance their own expression though several mechanisms,
the master transcription factors could not be included in the linear models describ-
ing their own expression; indeed, auto-activating loops cannot be represented
in linear models, as they only quantify the correlation between factors and one
factor always correlates 100% with itself (so that T-bet would be best explained
by only T-bet itself, for example). However, we expect that this is not a major
restriction of the analysis, because auto-activation has primarily been implicated
in the maintenance of master transcription factor expression, whereas we study the
induction phase. In contrast to the master transcription factors, we had separate
measurements for the total and active, phosphorylated STATs, allowing us to use,
for example, pSTAT1 as a regulator for total STAT1. The distinct measurements
of pSTATs, used as regulators, and total STATs, which are regulatees, allowed the
identification of positive feedback loops of the phosphorylated STATs on the total
STATs. No such distinction could be made for the master transcription factors,
and a variable cannot be simultaneously regulator and regulatee in linear models.
Hence models could not include auto-activation of T-bet and GATA-3.
3.2.1 The regulation of STAT expression happens on a slower
timescale than the regulation of T-bet and GATA-3
In contrast to the regulation of STAT phosphorylation by the cytokines, which is a
fast process, regulation of expression can affect the protein levels for several days
thanks to a longer protein half-live and the effect of epigenetic modifications, so
that we considered the possibility that the regulatory effects of the transcription
factors were cumulative over time. Indeed, when measuring the amount of a
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Figure 3.5: Possible ways of transcription factor transcription regulation. The general assumption is
that each transcription factor can contribute in a negative or positive manner to the expression of another
transcription factor, and that these contributions are cumulative over time, leading to up to 32 different
models for a transcription factor. Possible models for T-bet are A+i and B+i (i = 1...8), for GATA-3, A+i
and C+i (i = 1...8), and for all three STATs X+i (X = A...D and i = 1...8).
protein species at a certain time point, not only the acutely induced protein can be
detected, but also the proteins produced at earlier time points still present in the
cell. Furthermore, we postulated that the effect of signalling on the transcription
factor expression decreased with time, e.g., that signalling occurring on day 1
had less influence on the expression on day 4 than signalling occurring on day 4
due to protein degradation, and that the correlation between a regulatee and a
regulator would therefore be stronger when quantified at the same time point than
if the regulator was measured at an earlier time. We thus express the relationship
between a regulatee and its regulators as follow:
TFi,T =
∑
j
αj ·
T∑
t
e−λ·(T−t) · TFj,t
for T = 1...5 and all combinations of j for each i, and allowing each αj = 0; i.e., all
possible combinations of transcription factors. The factor e−λ·(T−t) is the weight of
the regulators depending on the time point t of their measurement. We thus had
16 different models for T-bet and GATA-3, and 32 for each of the STAT proteins
(Figure 3.5).
When visually analysing the data, we chose to focus our analysis on day 4, as
the Th cells had already reached a distinct phenotype by that point as judged by
master transcription factor expression. Hence we used the weighted sum of the
pSTATs as well as of T-bet and GATA-3 amounts from day 1 to 4 to explain the total
expression of the transcription factors on day 4, but still considered the similar
analysis performed on the other days which yielded similar results. Indeed, the
regression analysis was performed in the same fashion using the weighted sum
from day 1 to day n to explain the expression on day n, where n = 1, 2, 3, 4, 5; the
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Figure 3.6: Influence of λ on the weight each day. The functions e−λ·(T−t) with T = 4 and t = 1...4
describe the decrease of the weight of each transcription factor with time for different values of λ.
T-bet GATA-3 STAT1 STAT4 STAT6
λ (days−1) 0.8 1 0.4 0.2 0.4
Table 3.2: λ values of the best fits
qualitative and quantitative results (i.e., which regressors were significant as well
as their weight) of the regression analysis for the different days were compared
and found to be consistent over time. We started by estimating the best value for
λ, which represents the ‘memory’ of the regulated transcription factor for previous
influence of other transcription factors. The influence of the value of λ on the
weight given to each day is illustrated in Figure 3.6: the higher λ is, the less early
time points influence the expression at later time points; e.g., with λ = 0, all time
points have the same weight, while with λ = 1, the weight of day 1 is less than one
tenth of that of day 4 in explaining the expression of the regulatee on day 4. To
estimate λ, we used the most complex linear model of each family (always leading
to the best R2), fitted the α coefficients for increasing λ values and compared
the resulting R2. The value of λ leading to the highest R2 was used for further
analysis. We obtained the best fits to the data for all transcription factors if earlier
time points retained an influence on controlling the final expression level but with
reduced weight (Figure 3.7 and Table 3.2). Specifically, the earlier time points seem
to be more important for the STAT proteins (with λ values of 0.4, 0.2 and 0.4 for
STAT1, STAT4 and STAT6, respectively) than for the master transcription factors
(with λ values of 0.8 and 1 for T-bet and GATA-3, respectively).
The expression of the transcription factors show a ‘memory’ for previous tran-
scription factor activity as it is influenced by the expression of regulators several
days earlier. This early expression of the regulators has a more important effect
on the STATs than on the master transcription factors.
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Figure 3.7: Regulation on earlier days have less influence on transcription factor expression than
regulation directly preceding the measurement. The most complex model for each transcription factor
was fitted with different values for λ for day 4 of culture and the resulting R2 were compared.
3.2.2 T-bet expression is inhibited by GATA-3, while GATA-3 ex-
pression is repressed by pSTAT1 and pSTAT4
Master transcription factors are crucial for determining the phenotype of Th cells
after differentiation. In Chapter 2, we observed the expected up-regulation of
T-bet downstream of IFN-γ and IL-12 and of GATA-3 downstream of IL-4, but
also inter-lineage correlations as GATA-3 expression was repressed by both Th1
cytokines. However, as several transcription factors correlate positively with one
cytokine (e.g., pSTAT4, pSTAT1 and T-bet with IL-12), classical analysis of the data
could not tell on which transcription factors were responsible for the observed
effects. In order to study and quantify these interactions and systematically search
for other possible regulatory mechanisms, we proceeded to analyse the regulation
of T-bet and GATA-3 during our titration experiments using a linear regression
analysis approach. We used the weighted sums over time of the pSTATs and T-bet
or GATA-3 as explanatory variables for GATA-3 or T-bet, respectively, as well as
the values of λ determined as described in the previous section for the weighting
factors (c.f. Table 3.2 and Figures 3.5, 3.6 and 3.7). We then fitted all possible
models to the titration data and compared the results for the different models in
each family in order to find the best-fitting one. To do so, we classified the models
by R2 and AIC values, and selected the model with the lowest AIC comprising
only parameters that were significantly different from zero (Figure 3.8). As for the
pSTAT models, we ascertained that the standard model diagnostics of the selected
models were satisfactory (Supplementary Figure 7.5).
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Figure 3.8: T-bet is regulated by pSTAT1, pSTAT4 and GATA-3, while GATA-3 is only regulated by
the pSTATs. The best model is boxed and is the one with the lowest AIC, the greatest R2 and only
significant regressors. Left: models describing T-bet on day 4; right: models describing GATA-3 on day 4.
T-bet GATA-3
Day pSTAT1 pSTAT4 GATA-3 R2 pSTAT1 pSTAT4 pSTAT6 R2
1 0.98 0 0 0.8 -0.31 -0.03 0.89 0.74
2 0.92 0.18 -0.1 0.87 -0.17 -0.13 0.87 0.78
3 0.58 0.47 -0.24 0.83 -0.3 -0.21 0.87 0.84
4 0.34 0.62 -0.32 0.82 -0.35 -0.21 0.82 0.81
5 0.18 0.69 -0.34 0.81 -0.36 -0.35 0.68 0.59
Table 3.3: Best-fit parameters and R2 for T-bet and GATA-3 on each day.
The values corresponding to the best fit for each model family are shown in
Table 3.3 and represented graphically for day 4 in Figure 3.9a. The regression
models fit the data very well (R2 = 0.82 and 0.81 for T-bet and GATA-3, respectively,
on day 4). They recover the known mechanisms of T-bet up-regulation by pSTAT4
and pSTAT1, and of GATA-3 up-regulation by pSTAT6. Surprisingly, no direct
role for T-bet in GATA-3 regulation emerges: the negative regulation of GATA-3
observed downstream of IFN-χ and IL-12 is predicted to be carried out by both
pSTAT1 and pSTAT4. Moreover, T-bet is predicted to be inhibited by GATA-3 and
not by pSTAT6. In this respect it is interesting that no clear negative correlation to
IL-4 could be observed in our previous qualitative analysis, supporting an effect
mediated by GATA-3 which is regulated by more than IL-4 rather than a direct
effect of pSTAT6 which is tightly correlated to the IL-4 concentration.
The kinetic nature of the data allowed us to do a linear regression analysis for
the expression on each day in order to study the changes in regulation during the
week of differentiation. The best models were able to explain T-bet and GATA-3
expression well on all five days (R2 for T-bet 0.8 to 0.87 and for GATA-3 0.59 to 0.84,
Table 3.3). The strength of regulation of pSTAT1 and pSTAT6 on GATA-3 show
little consistent change with time, while the effect of pSTAT4 increases during
differentiation. However, when considering T-bet regulation on the different days
(Table 3.3 and Figure 3.9b), a decrease in the strength of regulation by pSTAT1 can
be observed from day 2 on, while the effect of both pSTAT4 and GATA-3 increase
until the end of the kinetics.
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Figure 3.9: Observed ways of MTF regulation. a Graphical representation of the best linear models
describing the effect of pSTAT1, pSTAT4, pSTAT6 and GATA-3 on T-bet and GATA-3 expression. Grey
arrows represent previously described interactions, green arrows hitherto undescribed mechanisms.
Numbers show the strength of regulation on day 4. b Evolution of the relative weights (absolute values)
of pSTAT1, pSTAT4 and GATA-3 regulation on T-bet during the culture.
Linear regression analysis predicts T-bet to be up-regulated by pSTAT1 and
pSTAT4, the first having a greater effect at earlier time points and the latter
at late time points. GATA-3 is predicted to have an increasing negative effect
on T-bet. On the Th2 side, GATA-3 is predicted to be positively regulated by
pSTAT6 with little change over time, and negatively regulated by both pSTAT1
and pSTAT4, the latter having an increasing effect with time.
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Figure 3.10: pSTATs have an important role in the regulation of STAT expression. The best model is
boxed and is the one with the lowest AIC, the greatest R2 and only significant regressors. Top left: models
describing STAT1 on day 4; top right: models describing STAT4 on day 4.; bottom; models describing
STAT6 on day 4.
3.2.3 Total STAT expression is strongly regulated by the pSTATs
and master transcription factors
In Chapter 2, we observed dynamical regulation of the total protein expression
of STAT1, STAT4 and STAT6 downstream of IFN-χ, IL-12 and IL-4. STAT1 and
STAT4 were positively correlated to IFN-χ and negatively to IL-12, while STAT6
was strongly induced in the presence of IL-4 and repressed by IFN-χ. Furthermore,
STAT4 expression decreased in response to IL-4 in certain conditions. As was the
case for T-bet and GATA-3, simple visual analysis of the data did not allow for
the quantification of the observed regulation, nor for the determination of the
transcription factor responsible for the observed effect. We thus proceeded to
systematically extract the regulatory network underlying total STAT expression
regulation, using the same regression analysis described above: as the most
prominent cytokine-specific active transcription factors are the pSTATs and T-
bet and GATA-3, we took them as explanatory variables for the regression models,
analogous to the models for T-bet and GATA-3 expression above, and included
a weighted sum of the regulators with the previously determined values for υ
(c.f. Table 3.2 and Figures 3.5, 3.6 and 3.7). After fitting all possible models to the
titration data, we selected the best models according to the R2 and AIC values
(Figure 3.10) and verified standard model diagnostics (Supplementary Figure 7.6).
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STAT1 STAT4
Day pSTAT1 pSTAT4 T-bet R2 pSTAT4 T-bet GATA-3 R2
1 1.1 -0.16 0 0.79 0 0 0 0
2 0.9 -0.47 0.4 0.86 0 0.35 -0.16 0.21
3 0.92 -0.6 0.38 0.8 -0.18 0.46 -0.29 0.3
4 0.88 -0.44 0.39 0.83 -0.71 0.81 -0.12 0.51
5 0.92 -0.41 0.22 0.87 -0.41 0.78 -0.18 0.43
STAT6
Day pSTAT1 pSTAT6 R2
1 0 0.73 0.52
2 0 0.76 0.57
3 -0.35 0.79 0.67
4 -0.49 0.78 0.72
5 -0.39 0.56 0.38
Table 3.4: Best-fit parameters and R2 for STAT1, STAT4 and STAT6 on each day.
We again achieved good fits to the collective data on day 4 (R2 = 0.83, 0.51 and
0.72 for STAT1, STAT4 and STAT6, respectively; Table 3.4 and Figure 3.11). The
models reveal four positive and four negative regulations of STAT expression on
day 4 (Figure 3.11). All positive interactions act within the Th1 or Th2 pathways.
By contrast, negative regulations are observed between the Th1 and Th2 pathways,
but also within the Th1 pathway. STAT1 is found to be up-regulated by both
pSTAT1 and T-bet, but repressed by the Th1 factor pSTAT4. STAT4 is regulated in
a similar fashion: its expression is increased by T-bet and repressed by pSTAT4;
in addition, it is down-regulated by GATA-3. STAT6 is induced by pSTAT6 and
down-regulated by pSTAT1.
Kinetic analysis show that the effect of pSTAT1 on STAT1 expression stays
relatively constant, while those of pSTAT4 and T-bet on STAT1 tend to increase
with time. This can also be observed when considering STAT4 regulation; the effect
of GATA-3 on the latter shows no constant change with time. The up-regulation
of GATA-3 by pSTAT6 remains similar throughout the week, while repression by
pSTAT1 only becomes significant on day 3.
Linear regression analysis predicts that several self-reinforcing loops are in-
volved in the regulation of total STAT expression: pSTAT1 and pSTAT6 up-
regulating STAT1 and STAT6, respectively, and T-bet activating STAT1 and
STAT4 expression. In contrast, pSTAT4 is predicted to inhibit the expression of
both Th1-specific signal transducers STAT1 and STAT4. Mutually repressive
mechanisms described by the best-fitting models include the down-regulation
of STAT6 by pSTAT1 and of STAT4 by GATA-3.
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Figure 3.11: Observed ways of STAT regulation. Graphical representation of the best linear models
describing the effect of pSTAT1, pSTAT4, pSTAT6, T-bet and GATA-3 on STAT1, STAT4 and STAT6
expression. Grey arrows represent previously described interactions, green arrows hitherto undescribed
mechanisms. Numbers show the absolute value of strength of regulation on day 4; 0 stands for non-
significant effect.
3.3 Master transcription factors expression is predict-
ive for the cytokine recall response
We determined how cytokine signals influence transcription factor expression via
specific signal transducers, the STAT proteins. The next step was to study how
this affected the function of Th cells, which is carried out by secretion of effector
cytokines. In chapter 2, we observed similarities in the expression patterns of T-bet
and/or GATA-3 and that of IFN-γ, TNF-α, IL-2, IL-4 and IL-13, while the pattern
of IL-10 expression seemed unique. We thus studied the relationship between
master transcription factors and the cytokines produced by the differentiated
cells upon restimulation using linear regression analysis. Binding of the master
transcription factors to cytokine genes has been shown, as well as contributions of
the STAT proteins. However, in the setup used, cytokine production was measured
after strong antigen stimulus in the absence of polarising cytokines and hence
without acute STAT activation. We thus constructed linear models explaining the
fraction of cytokine producers as functions of T-bet and/or GATA-3 and omitted
pSTAT contribution. The fraction of cells expressing each cytokine could thus be
explained by a family of four linear functions of either T-bet, GATA-3, both of
them or none of them.
Fi = α1,i T-bet + α2,i GATA-3
where F is the fraction of producers of cytokine i for i = IFN-γ, IL-4, IL-13, TNF-α,
IL-2, IL-10 and allowing each αj,i = 0.
The best model among a family was selected, as described before, according
the R2, AIC values and significance of the parameters of each fit, and standard
diagnostics were checked (Supplementary Figure 7.7). We found that IFN-γ
and IL-4 were well explained as functions of only T-bet or GATA-3, respectively
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Figure 3.12: Cytokine expression can be expressed as functions of T-bet and GATA-3 expression.
FACS-sorted naive IFN-γ- and IL-4-competent CD4 T cells were activated with APCs and GP61−80 peptide
under the indicated conditions. IL-12 and IL-4 were titrated against each other. On day 5, T-bet and GATA-
3 expression were measured and the cells were restimulated with PMA and ionomycin in the presence
of brefeldin A for 3 hours before cytokines were stained intracellularly. Nonlinear functions expressing
cytokine producers as function of T-bet and/or GATA-3 were derived based on linear regression analysis
and fitted to the data.
(R2 = 0.83 and R2 = 0.71), suggesting no direct role of the adverse factor in the
regulation of their recall response by antigen alone. By contrast, IL-13 is better
accounted for by both MTFs (R2 = 0.49), correlating positively with GATA-3
and negatively with T-bet. Both TNF-α and IL-2 are explained well as negative
functions of GATA-3 (R2 = 0.79 and 0.72, respectively). Of all cytokines, the IL-10
recall response was least well explained by the expression levels of the MTFs
(R2 = 0.44). The linear fits could be further improved by empirically choosing
appropriate nonlinear functions based on the results of the linear fits, with the
exception of IL-10 (Figure 3.12). The nonlinear functions suggest cooperativity
(i.e., Hill coefficients larger than 1) for the activating and inhibiting actions of both
master transcription factors.
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The linear analysis of cytokine expression upon recall response show that
quantitative differences in T-bet and GATA-3 expression levels are highly pre-
dictive for the fraction of cytokine-expressing cells upon antigen reencounter.
The expression of the Th1 and Th2 signature cytokines IFN-γ and IL-4 were
strongly positively correlated to T-bet and GATA-3, respectively, while TNF-α
and IL-2 responded negatively to GATA-3. IL-13 was correlated positively to
GATA-3 and negatively to T-bet.
3.4 Conclusion
Linear regression analysis of time-resolved dose-response data allowed us to recon-
struct the signalling network that governs master transcription factor expression
in Th cells differentiated with mixed Th1-Th2 stimuli. Specifically, we predicted
novel functional roles for pSTAT1 as well as pSTAT4 and found numerous regulat-
ory mechanisms acting on STAT1, STAT4 and STAT6 expression, thus mediating
rewiring of the signalling pathways during differentiation. Furthermore, the
expression levels of both T-bet and GATA-3 were correlated to the amount of
phosphorylated pSTAT1, pSTAT4 and pSTAT6, which in turn were determined by
cytokine signals and total STAT expression− the latter being regulated by both the
pSTATs and the master transcription factors. Although there were positive cross-
effects at the STAT activation level (STAT1 and STAT4 phosphorylation by IL-4),
all interactions between the Th1 and the Th2 players were negative at the layer of
transcription factor regulation. The regulatory mechanisms involving only Th1
or Th2 factors were enhancing ones, except for negative pSTAT4 effects on both
STAT1 and STAT4 expression. In summary, the amount of polarising cytokines
present during differentiation determines the extent of STAT phosphorylation,
total STAT expression, and master transcription factor expression in the cells,
which in turn determines the probability of cytokine expression by a cell during an
immune response, linking primary differentiation conditions to functional output.

Chapter 4
Dynamical model
In the previous chapters, we defined the topology of the network of interactions
between the cytokines IFN-γ, IL-12 and IL-4, the downstream transcription factors
STAT1, STAT4 and STAT6, and the master transcription factors T-bet and GATA-
3, using linear regression analysis on quantitative, time-resolved dose-response
data (c.f. Figure 5.1). The network depicts positive feedback loops inside the
Th1 and Th2 modules (i.e., up-regulation of STAT1 and STAT4 by T-bet, auto-
activation of STAT1 and STAT6). Between the two modules, negative interactions
dominate. The Th1 STATs play a major role in inhibiting Th2 differentiation: both
STAT1 and STAT4 repress GATA-3 in a T-bet independent manner, and STAT1
also down-regulates STAT6. Negative regulation of the Th1 pathway by the Th2
module is mediated by GATA-3 inhibiting T-bet expression. However, positive
cross-talk in the form of STAT1 and STAT4 phosphorylation downstream of IL-4
was also observed, as well as negative feedback of STAT4 on both STAT1 and
STAT4 expression inside the Th1 pathway.
The linear regression approach was very helpful for the determination of cor-
relations between the different protein species considered, but could not explain
the kinetics of protein expression during primary differentiation. Furthermore, as
several factors correlated strongly with each other (e.g., T-bet with pSTAT1 and
pSTAT4, pSTAT1 with IFN-γ and IL-12, and pSTAT4 with IL-12) and correlation
does not inform about causality, linear modelling could not determine unambigu-
ously which of the correlated factors was responsible for a given effect (e.g., is
pSTAT1 or T-bet responsible for the up-regulation of STAT4, or does the correlation
result from another mechanism not considered?). In this chapter, we developed
a dynamical model that relies on assumptions about causal relationships. By
confronting this model, based on ordinary differential equations (ODEs), with the
time-resolved data, we will gain further insight into the topology and dynamics of
the network.
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4.1 The fitted dynamical model is able to reproduce
the kinetics of STAT phosphorylation as well as
STAT, T-bet and GATA-3 expression
The development of a quantitatively predictive dynamical model requires the
description of the network of interactions being modelled as well as data to
estimate the model’s parameter. The topology of the Th1/Th2 signalling network
derived from the linear regression analysis was described in Chapter 3, while
the experiments presented in Chapter 2 provide quantitative data about STAT
phosphorylation as well as STAT and master transcription factor expression. We
thus proceeded with the development, fitting and testing of a dynamical model of
Th1/Th2 cell differentiation.
The network topology described in the previous chapter was used to develop
a simple dynamical mechanistic model. The model is based on ordinary differen-
tial equations and explains the expression of T-bet, GATA-3, STAT1, STAT4 and
STAT6 as well as the phosphorylation of the STATs, taking the polarising cytokine
concentrations as inputs. To account for receptor saturation and desensitization,
the logarithms of the concentrations are used. In the model used from here on, the
cytokine concentrations are assumed to decrease with time due to consumption
and degradation according to hyperbolic tangent functions (Figure 4.1). :
[IFN-γ] = CIFN-γ · (1− tanh(t− TIFN-γ)) (4.1)
[IL-12] = CIL-12 · (1− tanh(t− TIL-12)) (4.2)
[IL-4] = CIL-4 · (1− tanh(t− TIL-4)) (4.3)
The Cs are the logarithm of the starting cytokine concentrations, t the time in days,
and the T s are the half-lives of the cytokines.
The phosphorylation of the STATs is fast (minutes) compared to the timescale
of the experiment (5 days). Therefore, we express the pSTATs as algebraic functions
of cytokine concentrations, assuming a linear relationship:
pS1 = (α1[IFN-γ] + α2[IL-12] + α3[IL-4]) · S1 (4.4)
pS4 = (α4[IL-12] + α5[IL-4]) · S4 (4.5)
pS6 = (α6[IL-4]) · S6 (4.6)
The amounts of phosphorylated STATs are represented by pS1, pS4 and pS6, while
total STAT protein expression levels are represented by S1, S4 and S6. The αs the
strength of the cytokine effects on STAT phosphorylation.
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Figure 4.1: Different possible kinetics for the cytokine concentrations. The functions (1− tanh(t−T ))
with different T values used to describe the kinetics of cytokine concentration.
The transcription factor protein expression was modelled by a system of five
ordinary differential equations, one for each protein. The pSTATs were assumed
to act in concert with antigen signalling (as differentiation does not occur in the
absence of the latter), so that an equation describing the dynamics of the antigen
stimulus was added to the system:
Ag = (1− e(−t)) · e(−l2·t) (4.7)
S˙1 =
BS1 + β1 · T + β2 · pS1 · Ag
1 + β3 · pS4 · Ag − δS1 · S1 (4.8)
S˙4 =
BS4 + β4 · T
1 + β5 · pS4 · Ag + β6 ·G − δS4 · S4 (4.9)
S˙6 =
BS6 + β7 · pS6 · Ag
1 + β8 · pS1 · Ag − δS6 · S6 (4.10)
T˙ =
BT + β9 · pS1 · Ag + β10 · pS4 · Ag
1 + β11 ·G − δT · T (4.11)
G˙ =
BG + β12 · pS6 · Ag
1 + β13 · pS1 · Ag + β14 · pS4 · Ag − δG ·G (4.12)
S1, S4, S6, T and G represent STAT1, STAT4, STAT6, T-bet and GATA-3 protein
expression, respectively. Ag represents the antigen stimulus, which increases with
time constant 1 per day and decreases with time constant l2 (Figure 4.2). pS1,
pS4 and pS6 represent the phosphorylated forms of STAT1, STAT4 and STAT6,
respectively. Each protein is produced with a basal rate Bi and degraded with
a rate δi. In addition to that, the positive and negative regulatory mechanisms
described by the linear regression analysis are added to the production rate with
weights βj . For simplicity, we only write dynamic equations for the protein
concentrations and not the respective mRNAs; due to their short lifetime, mRNA
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Figure 4.2: Different possible kinetics for the antigen signal. The functions (1 − e(−t)) · e(−l2·t) with
different l2 values used to describe the kinetics of antigen signalling.
concentrations will rather rapidly adapt to the given stimulus and hence assume
quasi-steady states.
STAT1 STAT4 STAT6 T-bet GATA-3
B 0.21 0.24 0.21 0.01 0.11
Table 4.1: Basal production rates
The model written above is composed of an algebraic part (equations 4.1 to
4.7) and a differential part (equations 4.8 to 4.12) and includes all the connections
derived from the linear regression analysis; we assumed that all regulators acted
in an additive manner. We proceeded to fit this model to the normalised titration
data in two steps: first, we fitted the algebraic part to determine the best α and
T values to model the pSTAT intensities; the T and α parameters were estimated
using Wolfram Mathematica 10 independently of the differential equation part of
the model describing transcription factors expression. The pSTAT intensities pS1,
pS4 and pS6 were fitted to the corresponding data values from the IFN-γ, IL-12
and IL-4 titrations, taking the experimental values for the total STAT intensities S1,
S4 and S6 as inputs.
Second, we fitted the parameters of the ODE system describing transcription
factor expression with Matlab using the Data2Dynamics (D2D) framework185,186.
The basal rates Bi were fixed as to obtain the initial conditions derived from the
data (Table 4.1). Equations 4.1 to 4.6 with the previously fitted values for the α and
T parameters were used as inputs. l2, the δ and the β parameters were estimated.
Furthermore, we fitted an error model to the data constituted of an absolute error
Eabs and a relative error Erel to the ODE model.
We first considered the algebraic part of the model; the best-fit parameter
values and their confidence intervals are shown in Table 4.2. The best-fit values for
the T parameters show that cytokine degradation and consumption play a minor
role in our time scale: only the IFN-γ concentration decreases significantly before
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Figure 4.3: Cytokine degradation is slow with half-lifes around 5 days. The functions (1− tanh(t−Ti)
with the fitted values for TIFN-γ , TIL-12 and TIL-4 describe the degradation and consumption of IFN-γ, IL-12
and IL-4 during the five days of culture.
day 5 (Figure 4.3). The values for the α parameters are consistent with our linear
regression analysis: The greatest contributions come from the canonical cytokine
upstream from the STAT (i.e., IFN-γ for pSTAT1, IL-12 for pSTAT4 and IL-4 for
pSTAT6), with smaller additions from IL-12 and IL-4 for pSTAT1 and from IL-4 for
pSTAT4 (Table 4.2).
Effect on Effect of Parameter Value Lower bound Upper bound
IFN-γ Time TIFN-γ 3.45 3.17 3.72
IL-12 Time TIL-12 5.85 5.37 6.33
IL-4 Time TIL-4 5.36 5.16 5.57
pSTAT1 IFN-γ α1 0.34 0.3 0.39
pSTAT1 IL-12 α2 0.21 0.16 0.25
pSTAT1 IL-4 α3 0.22 0.17 0.26
pSTAT4 IL-12 α4 0.49 0.45 0.53
pSTAT4 IL-4 α5 0.13 0.1 0.17
pSTAT6 IL-4 α6 0.54 0.52 0.56
Table 4.2: Parameter values for the best fit of the model describing STAT phosphorylation
Having determined the values of the parameters of the algebraic part of the
model using the experimental values for the total STAT, we could input the func-
tions describing cytokine concentration and pSTAT intensity in the complete model
and estimate the parameters regulating the expression of T-bet, GATA-3, STAT1,
STAT4 and STAT6. To do so, we used only the starting cytokine concentrations
as input values and fitted STAT1, STAT4, STAT6, T-bet and GATA-3 expression to
the corresponding normalised experimental values from the kinetic titration ex-
periments. The fitting procedure was performed 300 times with different starting
values for the parameters generated by latin hypercube sampling187 to ascertain
that a global minimum was found (Supplementary Figure 4.4a); the 95% confid-
ence intervals and the identifiability of the parameters giving the best fit were
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Effect on Effect of Parameter Value Lower bound Upper bound
Antigen Time l2 0.53 0.44 0.61
Stat1 T-bet β1 1.27 1.02 1.57
Stat1 pSTAT1 β2 5.65 4.65 6.82
Stat1 pSTAT4 β3 11.8 9.88 14.06
Stat4 T-bet β4 0.27 0.14 0.42
Stat4 pSTAT4 β5 2.1 0.44 4.28
Stat4 GATA-3 β6 0.83 0.38 1.52
Stat6 pSTAT6 β7 1.51 1.21 1.86
Stat6 pSTAT1 β8 1.31 0.59 2.16
Tbx21 pSTAT1 β9 3.95 3.27 4.89
Tbx21 pSTAT4 β10 3.26 2.66 4.07
Tbx21 GATA-3 β11 6.68 4.90 9.47
Gata3 pSTAT6 β12 4.98 3.93 6.37
Gata3 pSTAT4 β13 9.58 6.09 14.58
Gata3 pSTAT1 β14 9.13 5.06 13.58
Stat1 Degradation δS1 1.56 1.41 1.73
Stat4 Degradation δS4 0.46 0.36 0.55
Stat6 Degradation δS6 0.45 0.42 0.49
Tbx21 Degradation δT 0.27 0.18 0.38
Gata3 Degradation δG 0.46 0.41 0.51
All Absolute error Eabs 0.04 0.03 0.04
All Relative error Erel 0.31 0.29 0.33
Table 4.3: Parameter values for the best fit of the model describing TF regulation
estimated using the profile likelihood188,189. The resulting best-fit parameters
and their confidence intervals are shown in Table 4.3. All fitted parameters were
uniquely defined as determined by the profile likelihood estimations (Figure 4.4b).
The model with the best-fit parameter values allowed a good reproduction of the
global titration data, as illustrated in Figure 4.5 by scatter plots of the data points
versus the model predictions.
Having obtained uniquely defined parameters by fitting the model to the data,
we evaluated the relevance of each interaction in the model based on the linear
regressions. In order to do this, we compared the results of the fit of the complete
model to the fits of all possible models lacking one specific interaction (defined
through a regulator and its target) using the AIC (Table 4.4). Leaving out any
interaction resulted in a significantly worse fit of the model to the data (∆AIC
> 2).
To determine if the dynamical model was able to reproduce the dynamical
behaviour of the system, we selected different conditions for which to compare the
model to the data visually, as the large number of conditions made inspection of
the whole dataset difficult. We simulated the phosphorylation kinetics of the three
STATs in response to IFN-γ, IL-12 and IL-4 separately (Figure 4.6). The model was
able to reproduce the dynamics of STAT phosphorylation (the total STAT values
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Figure 4.4: Fitting the model leads uniquely defined parameters. Profile likelihood estimation of the
parameter values from the differential equation part of the model.
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Figure 4.5: The data correlates to the values generated by the fitted model. The normalised data for
T-bet, GATA-3, STAT1, STAT4 and STAT6 expression from day 1 to day 5 in all conditions was plotted
against the corresponding values computed by the fitted model.
Target T-bet T-bet T-bet GATA-3 GATA-3 GATA-3
Regulator STAT1 STAT4 GATA-3 STAT1 STAT4 STAT6
∆AIC 874.4 463.7 320.7 75.4 62.4 1193.1
Target STAT1 STAT1 STAT1 STAT4 STAT4 STAT4 STAT6 STAT6
Regulator STAT1 STAT4 T-bet STAT4 T-bet GATA-3 STAT1 STAT6
∆AIC 164.7 458.1 207.7 3.5 18.3 16.1 11.4 206.9
Table 4.4: Difference in the AIC value of all possible models lacking one interaction to the complete
model
generated by the model were used for the simulation, and not the data values
used for the fitting procedure of the algebraic part of the model); the simulated
and experimental responses of all three pSTATs to the amounts of IFN-γ, IL-12
and IL-4 used in ‘classical’ Th1 and Th2 cultures (i.e., 10 ng/ml IFN-γ, 5 ng/ml
IL-12 and 10 ng/ml IL-4) are depicted in Figure 4.6a.
In addition, we chose Th1, Th2 and hybrid Th1/2 conditions and considered
transcription factor regulation from day 1 to day 5, and compared the simulated
model values to the experimental values (Figure 4.6b). The up-regulation of T-bet
and GATA-3 was accurately reproduced, although GATA-3 was overestimated in
the classical Th2 conditions. STAT1 and STAT6 dynamics could also be explained
by the model (Figure 4.6c). STAT4 was more problematic, consistently with the
low R2 values from the linear analysis.
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Figure 4.6: The model can reproduce the time courses of up-regulation of the studied factors. a
Phosphorylation of STAT1 (blue), STAT4 (green) and STAT6 (red) downstream of IFN-χ (left), IL-12
(middle) and IL-4 (right) as predicted by the model (solid lines) and as seen in the data (dots). b up-
regulation of T-bet (left) and GATA-3 (right) during differentiation under Th1 (blue), Th2 (red) and
hybrid Th1/2 (purple) conditions as predicted by the model (solid lines) and as seen in the data (dots). c
up-regulation of STAT1 (left), STAT4 (middle) and STAT6 (right) during differentiation under Th1 (blue),
Th2 (red) and hybrid Th1/2 (purple) conditions as predicted by the model (solid lines) and as seen in the
data (dots). The dots represent the normalised geometric mean indices ◦ SD, and the model curves are
shown with the error margins fitted to the data.
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A dynamical model based on the network topology derived from linear regres-
sion analysis was able to describe and quantitatively reproduce the dynamical
behaviour of its main components, in our case, pSTAT1, pSTAT4, pSTAT6, T-bet,
GATA-3, STAT1 and STAT6.
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4.2 The dynamical model reproduces a continuum of
T-bet and GATA-3 expression levels in response
to graded stimuli
Classically, mutual inhibition and auto-activation motifs as present in our model
are thought to give rise to a bistable system in steady state, which would lead to a
digital switch between high T-bet expression and high GATA-3 expression under
mixed Th1-Th2 stimuli156, or a quadristable system allowing for an intermediate
co-expressing steady state as well as a naive low expressing state (MSc dissertation,
E. Pellet). However, our experiments have shown that there is a continuum of
expression patterns of T-bet and GATA-3 in response to titrated cytokine amounts
during differentiation (cf. Figure 2.9). Therefore, we asked which kind of steady
states our parametrised model has.
To analyse the stability of our system upon differentiation in a visually intuitive
manner, we considered the phase plane of T-bet and GATA-3 expression under
quasi-steady state assumption for STAT1, STAT4 and STAT6, i.e., the assumption
that STAT amounts did not vary anymore (S˙1 = S˙4 = S˙1 = 0, Figure 4.7) with fixed
values for the pSTAT intensities. We thus reduced the system to two dimensions,
T-bet and GATA-3. This approach allows to study the system at steady state and
to determine the possible stable expression patterns of T-bet and GATA-3 at the
end of differentiation. Using Wolfram Mathematica 10, we computed the T-bet-
GATA-3 pairs of values at which GATA-3 remains stable by solving G˙ = 0 and
T˙ = 0 for GATA-3 (GATA-3 nullclines, red lines), and those at which T-bet remains
stable by solving for T-bet (T-bet nullclines, blue lines). Thus, the intersection of a
T-bet and GATA-3 nullcline represents a steady state for T-bet and GATA-3. We
also computed the vector field (blue arrows), which shows if T-bet and GATA-3
expression levels are increasing or decreasing at each point of the T-bet-GATA-3
phase plane. We titrated the input Th1 stimuli IL-12 and IFN-γ versus the Th2
stimulus IL-4 and observed the changes in the T-bet-GATA-3 phase plane.
Interestingly, our model has a unique stable steady state that moves along the
axes depending on the cytokine stimuli. Thus the model shows a continuum of T-
bet-GATA-3 expression patterns in response to mixed stimuli rather than division
of the population between GATA-3 and T-bet-expressing cells depending on the
polarising stimuli, which would become manifest by two stable steady states on
the GATA-3 and T-bet axis, respectively (Figure 4.7). This was indeed what we
had previously observed experimentally on day 5 of the IL-12-IL-4 cross-titration
in IFN-γ-producing cells: a unimodal population expressing more T-bet in the
presence of higher Th1 cytokine concentrations, and more GATA-3 in the presence
of higher IL-4 concentrations (see Figure 2.9).
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Figure 4.7: Steady-state behaviour of the dynamical model. Phase plane analysis of T-bet and GATA-3
under the assumption of quasi-steady state for all other variables. The system has only one stable steady
state; its value depends on cytokine inputs and moves gradually in the T-bet-GATA-3 space.
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Figure 4.8: The model quantitatively reproduces independent data from an IL-12-IL-4 crosstitration.
FACS-sorted naive IFN-γ- and IL-4-competent CD4 T cells were activated with APCs and GP61−80 peptide
under the indicated conditions. IL-12 and IL-4 were titrated against each other. T-bet and GATA-3
expression on day 5 as well the the values predicted by the model are shown as heat maps and dot plots.
Having determined that the dynamical model possessed only one steady state
for T-bet and GATA-3 expression, we then considered the quantitative response
of the model to graded mixed Th1-Th2 stimuli during differentiation in the form
of the expression intensity of the master transcription factors. To do so, we
simulated the results of an IL-12-IL-4 cross-titration experiment after five days of
differentiation. Under these conditions, IFN-γ is produced by the Th cells (and not
added in a controlled manner), we extrapolated the IFN-γ concentration based on
the T-bet expression on day 5 using the model for IFN-γ production described in
Chapter 3 (see Figure 3.12):
%IFN-γ+ = 0.9 · T
3.2
0.06 + T3.2
Figure 4.8 shows the comparison of the experimental values of T-bet and GATA-
3 expression to the values predicted by the model with the best-fit parameters
estimated previously. Heatmaps of T-bet and GATA-3 expression show a similar
response to IL-12 and IL-4 (Figure 4.8a) between the experimental data and the
model; T-bet showed, in both cases, an increase in the presence of IL-12 and IFN-γ
and a decrease in the presence of IL-4, while the opposite was true of GATA-3. To
verify that the model was able to quantitatively reproduce the data, we computed
the correlation between the data and predicted values; the model was able to
predict the expression of T-bet and GATA-3 accurately with correlation coefficients
R2 of 0.92 for T-bet and 0.86 for GATA-3 (Figure 4.8b).
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The dynamical model developed in this study has a single, stable fixed point
considering the quasi-steady state for T-bet and GATA-3. The value of this
fixed point moves continuously along the T-bet and GATA-3 axes depending
on the input cytokine stimuli. Furthermore, the model was able to reproduce
accurately the continuum of T-bet and GATA-3 expression levels derived from
an independent IL-12-IL4 cross-titration experiment.
4.3 The novel effects of pSTAT1 and pSTAT4 are T-
bet-independent
The linear models described several novel effects of pSTAT1 and pSTAT4 on
GATA-3, STAT1, STAT4 and STAT6, which were included in the dynamical model.
Specifically, pSTAT1 was predicted to up-regulate STAT1 expression while re-
pressing STAT6 and GATA-3 expression. Moreover, pSTAT4 was predicted to
repress STAT1, STAT4 and GATA-3 expression. Although the selection of the
best-fitting models leading to those interactions was unambiguous according to
the AIC (∆AIC > 2, see Figures 3.5, 3.8 and 3.10), the next best models also fitted
the data well and often substituted one pSTAT effect for a T-bet effect, or added
a T-bet effect to the selected model. For example, the best model for GATA-3
included pSTAT1, pSTAT4 and pSTAT6 as regulators (model A1), the next best
models, according to the AIC, were models C7, in which T-bet replaced both
pSTAT1 and pSTAT4; C3, in which T-bet replaced pSTAT4; C4, in which T-bet
replaced pSTAT1 and C1, in which a T-bet effect was added to that of pSTAT1
and pSTAT4. This is due to the high correlation between pSTAT1, pSTAT4 and
T-bet. It is therefore unclear how unambiguously the linear models can distinguish
between T-bet-dependent and T-bet-independent effects.
To evaluate the importance of these effects in the dynamical model, we com-
pared models corresponding to the linear model predictions with models lacking
pSTAT1 (Figure 4.9a) or pSTAT4 (Figure 4.9b) effects on a specific target protein.
We compared the results of the IFN-γ (for pSTAT1) or IL-12 (for pSTAT4) titrations
to the predictions of the complete model (as predicted by the linear regression
analysis) and of models lacking the studied effects (e.g., repression of GATA-3 by
pSTAT1).
In all cases, the original model reproduced the data significantly better than an
incomplete model, both qualitatively and quantitatively. The absence of a pSTAT1
effect on GATA-3 and STAT6 lead to an overestimation of both factors, while the
positive correlation between STAT1 and IFN-γ was lost if pSTAT1 wasn’t allowed
to regulate its total expression, suggesting an important role for STAT1 in GATA-3,
STAT1 and STAT6 regulation (Figure 4.9a). Similarly, the absence of pSTAT4 effects
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Figure 4.9: The model predicts important novel roles for pSTAT1 and pSTAT4. a Response of GATA-3,
STAT1 and STAT6 to an IFN-χ titration in the presence of IL-12 and IL-4 as predicted by the model (solid
lines) and as seen in the data (dots) for day 4. b Response of GATA-3, STAT1 and STAT4 to an IL-12
titration in the presence of IFN-χ and IL-4 as predicted by the model (solid lines) and as seen in the data
(dots) for day 4. The black lines are predictions by the complete model and the green lines predictions by
a model without pSTAT1 (a) or pSTAT4 (b) effects on the plotted factor. The dots represent the normalised
geometric mean indices ◦ SD, and the model curves are shown with the error margins fitted to the data.
on GATA-3, STAT1 and STAT4 caused the model to predict too high values for
those factors (Figure 4.9b).
Having established that pSTAT1 and pSTAT4 had important effects on GATA-3,
STAT1, STAT4 and STAT6 in our model, we went to test experimentally if those
effects were indeed carried out by the predicted factor, i.e., present in a T-bet-
independent manner. We first considered the role of T-bet in effects downstream
of IFN-χ predicted to be mediated by pSTAT1. To do so, we performed IFN-
χ titrations in Tbx21-/- and T-bet-competent cells and compared the responses
of GATA-3, STAT6 and STAT1 to IFN-χ (Figure 4.10). Repression of GATA-3
and STAT6 through IFN-χ was fully retained in Tbx21-/- cells and hence T-bet-
independent. STAT1 expression also remained IFN-χ-sensitive in the absence of
T-bet, indicating direct transcriptional auto-activation of STAT1. Interestingly, even
though we found T-bet to have a positive effect on STAT1, cells without T-bet had
overall higher STAT1 expression, possibly as an adaptive response to the absence
of T-bet. Thus, the novel effects of IFN-χ on both Th1 and Th2 differentiation
pathways were T-bet-independent and likely mediated directly by pSTAT1.
Next we considered the predicted pSTAT4 effects downstream of IL-12, again
by using Tbx21-/- cells to assess the role of T-bet, but additionally using Stat4-/-
cells ≻ as IL-12 can signal via STAT4 and STAT1. This allowed to test wether the
observed effect downstream of IL-12 was indeed pSTAT4-mediated (Figure 4.11) or
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Figure 4.10: The observed regulatory effects downstream of IFN-γ are T-bet-independent FACS-sorted
WT and Tbx21-/- naive CD4 T cells were activated with APCs and GP61−80 peptide under the indicated
conditions. IFN-γ was titrated, and transcription factor expression levels were measured on day 4 by flow
cytometry. The dose response of GATA-3, STAT6 and STAT1 to IFN-γ in the absence or presence of T-bet
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Figure 4.11: The observed regulatory effects downstream of IL-12 are T-bet-independent. FACS-sorted
WT, Tbx21-/- and Stat4-/- naive CD4 T cells were activated with APCs and GP61−80 peptide under the
indicated conditions. IL-12 was titrated, and transcription factor expression levels were measured on day
4 by flow cytometry. The dose response of GATA-3, STAT1 and STAT4 to IL-12 in the absence or presence
of T-bet or STAT4 on day 4 of differentiation are shown in Th1 conditions (blue) for the Th1 factors and in
hybrid conditions (purple) for the Th2 factors. Normalised geometric mean indices are plotted.
depended on T-bet or the activation of STAT1 by IL-12. The repression of GATA-3
by IL-12 was independent of T-bet and STAT1 but strongly dependent on STAT4.
Similarly, STAT1 repression by IL-12 did not require T-bet; in addition to that, in
the absence of STAT4, the STAT1 levels were somewhat lower than in WT cells
and unresponsive to IL-12. Finally, the expression of STAT4 depended strongly
on T-bet: The STAT4 levels were nearly zero in the absence of the latter. Given
this positive effect of T-bet, the observed decrease of STAT4 levels with the IL-12
dose in T-bet-competent cells might be attributed to an inhibitory effect of STAT4
on its own expression rather than a negative T-bet effect. Together these findings
indicate that STAT4 mediates the repression of both Th1 and Th2 differentiation
pathways in a T-bet-independent manner.
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The dynamical model was able to explain the emergence of a continuum of
mixed Th1-Th2 phenotypes in response to ambiguous polarising signals while
reproducing the up-regulation dynamics of the main transcription factors.
Furthermore, it predicted important, T-bet-independent roles for both pSTAT1
and pSTAT4, which we were able to confirm experimentally.
4.4 Conclusion
A simple dynamical model based on the network topology derived from linear re-
gression analysis was developed, including all interactions predicted by the linear
models in the form of ordinary differential equation for the total protein expression
and linear combinations of cytokine concentration for STAT phosphorylation. The
parameters of the model were estimated by fitting the latter to the titration data,
resulting in all parameters being uniquely defined. The fitted model was able to re-
produce the kinetics of up-regulation of the STATs, T-bet and GATA-3 as well as of
phosphorylation of the STATs in response to IFN-γ, IL-12 and IL-4. Furthermore, it
could replicate independent T-bet and GATA-3 protein expression data generated
during an IL-12-IL-4 cross-titration. Phase plane analysis of the model for T-bet
and GATA-3 at quasi-steady-state showed a single stable steady state, predicting
a continuum of T-bet-GATA-3 co-expression patterns at the single-cell level in
opposition to splitted T-bet- or GATA-3-expressing populations, as was observed
experimentally. Finally, the model described important, T-bet independent effects
of pSTAT1 and pSTAT4 on STAT1, STAT6 and GATA-3 as well as STAT1, STAT4
and GATA-3, respectively, which were confirmed experimentally using Tbx21-/-
and Stat4-/- cells.

Chapter 5
Discussion
In nearly three decades of history of Th cell research, many molecular interactions
that govern the functional phenotypes have been defined in great detail. Nev-
ertheless, a surprising finding of a continuum of hybrid Th1/Th2 states83,84,82,
with hybrid cells being maintained stably in memory phase70,82 has recently been
made. Here we have developed a systematic approach for the reconstruction
of regulatory networks that integrates multiple cytokine stimuli and applied it
to Th cell differentiation, more specifically to Th1, Th2 and hybrid Th1/2 cell
differentiation. Without investing prior knowledge about the interactions between
the known key players in Th1 and Th2 differentiation, we recovered all previously
well-documented regulatory interactions and uncovered numerous novel ones.
We were able to develop a dynamical model of Th1-Th2 cell differentiation based
on those findings that accounts for continuous levels of T-bet and GATA-3 co-
expression. Here, we will summarise our findings and discuss their significance
and importance for cellular differentiation and plasticity.
5.1 Summary of the Th1-Th2 signalling network
Using linear regression analysis on time-resolved dose-response data, we were
able to infer the signalling network leading to hybrid Th1/2 cell differentiation.
The network described in this work is summarised in Figure 5.1. Figure 5.1a
shows the relationships between cytokines, transcription factor activation and
transcription factor expression; Figure 5.1b recapitulates the strength of the effects
on gene expression, and finally, Figure 5.1c outlines the principal ways of cytokine
production regulation. This network has implications for the understanding of
hybrid differentiation and the existence of a continuum between Th1 and Th2
phenotypes. We classified the interactions detected by our analysis into three
types: auto-activating, mutually inhibiting and dampening interactions. While
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Figure 5.1: The results from the regression analysis were used to design a complete model of Th1/Th2
differentiation from the cytokine level to the MTF level and back to the cytokines. a Graphical rep-
resentation of the cytokine-STAT-MTF interactions. b Numerical summary of the interactions between
transcription factors on day 4 of culture. c Model of cytokine production regulation during recall response.
most of the mechanisms uncovered during the linear analysis were described
in previous publications, showing that the method used to reconstruct the gene
network is efficient, several novel interactions were also predicted (novel meaning
here that it has not yet been described in murine Th cells). Below is a list of all
interactions, their type as well as the references to previous publications.
Auto-activating interactions occur when one member of a pathway induces or
up-regulates a member of the same pathway. These mechanisms may help
maintain the acquired phenotype after differentiation and counteract mutual
inhibitory mechanisms in the presence of adverse stimuli. The following
interactions are auto-activating in our network:
In the Th1-pathway:
• The phosphorylation of STAT1 downstream of IFN-γ 171,172
• The phosphorylation of STAT4 downstream of IL-12173,174
• The phosphorylation of STAT1 downstream of IL-12190
• The up-regulation of T-bet by pSTAT194,191,96
• The up-regulation of T-bet by pSTAT4191,96
• The up-regulation of STAT1 by T-bet (novel)
• The up-regulation of STAT4 by T-bet (novel)
• The up-regulation of STAT1 by pSTAT1 (novel)
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• The up-regulation of IFN-γ by T-bet46
In the Th2-pathway:
• The phosphorylation of STAT6 downstream of IL-4175,176
• The up-regulation of GATA-3 by pSTAT6192
• The up-regulation of STAT6 by pSTAT6 (novel)
• The up-regulation of IL-4 by GATA-348
Mutually inhibiting interactions between the Th1 and the Th2 modules occur
when one member of a pathway represses a member of the other pathway.
Mutually inhibiting mechanisms limit the effects of signalling from the ad-
verse pathway and insure that hybrid cells do not cumulate full Th1 and Th2
functions, but display reduced Th1 and Th2 functions. They are respons-
ible for the balance between Th1-like and Th2-like phenotypic properties in
hybrid cells. Those mechanisms include the following interactions in our
system:
From the Th1-pathway to the Th2-pathway:
• The down-regulation of GATA-3 by pSTAT1 (novel)
• The down-regulation of GATA-3 by pSTAT4 (novel, although a negat-
ive correlation between IL-12 and GATA-3 was shown122, the roles of
STAT4 and T-bet were not studied)
• The down-regulation of STAT6 by pSTAT1 (novel)
From the Th2-pathway to the Th1 pathway:
• The down-regulation of T-bet by GATA-3 (novel)
• The down-regulation of STAT4 by GATA-3122,121
Dampening interactions occur when one member of a pathway down-regulates
or represses a member of the same pathway, or up-regulates a member of
the other pathway. Those mechanisms might support the development of
hybrid cells by putting a break on one pathway to allow adverse signalling
to act and also prevent over-activation of the cells in continued presence of
cytokine signals. In our network, they include:
In the Th1-pathway:
• The down-regulation of STAT1 by pSTAT4 (novel)
• The down-regulation of STAT4 by pSTAT4 (novel)
In the Th2-pathway:
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• The phosphorylation of STAT1 downstream of IL-4 (novel, described in
human colorectal cell lines193, in CD8 T cells194 and in Th2, but not Th1
cells195)
• The phosphorylation of STAT4 downstream of IL-4 (novel, described in
NK cells196)
Interestingly, an important part of the mutual inhibition was mediated by the
STATs and not the master transcription factors themselves. Indeed, while GATA-3
repressed T-bet and STAT4, the repression of the Th2-pathway was carried out
by pSTAT1 and pSTAT4 and was thus transient, as the STATs do not remain
phosphorylated long after removal of the stimuli (e.g., half-life of pSTAT1 < 2h197).
While a negative effect of IL-12 signalling on GATA-3 expression was described122,
this predates the discovery of T-bet as a Th1 master transcription factor, and thus
did not directly imply STAT4, as our work now clarified. The predominant role of
phosphorylated STAT protein over master transcription factors in regulating the
expression of the key Th1 and Th2 proteins explains how a continuum of graded T-
bet and GATA-3 expression is possible: while direct inhibition and auto-activation
of T-bet and GATA-3 would result in a system having at most four possible stable
expression patterns (corresponding to the naive, Th1, Th2 and hybrid phenotype),
the transient nature of the STAT signals makes them rheostats in the Th1/Th2
system by changing the position of the single stable steady state in function of the
cytokine inputs. This helps explain how a continuum of intermediate phenotypes
can emerge in the presence of mutual repression.
5.2 STAT activation
STAT signalling is not only essential to the immune system, but is involved in
several developmental processes and oncogenesis (e.g., STAT1 plays a role in
mammary gland development198 and gliomas199). Over 40 different factors can
activate STAT signalling pathways, thus regulating processes such as apoptosis,
differentiation and proliferation200. The study of quantitative STAT regulation in
response to different cytokines is thus not only relevant to the Th cell differenti-
ation pathways considered in this study. The analysis of STAT phosphorylation
downstream of the studied cytokines led to several interesting observations: the
long maintenance of STAT phosphorylation during a cell differentiation process,
the presence of several cross-activations outside the canonical pathways and even
between the Th1 and Th2 pathways, and the absence of negative effects directly
correlating to specific cytokine signals.
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The kinetics of STAT phosphorylation allow for a rewiring of the signalling
network
We observed that, although transient, STAT phosphorylation was long-lasting in
physiological conditions, in contrast to the prevailing paradigm in signal trans-
duction research studying short-term signalling dynamics (over at most a few
hours199). As phosphorylation and de-phosphorylation of STAT molecules are
fast processes and thus pSTATs have short half-lives (e.g., half-life of pSTAT1 <
2h in Daudi B lymphoblastoid cells197), this is very likely the result of continu-
ous phosphorylation in the presence of cytokines. The setup we used for Th cell
differentiation included the incubation of naive cells directly after their ex vivo
isolation until the end of the experiment five days later. Under such conditions,
the peak of STAT1, STAT4 and STAT6 phosphorylation downstream of IFN-γ,
IL-12 and IL-4, respectively, could be observed between day 3 and day 4. Fur-
thermore, phosphorylation was unimodal among the cell population during the
whole differentiation week, indicating that all cells were actively transducing
the cytokine signals during that time. This prolonged phosphorylation period
could be relevant for several aspects of Th cell differentiation: it could allow a
cell to respond differentially to a short cytokine exposure than to a prolonged
exposure, minimising unwanted differentiation or activation of the immune cells
(e.g., growth inhibition by pSTAT1201); it could also allow the active STATs to
act as transcription factors for longer periods, thus fine-tuning the regulation of
their target genes, specifically the Stat genes themselves, leading to rewiring of
the signalling network already during differentiation and modulating the cellular
response.
The starting and ending time points of STAT activation seemed to be controlled
by several factors, including cytokine availability and cytokine receptor expression.
Indeed, regulation of cytokine receptors takes place during differentiation (Sup-
plemental Figure 7.2). The β2 chain of the IL-12 receptor has a very low expression
in naive cells, is up-regulated by IFN-γ signalling and repressed by IL-4 sig-
nalling202,122,123 (Supplemental Figure 7.2a). We found IL12Rβ2 to be up-regulated
strongly in the presence of IFN-γ between day 1 and day 3; which correlates with
the intensity of STAT4 phosphorylation downstream of IL-12: STAT4 activation
peaks at a later time than STAT1 and STAT6 activation. The IFN-γ receptor α
chain is down-regulated during Th1 differentiation203,204, which could explain the
absence of STAT1 phosphorylation in Th1 cells at the end of differentiation, when
both pSTAT4 and pSTAT6 can be observed. Furthermore, as an important role for
STAT1 signalling during Th1 differentiation is the up-regulation of components
of the IL-12 signalling pathway, strong STAT1 signalling is not needed anymore
for Th1 differentiation once Th cells are fully IL-12 responsive. As STAT1 has
been shown to exert growth inhibition downstream of IFN-γ 201, limiting STAT1
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phosphorylation could be crucial for obtaining an effective immune response. The
α chain of the IL-4 receptor is strongly up-regulated in the presence of IL-4205
(Supplemental Figure 7.2b), making GATA-3-expressing cells more responsive
to subsequent IL-4 signals than their Th1 counterparts and thus contributing to
the maintenance of GATA-3 expression. These facts are consistent with STAT
regulation by pSTATs and participate in the rewiring of the signalling network, as
will be discussed in more details below.
Non-canonical effects on STAT phosphorylation are positive and can favour
the opposite pathway
As mentioned above, several non-canonical inductions of STAT phosphorylation
by cytokines were visible in our data: the activation of STAT1 downstream of
IL-12190, and the activation of STAT1 and STAT4 downstream of IL-4. According
to our model, IFN-γ was responsible for the activation of STAT1 during the first
two days of differentiation, while IL-12’s (lesser) effect was most visible on days 3
and 4. Thus, IFN-γ and IL-12 could be acting additively to achieve the required
amount and duration of STAT1 activation for differentiation in the Th1 direction,
potentially minimising the inhibitory effect of STAT1 on cell proliferation. The
effect of IL-4 was more surprising, as its canonical pathway through STAT6 induces
Th2 differentiation. The activation of Th1-factors could be useful for permitting
more plasticity and favouring hybrid phenotypes, or leading to the regulation of
STAT1 and STAT4 target genes that are not Th1-specific; it is unclear which form of
dimers are formed by STAT1 and STAT4 downstream of IL-4, so the target genes of
IL-4-induced pSTAT1 could be different from those of the IFN-γ induced pSTAT1.
The linear regression analysis revealed no direct negative effects of any cy-
tokine on the phosphorylation of any STAT. Although a reduction in pSTAT4 levels
could be observed at day 4 of culture in the presence of IL-4, this is most likely ex-
plained by the GATA-3-mediated repression of STAT4 after GATA-3 up-regulation
downstream of IL-4. Even though suppressors of cytokine signalling (SOCS)179,180
protein have been implicated in the repression of the IFN-γ 206, IL-12207 and IL-4208
pathways, the absence of negative effects on STAT phosphorylation in this study
study suggests that SOCS proteins play no cytokine-specific role in primary in
vitro differentiation, or that their negative effects are generally masked by the
STAT-activating cytokine effects. SOCS protein could act by regulating general
STAT phosphorylation independently of the cytokine stimuli received by the cells.
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5.3 Transcription factor regulation
Master transcription factors such as T-bet and GATA-3 are defined by the fact that
they are necessary and sufficient for programming a specific cell fate69. This sim-
plified paradigm also considers that a master transcription factor is only expressed
in cells having the corresponding cell fate; however, more and more cases of stable
co-expression of so-called ‘master transcription factors’ have been described in
differentiated Th cell (e.g., FoxP3 and Bcl-6209, T-bet and GATA-370 or GATA-3
and FoxP3210). Furthermore, the discovery of new Th cell lineages relying on
STAT signalling40 and the study of STAT binding and the resulting epigenetic
modifications211 has led to a re-evaluation of the importance and roles of STAT
transcription factors for Th cell differentiation. Those facts motivated our detailed
analysis of the response of T-bet, GATA-3 and STAT protein dose-response to
polarising cytokines.
This study analysed in detail the expression of five transcription factors crucial
for Th1 and Th2 cell differentiation: T-bet, GATA-3, STAT1, STAT4 and STAT6.
As master transcription factors, T-bet and GATA-3 are responsible for regulating
many effector proteins in Th1 and Th2 cells. Although many aspects of their regu-
lation have been studied, we focused on the mechanisms allowing the emergence
of mixed Th1-Th2 phenotypes. We discovered that the expression levels of the
STAT proteins are also dynamically regulated by the phosphorylated STATs them-
selves and GATA-3. The regulation of STAT proteins during differentiation partly
mediated the rewiring of the signalling pathways, thus modulating the response
of the cells to cytokines during a secondary antigen encounter and during primary
differentiation, as STAT phosphorylation was found to be long-lasting und could
thus be influenced by rewiring during the late phase of differentiation. The effect
of TCR-induced transcription factors on T-bet and GATA-3 was also looked into,
as high antigen concentrations has been reported to lead to Th1 differentiation and
low concentrations to Th2 development133,134,135,136. STAT5 downstream of IL-2
co-operate with GATA-3 to induce IL-4 in Th2 cells108,112,113, but was not found to
be differentially expressed in this study (data not shown).
Several other transcription factors that have not been considered here have
been implicated in Th1 and Th2 differentiation. Eomes97, Runx398,97, Hlx99 and
Ets transcription factors100,101 co-operate with T-bet to induce IFN-γ expression,
while Onecut2 might form a positive feedback loop on T-bet expression102. In
the Th2 pathway, c-Maf and junB are involved in IL-4 regulation212,114,116. Dec2 is
induced by GATA-3 and in turn induces IL-4, IL-5 and IL-3 expression119,47,123. T
cell factor 1 was shown to up-regulate GATA-3 and repress IFN-γ downstream of
TCR signalling59. The latter negative regulation was also carried out by c-Maf114.
Furthermore, Ikaros silences T-bet and IFN-γ in Th2 cells125,126. These transcrip-
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tion factors would be good candidates for further analysis using dose-response
experiments and linear regression; however, the mostly high coefficients of de-
termination obtained with the transcription factor considered here suggest that
other factors play a minor role in the determination of the quantitative response
during primary differentiation. This observation is in line with the fact that ectopic
expression of T-bet or GATA-3 alone, but not of the other transcription factors in
isolation, drives the expression of Th1 or Th2 cytokines, respectively.
Antigen concentration does not bias Th cell differentiation when Il12-/-Ifng-/-
APCs are used
Our data showed no specific correlation between antigen concentration and Th1
or Th2 differentiation, but a general higher protein expression with higher antigen
doses. However, a correlation between lineage decision and strength of antigen
stimulus has been shown previously133,134,135,136. One study136 attributed the
correlation between antigen dose and Th1 differentiation to the up-regulation of
CD40L on the Th cells, leading to IL-12 production by the dendritic cells used as
APCs; as the APCs used in this study were IL-12-deficient, this effect could not
be observed here. Other work133,134 linked this effect to the abrogation of early
IL-2-induced IL-4 production by the Th cells. Another study135 stated that this bias
was unlikely to be due to autocrine IL-4 signalling. However, the mouse strain
used (transgenic mice with a TCR specific for the carboxy terminus of pigeon
cytochrome c on the B10.a background) was different than the one used in this
study (transgenic mice with a TCR specific for the GP61−80 petide on the C57BL/6
background), possibly changing the balance of Th1/Th2 cytokines produced upon
primary stimulation. Indeed, no other work analysed the response to titrated
antigenic peptide in LCMV-specific Th cells. The discrepancy between our data
and the published data led us not to consider the dose of antigen triggering TCR
signalling any further in this work. A detailed study of the dose-response of signal
transcription downstream of the TCR is beyond the frame of this study; it could,
however, help infer the mechanisms involved and explain the differences between
the experiments shown here and previously published observations.
Phosphorylated STATs play a central role in transcription factor regulation dur-
ing Th1-Th2 cell differentiation
In general, STAT proteins are known to activate the expression of their target genes,
often lineage-defining ones, as is the case with pSTAT1 and pSTAT4 inducing T-bet
and pSTAT6 inducing GATA-3; only few direct transcriptional repressive mech-
anisms have been documented213,214 until evidence of the induction of repressive
epigenetic modifications by the STATs has been published150. We found evidence
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of several negative regulations by the pSTATs (i.e., the repression of GATA-3 and
STAT6 by pSTAT1 and of STAT1, STAT4 and GATA-3 by pSTAT4) and novel posit-
ive regulations. Different mechanisms have been proposed for gene regulation by
the STATs, including direct initiation of gene regulation and creation of epigenetic
patterns around their binding sites211. STAT-dependent permissive epigenetic
patterns include high levels of H3K4me3, high levels of H3K36me3 and low levels
of H3K27me3. In contrast, repressive patterns include high levels of H3K27me3
and low levels of H3K36me3150. In agreement with our findings of repressive ac-
tions of pSTAT4, STAT4 binding to the Stat4, Gata3 and Stat1 genes was shown150.
Although the epigenetic patterns around the binding sites could not be identified
as clearly permissive or repressive, the expression of STAT1 and GATA-3 were
increased in STAT4-deficient Th1 cells compared to wild-type (by a factor of about
1.5 for STAT1 and 5.9 for GATA-3150), consistent with our own observation in
differentiating Stat4-/- cells. No ChIP-Seq data is available for STAT1 binding
in murine Th cells. Information about the binding of STAT1 to the Gata3 and
Stat6 genes as well as comparisons of their expression levels in differentiating
Stat1-/- T helper cells would be helpful in testing the predictions of our models on
these points. A study of STAT1 DNA-binding activity and induction of epigenetic
modifications would be of high relevance, as the central role of IFN-γ-controlled
(and also IL-12-controlled) STAT1 in transcription factor expression regulation
seems to have been hitherto underappreciated. STAT1 not only acts as an inducer
of T-bet, but also auto-activates and potentiates STAT4 signalling as discussed in
the previous section and further supports Th1 differentiation by repressing both
STAT6 and GATA-3.
An unresolved question is to what extent the intricate activations and inhibi-
tions described here are T cell specific. For example, auto-activation of STAT1 and
auto-inhibition of STAT4 might serve specific functions in determining Th cell fate,
but might not be relevant in other cell types. T cell specificity might be achieved
by enhancers that are selectively active in T cells.
The timescale of T-bet and GATA-3 regulation is shorter than that of STAT
regulation
The main assumption we made for the linear regression analysis was that the
effects of the pSTATs on transcription factor expression were cumulative over time,
and that each transcription factor could have a different ‘memory’ for binding of
pSTATs in the past. This assumption is based on several facts: first, contrary to
phosphorylation or de-phosphorylation, which happen in a timescale of minutes
to hours197, protein half-lives are in a timescale of hours to days, meaning that
the protein produced following the binding of a transcription factor could still
be present in the cell for days once the regulator is not bound anymore. Second,
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transcription factors are known to induce epigenetic modifications that modulate
the expression level of their targets durably.
During our evaluation of the parameter quantifying memory in the linear
models, we found that T-bet and GATA-3 were relatively little influenced by past
binding of their regulators in comparison to STAT proteins. These differences
could be due to differences in protein half-life (e.g., GATA-3 has a half-life of
about 1 hour215, whereas STAT1’s half-life is about 16 to 20 hours216) or/and to
a different type of regulation: an acute regulation of transcription would have
shorter-lasting effects than the induction of epigenetic changes at the target gene’s
locus. This difference in transcription factor binding ‘memory’ suggests that
GATA-3 and T-bet expression stays plastic during differentiation, and thus can
react faster to changes in the signalling environment, whereas STAT expression
is more stable. A global mapping of H3K4me3 and H3K27me3 showed that,
while cytokine genes show a pattern consistent with terminal commitment in
differentiated cell, exhibiting permissive marks for the cells of the corresponding
lineage and repressive marks for the others, master transcription factor genes are
in a bivalent poised state, i.e., exhibit both repressive and permissive marks149.
That bivalent state seems to allow a greater expression flexibility217. Similarly, the
epigenetic patterns on the STAT loci were undetermined; a systematic analysis of
the epigenetic changes at the STAT and master transcription factor loci following
stimulation with different cytokine doses and combinations could help unravel the
mechanisms implicated in the fast versus slow regulation of master transcription
factors versus STATs.
We used only one memory parameter per linear model, i.e., the effects of all
regulators on a specific target decrease with time at the same rate. This is an
assumption we made for simplicity’s sake as the models were fitting the data well.
However, more accurate models would have a different memory parameter for
each regulator, as there is no biological reason suggesting that all transcription
factors act in a similar manner on a common target; on the contrary, not only are
there repressors and activators, but some transcription factors act on the epigenetic
level, other activate or repress transcription more directly while some recruit other
transcription factors to the loci they bind to. Thus, a more detailed computational
analysis could help further unravel the mechanisms at work.
Synergistic effects of cytokines
In addition to the direct effects of the pSTATs on the expression of T-bet and
GATA-3 the linear analysis described, we observed complex effects when visually
analysing the data: IFN-γ seemed to potentiate the effects of IL-12; in addition to
that, IL-4 diminished the effect of IL-12 on T-bet: in its presence, IL-12 was not
sufficient for optimal T-bet expression anymore82. Those effects were not directly
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described by the equations describing T-bet or GATA-3 expression, neither in the
linear models, nor in the dynamical model as only additive effects of the pSTATs
were included. However, those observations cannot only be explained by potential
direct synergetic effects of the pSTATs on their targets T-bet and GATA-3, but also
by indirect effects through the regulation of signalling pathway components seen
in this study and other published work. In the case of IFN-γ and IL-12 augmenting
each other’s effects on T-bet and GATA-3, it could be mediated by T-bet itself:
both pSTAT1 and pSTAT4 increase T-bet expression, which in turn up-regulates
STAT1 and STAT4. Furthermore, the IL-12Rβ2 chain is up-regulated by IFN-γ
and repressed by IL-4202,122,123, thus modulating the sensitivity of the cells to IL-12.
An analogous mechanism could be in place to explain the effect of pSTAT6 on
the up-regulation of T-bet: GATA-3 is up-regulated by pSTAT6, and was found
to down-regulate both STAT4 and T-bet in this work. This could be why STAT1
activation by IFN-γ is necessary to obtain a unimodal T-bet up-regulation in hybrid
Th1/2 cells82.
STAT regulation showed similar effects of cytokine combinations as master
transcription factor expression. The fact that IL-12 does not seem to down-regulate
STAT1 in the absence of IFN-γ could be explained by the fact that IFN-γ is needed
to up-regulate STAT1, which is expressed only at a basal level in the absence of
the latter, and thus cannot be further down-regulated by pSTAT4 downstream of
IL-12, or by the fact that IFN-γ is needed to achieve IL-12 responsiveness96. The
latter could also explain the enhanced repression of STAT4 downstream of IL-12
in the presence of IFN-γ. The reduced effect of IFN-γ on STAT1 in the presence of
IL-12 could be linked to the down-regulation of the IFNgRα chain during IL-12-
favoured Th1 differentiation203,204. The down-regulation of STAT4 in response to
IL-4 is, according to our model, GATA-3-mediated and weak compared to other
effects on STAT4, and could thus be masked by the up-regulation in response to
IFN-γ.
Network rewiring occurs during primary differentiation
We discussed earlier how the kinetics of STAT phosphorylation are controlled,
mainly through regulation of total STAT and cytokine receptor expression. These
regulations act in a cumulative manner and contribute to the rewiring of the sig-
nalling network. Network rewiring is the process that makes the topology of a
network dynamic, allowing for sequential effects to lead to a correct final differ-
entiated state. It has been shown to be of importance in several developmental
processes218 and is relevant to cancer biology and treatment219.
Our data and earlier publication show evidence of extensive network rewiring
during Th cell differentiation. One clear example of rewiring in the settings used
in this work is the IFN-γ pathway: naive Th cells are IFN-γ responsive, as can
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be seen by a fast phosphorylation of STAT1 in presence of IFN-γ. During Th1
differentiation, The IFN-γ receptor is down-regulated203,204 and no pSTAT1 can be
detected in Th1 cells on day 5 of culture, in contrast to pSTAT4 and pSTAT6 that are
still present. Similar mechanisms can be observed in other parts of the Th network;
indeed, as STAT4 is up-regulated by T-bet and STAT1, so is the IL-12 receptor96,
increasing the potential of IL-12 signalling; the lower levels of IL-4 receptor in
Th1 cells are mirrored by the down-regulation of STAT6 by pSTAT1. The effect of
the down-regulation of the IFN-γ receptor in Th1 cells203,204 could be augmented
by the repression of STAT1 by pSTAT4. Thus, by regulating the expression of
total STAT proteins and cytokine receptors, the potential of the cell to receive
a signal is modified, which can help stabilise an acquired phenotype, prevent
over-activation of a specific pathway, and regulate the plasticity of the cells220. In
addition to that, cytokines influence cell proliferation (Supplementary Figure 7.9),
which emphasises the need for a fine-tuned control of cytokine responsiveness.
Finally, rewiring of the network during differentiation allow the cells to respond
differentially to a specific stimulus depending on their environment and could be
crucial for permitting graded T-bet and GATA-3 expression. In this context, the
rewiring of the network during primary differentiation by long activated STATs
could be primordial.
Direct auto-activation of T-bet and GATA-3 does not significantly improve the
model’s predictions
Auto-activation is an important motif in cell differentiation and lineage decision,
as both direct and indirect auto-activating mechanisms of lineage-specific factors
can help maintain the cell phenotype. GATA-3 has been shown to trans-activate its
own gene117,118, and while a similar mechanism has been proposed for T-bet, only
an indirect loop has been published102. Despite these facts, both our linear analysis
and dynamical models lack auto-activatory loops. Regulatory loops cannot be
described by linear models, so that the topology resulting from our regression
analysis could not include them; however, based on the literature, we still tested
dynamical models including auto-activatory effects. Surprisingly, the addition
of auto-activatory terms for T-bet and GATA-3 did not improve the model fit,
suggesting that auto-activation does not play a significant role in the settings
under which T-bet and GATA-3 were studied in this work. As we studied the
system under external stimulation (i.e., cytokine signals), it could be that those
responses are much stronger than auto-activation and thus mask the contribution
of the latter. Auto-activation would then become important in the resting cells,
once no differentiating cytokine signals are present anymore.
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5.4 Cytokine recall responses are predicted well by T-
bet and GATA-3 levels
Cytokines are the main effector molecules produced by Th cells and their regula-
tion has been extensively studied. Here, we focused on the response to gradual
and mixed Th1-Th2 stimuli, and used the percentage of cytokine producers after
TCR re-stimulation in differentiated cells as a quantitative measure of cell function
(as cytokine expression is stochastic even in otherwise unimodal T cell popula-
tions221). Cytokine production can be regulated at the epigenetic level as well
as by direct activation of transcription by several transcription factors; here, we
summarise some of the regulatory mechanisms relevant for this study modulating
the expression of IFN-γ, IL-2, TNF-α, IL-4, IL-13 and IL-10.
The expression of IFN-γ is up-regulated by T-bet46, STAT495,222, Hlx223, Runx398,
Eomes97 and members of the Ets family100,101. In contrast, GATA-3 represses IFN-
γ expression by inducing repressing histone marks124,123 and by repressing the
Runx3-Eomes-induced up-regulation of IFN-γ expression97. However, linear re-
gression analysis found that T-bet alone was a good predictor of the frequency of
IFN-γ expressing cells (in agreement with a detailed study of IFN-γ expression
in Th1 cells224), suggesting that T-bet is the limiting factor among the positive
regulators of IFN-γ and that direct negative effects of GATA-3 are negligible in our
setup. Alternatively, the per cell amount of IFN-γ, as opposed to the percent of
producers, could be regulated by other transcription factors than T-bet, although it
was shown that T-bet was also a good predictor of the per-cell amount of IFN-γ 224.
IL-2 production is strongly up-regulated by transcription factors downstream
of the TCR such as NFATs, OCT-1 and the NF-κB family members p65 (RelA) and
c-Rel225. T-bet has been shown to form heterodimers with RelA, thus preventing
the up-regulation of IL-2 by the latter226; furthermore, Ikaros, a Th2 protein,
was shown to repress IL-2 by maintaining hypoacetylated histones227. However,
linear regression analysis predicted that IL-2 was negatively regulated by GATA-3
and not T-bet, although GATA-3 was not found to bind the IL-2 locus123. The
effect is unlikely to be mediated by STAT6, as pSTAT6 was not found at the IL-2
locus either150. These results suggest that, in this particular setting, IL-2 could be
negatively regulated by a GATA-3 controlled factor, or by GATA-3 itself, perhaps
via a distal enhancer causing the lack of binding detection in the ChIP-experiments.
TNF-α production is highly regulated in a post-transcriptional manner228.
The p38-MAPK pathway downstream of LPS positively regulates the stability
of TNF-α mRNA229, while IL-10 negatively interferes with TNF-α production230.
IFN-γ is linked to TNF-α up-regulation231. Absence of IL-4 has been associated
with an increase in TNF-α in some settings232; furthermore, a decrease in TNF-α
was linked with GATA-3 over-expression233. Linear regression analysis allowed
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to accurately predict TNF-α expression based on GATA-3 expression; while the
mechanism underlying this correlation is unclear, the finding is coherent with
general knowledge about TNF-α expression being higher in Th1 cells than in Th2
cells.
Although IL-10 has originally been described as a Th2 cytokine234, it is ex-
pressed by Th1 cells in several conditions235,236. Several proteins implicated in
Th1 and Th2 differentiation have been shown to play a role in IL-10 regulation.
The transcription factor c-Maf is essential for IL-10 expression237; Lck, a tyrosine
kinase, has been associated with the up-regulation of IL-10 in Th1 cells238; STAT3
downstream of IL-12-family cytokines has been implicated in positive IL-10 reg-
ulation239. TGF-β and ICOS are also linked to IL-10 expression240,241. As IL-10
expression could not be predicted accurately by T-bet/and or GATA-3, it is prob-
able that its expression is mainly regulated by other transcription factors.
5.5 Limitations of the computational methods
We used linear regression analysis on protein data from multiple stimuli titration
experiments to compute a network of Th1 and Th2 signalling. Linear regression is
a robust, unbiased method, and allowed us to reconstruct the known signalling net-
work implicated in Th1 and Th2 cell differentiation as well as to discover hitherto
undescribed mechanisms. However, it has some limitations, the main one being
that this method does not consider causality, which also includes direct versus
indirect interactions. Direct interactions can only partially be distinguished from
indirect interactions because some factors strongly correlate (e.g., STAT1/STAT4
and T-bet, STAT6 and GATA-3). An experimental approach is necessary to clarify
which of two correlating factors is responsible for the observed effect. Linear
models describe correlations between factors and contain no information about
causality; regulatees and regulators can exchange places without influencing the
results of the modelling. Here, we benefitted from being able to assign regulators
and regulatees and considered a hierarchy of such regulator-regulatee groups. We
used the results of the linear regression analysis as a guide for experiments that
established wether STAT effects were direct or mediated by T-bet.
Furthermore, linear regression can only describe signalling going one way,
and not discover loops. However, if the active form of a transcription factor can
be distinguished from the total protein, as is the case with STAT proteins, auto-
activation can be discovered. The linear approach took each time point separately
in consideration, thus not explaining any of the dynamics of the networks.
To complement the linear regression approach, we built a dynamical model
based on ordinary differential equations. The structure of such a model directly im-
plies causality between factors and makes mechanistic assumptions. Furthermore,
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a single model is used to describe all factors at all time points, thus reproducing
the dynamics and all interactions of the studied system at once. The model we
describe here is able to reproduce the general behaviour of the system and in-
dependent data as well as the principal dynamics, thus validating the network
topology, there are some remaining discrepancies. Both T-bet and GATA-3 are
somewhat over-estimated at late time points; the peak of STAT4 expression present
in the data at day 3 is not visible in the model, and STAT6 up-regulation starts
too early. The model we used in this work is kept very simple, as each protein is
described by a single rate equation for its production. Detailed dynamical models
would describe the production of a functional transcription factor through several
equations corresponding, for example, to mRNA transcription, mRNA maturation,
nuclear export of mRNA, translation to protein, protein modifications and nuclear
import of the protein. Thus, our model summarises transcription, translation
and eventual post-translational modifications in a single equation, which may
partly explain why the kinetics of up-regulation are not reproduced accurately
by the model. Furthermore, we postulated that STAT phosphorylation could be
described as a linear process depending only on extrapolated cytokine availability.
Although the time courses of STAT phosphorylation are reproduced accurately
by the model, it should be kept in mind that cytokine concentrations were not
measured during the cultures and are thus inferred values based on assumed
kinetics for their degradation and consumption. A more detailed and accurate
way to model STAT phosphorylation would include receptor availability as well
as cytokine concentrations and could be modelled by differential equations.
Another simplification used in this work is the form chosen to model the
contribution of each of the transcription factors to the protein production rate.
Usually, Hill functions are used to model the probability of a regulator binding the
target genes; we decided to simply use the amount of transcription factor. Further-
more, with the exception of the pSTATs cooperating with the antigen signalling
to modulate the production of their target, all positive regulatory mechanisms
are considered independent, thus, the total production rate is the addition of the
basal rate to all positive regulations divided by the sum of all negative regulations.
However, synergistic actions of several transcription factors could take place.
5.6 Outlook
In this work, we developed a method for the inference of a gene network down-
stream of external stimuli and applied it to Th cell differentiation. The method and
the insights gained into the analysed network open the way for further research
using our approach into different biological systems as well as deeper analysis of
the Th1 and Th2 responses to mixed informative cytokine stimuli.
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This work left several open questions concerning Th1 and Th1 differentiation
under mixed stimuli. Our analysis of STAT phosphorylation suggested that the
strength and duration of downstream signalling strongly depended on cytokine
and cytokine receptor availability; thus, it would be interesting to combine the
approach used here with time-resolved measurements of both cytokine concen-
tration and cytokine receptor expression to gain more insight into the rewiring
mechanisms allowing the emergence of hybrid cells and Th cell plasticity. Further-
more, the linear analysis revealed strong correlations between, on the Th1 side,
T-bet and pSTAT1 as well as pSTAT4 and, on the Th2 side, GATA-3 and pSTAT6.
Although the choice of linear model based on R2 and AIC values gave clear results
as to which, between pSTAT and master transcription factor, was modulating the
expression of the target protein, an alternative model substituting one for the other
also often gave good results. We clarified this point for the Th1-pathway by using
Tbx21-/- and Stat4-/- cells, thus determining with certainty if the effects observed
downstream of IL-12 and IFN-γ were mediated by T-bet or more direct effect of the
pSTATs, but the question remains open for GATA-3 and pSTAT6. Thus, it would
be informative to perform an IL-4 titration in Gata3-/- Th cells to see which of the
interactions presented here and GATA-3-independent.
Previous work on hybrid Th1/Th2 cells showed that the hybrid phenotype is
stable in the memory phase, i.e., in the absence of external instructive signals, as
the Th1 and Th2 phenotypes are. However, the stability of the different expression
levels of T-bet and GATA-3 as well as of the components of the signalling pathways
in this memory phase has not been studied. In order to determine if resting
memory cells still display gradual master transcription factor levels and a gradual
response to a secondary activation, cells differentiated with different amounts of
cytokines should be transferred into naive recipient mice and their MTF levels
quantified in the resting cells. Indeed, even though the dynamical model presented
here predicts a continuum of expression levels, it represents the response of the
cells to instructive cytokines, and not their memory phenotype in the absence of
external cues; such models that include auto-activation and mutual repression of
T-bet and GATA-3 typically display only up to four steady states after removal
of cytokine signals: a naive state with low T-bet and GATA-3 expression, a Th1
state with high T-bet and low GATA-3, a Th2 state with high GATA-3 and low
T-bet and finally a hybrid state with intermediate T-bet and GATA-3 expression.
To understand how the cells quantitatively remember their activation history or
respond to different amounts and combinations of cytokines during secondary
activation would be helpful to comprehend the immune response after vaccination,
secondary infections or recurring activation of specific cells, as is the case in
allergies and autoimmune diseases.
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An interesting point that was not further studied in this work is the ‘memory’
of transcription factor for the previous binding of their regulators. During the
linear regression analysis, we used a parameter λ to quantify how long a target
transcription factor was influenced by its regulator. However, we used only one
value for each regulated target and applied it to all its regulators, an assumption
that is not justified by biological facts, even if it allowed us to find good fitting
models. Indeed, as mentioned above, λ summarises several mechanisms: protein
half-life is reflected in the λ value, but also long-lasting epigenetic changes at the
gene locus as well as modulation of acute transcription. Thus, the use of a different
parameter for each regulator could be informative as to the mechanism used by a
transcription factor to modulate transcription.
Although we used flow cytometry as a measurement tool, as it is well estab-
lished in the T cell system, this time-resolved approach to study dose-responses
could easily be generalised to other systems and other quantification methods.
Indeed, as long as the input signals are well determined and the targets quantifi-
able (RNA expression by RT-PCR, microarrays or sequencing, protein amounts
by flow cytometry, ELISA or western blot), dose-responses can be studied and
linear correlations inferred. As such, the method used here could be useful in
reconstructing signalling networks from different fields of biology. Detailed prior
knowledge about the main network components and the hierarchy between regu-
latees and regulators as we had is helpful, but not necessary to gain information
about the network; general gene annotation would be enough the determine the
general hierarchy of a system based on gene function. Thus, the method described
in this work could be easily generalised and used at a larger scale; the questions
we addressed allowed us to focus on a few key factors and keep the models, both
linear and dynamical, simple. Indeed, the dynamical model presented here is
a simple one; it could, however, be used as a basis for a more detailed model
of Th1 and Th2 differentiation, for example by using more complex functions to
model the production rates or by including more factors (e.g., cytokine receptors).
Furthermore, such a model could be adapted to include other Th differentiation
pathways, like the Th17 or Treg lineages.
5.7 Conclusion
The experimental approach used in this work to study the Th1-Th2 signalling
network is straight-forward and focuses mainly on two aspects: the dynamics of
up-regulation of the known main players in the network, and the dose-response
of these same factors to instructive stimuli. These aspects are studied on multiple
levels: signal transduction downstream of instructive stimuli, expression of tran-
scription factors, and finally, expression of effector cytokines as a read-out for cell
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function. Basing our study on established knowledge about Th1-Th1 cell differen-
tiation that Th1 versus Th2 cells arise when T-bet versus GATA-3 are up-regulated
via IFN-γ/STAT1 and IL-12/STAT4 versus IL-4/STAT6 signalling, leading to Th1-
versus Th2 effector cytokine expression, we designed an in vitro differentiation
protocol allowing us to quantify the main players in Th1-Th2 differentiation in
response to the aforementioned cytokines in a time-resolved manner. Specifically,
the polarising cytokines IFN-γ, IL-12 and IL-4 were titrated in different combin-
ations, signal transduction was quantified daily by measuring the amounts of
phosphorylated STAT1, STAT4 and STAT6 downstream of the cytokines by flow
cytometry, and then their target transcription factors T-bet and GATA-3, as well
as the total STAT1, STAT4 and STAT6 amounts were likewise quantified daily
by flow cytometry. Our functional read-out was the amount of cytokine (i.e.,
IFN-γ, TNF-α, IL-2, IL-4, IL-13 and IL-10) expressed upon antigen restimulation
after differentiation. Linear regression analysis allowed us to infer the regulatory
network underlying Th1, Th2 and hybrid Th1/2 cell differentiation in an unbiased
manner by selecting the significant relationships between all the analysed factors.
This method is potentially applicable to all systems where the dose-responses of
known players to external stimuli can be quantified.
Experiments showed that cells receiving distinct cytokine signals during dif-
ferentiation showed phenotypic characteristics corresponding to all the signals
received at the three layers studied: STAT phosphorylation, STAT and master
transcription factor expression and signature cytokine expression. The network
resulting from this analysis showed that the signals from distinct cytokines were
processed independently of each other; indeed, both linear regression analysis and
dynamic modelling were able to explain the expression of master transcription
factors and STAT proteins by additive effects of the upstream cytokines; although
synergistic effects were suggested by the visual analysis, most of them could be
explained by independent effect on members of the signalling pathways. Thus,
signal integration during differentiation is mediated by network rewiring and not
by complex interactions between the transcription factors.
Furthermore,the network predicted several mutually repressive mechanisms
between the Th1 and the Th2 pathways: the Th1 master transcription factor T-
bet was repressed directly by GATA-3, whereas GATA-3 was down-regulated by
pSTAT1 and pSTAT4 downstream of the Th1 cytokines IFN-γ and IL-12. Interac-
tions between pathways was not limited to the expression of master transcription
factor, but could also be observed at the level of STAT expression, in the form of
STAT1 repressing STAT6 and GATA-3 repressing STAT4, and phosphorylation as
IL-4 induce the activation of STAT1 and STAT4 additionally to STAT6. Interest-
ingly, the nature of those mutually repressive interactions led to a continuum of
expression levels and not to a digital switch between distinct states.
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Finally, we found that the expression of most effector cytokines was governed
by T-bet and GATA-3, as their expression levels were good predictors for the frac-
tion of cytokine expressing cells. Thus, cytokine amounts during differentiation
determine the amplitude of the functional response upon secondary TCR stimula-
tion, and the presence of a continuum of reachable T-bet-GATA-3 co-expression
levels allows for fine-tuning of the type-1 and type-2 immune responses induced
by a specific pathogen.

Chapter 6
Materials and methods
6.1 Experimental materials and methods
6.1.1 Differentiation of murine Th cells
Mice
LCMV-TCRtg (SMARTA1)242 mice expressing a TCR specific for the LCMV epitope
GP61−80 on C57BL/6 background were used as organ donors for the isolation
of splenocytes and lymph node cells to obtain Th cells. When indicated, TCRtg
mice were crossed with Ifng-/- mice243, Il4-/- mice244, Tbx21-/- mice245 or Stat4-/-
mice246. Il12p40-/-247 x Ifng-/- mice with a wild-type TCR were used as organ
donors for the isolation of splenocytes to obtain APCs. All mice were all on
C57BL/6 background. Mice were bred under specific pathogen-free conditions
at the Charite´, Berlin or at the Federal Institute for Risk Assessment (BfR), Berlin.
All animal experiments were performed in accordance with the German law for
animal protection with permission from the local veterinary offices.
Isolation of naive Th cells
Spleens and lymph nodes of 6-8 weeks old SMARTA1 mice were mechanically dis-
rupted to obtain single-cell suspensions. Erythrocytes were lysed by a 3-minutes
incubation in erythrocyte lysis buffer (10 mM KHCO3, 155 mM NH4Cl, 0.1 mM
EDTA, pH 7.5). Naive Th cells were then enriched by depleting CD8+ cells, macro-
phages, B cells, NK cells, dendritic cells, granulocytes, Treg cells and acute effector
Th cells using magnetic-activated cell sorting; cells were first incubated for 10
minutes on ice with biotin-conjugated antibodies (BD biosciences) specific to CD8a
(53-6.7), CD11b (M1/70), CD19 (1D3),NK1.1 (PK136) CD11c (HL3), Gr-1 (RB6-
8C5), CD25 (7D4) and CXCR3 (CXCR3-173), respectively, then with anti-biotin
microbeads (Miltenyi Biotec) for 10 minutes at 4◦C. Cells were then separated
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using LS columns (Miltenyi Biotec). Enriched naive CD4+ T cells were stained
with PE-Cy7-conjugated anti-CD4 (RM4-5), Pacific Blue-conjugated anti-CD44 PE-
Cy7, FITC-conjugated anti-CD62L (MEL-14) and PerCP-conjugated Streptavidin
(all from BD biosciences) before Streptavidin-negative CD4+CD62LhiCD44lowere
sorted using a FACS Aria II (Becton Dickinson) to a purity >99%.
Isolation of APCs
Spleens and mesenteric lymph nodes of Il12p40-/-247 x Ifng-/- mice were mechan-
ically disrupted to obtain single-cell suspensions. Erythrocytes were lysed by a
3-minutes incubation in erythrocyte lysis buffer (10 mM KHCO3, 155 mM NH4Cl,
0.1 mM EDTA, pH 7.5). T cells were then sorted out from the APC fraction us-
ing LS columns or an autoMACS separator (both from Miltenyi Biotec) after a
10-minutes incubation on ice with biotin-conjugated anti-Thy1.2 (53-2.1, BD bios-
ciences) followed by a 10-minutes incubation at 4◦C with anti-biotin microbeads
(Miltenyi Biotec).
T Cell Activation and Differentiation
Naive CD4+CD62LhiCD44loCD25-CXCR3- Th cells were cultured in RPMI 1640
+GlutaMax-I supplemented with 10% (v/v) FCS (Gibco), penicillin (100 U/ml;
Gibco), streptomycin (100 µg/ml; Gibco), and β-mercaptoethanol (50 ng/ml;
Sigma). Cultures were prepared in the presence of Il12p40-/-xIfng-/- or wild-type
APCs, 0.5 mg/ml LCMV-GP61−80, (R. Volkmer, Institute for Med. Immunology,
Charite´) and 5 ng/ml IL-2 (R&D Systems).
For Th1 differentiation, 10 ng/ml IFN-γ, 5 ng/ml IL-12 (R&D Systems) and 10
µg/ml anti-IL-4 (11B11) were added, unless specified otherwise. For Th2 differ-
entiation, 10 ng/ml IL-4 (R&D Systems) and 10 µg/ml anti-IFN-γ (AN18.17.24)
were added. Hybrid Th1/2 cells were cultured with 10 ng/ml IFN-γ, 5 ng/ml
IL-12 and 10 ng/ml IL-4. For some experiments, cells were cultured under neutral
conditions with 10 µg anti-IL-12 (C17.8), 10 µg anti-IFN-γ and 10 µg anti-IL-4. Cell
cultures were split on d2 or d3 and analysed until d5.
6.1.2 Flow Cytometry
Samples were acquired on a FACS Canto II (Becton Dickinson) and analysed with
FlowJo (TreeStar). Dead cells and doublets were excluded by a combination of for-
ward scatter height and width gating and a LIVE/DEAD fixable dye (Invitrogen).
If not specified otherwise, cells were stained for 15 minutes at 4◦C in a volume
of 50 µ in the presence of 10 µg/ml anti-FcγRII/III (2.4G2, ATCC) and 2.5 µg/ml
purified Rat IgG (Jackson Immunoresearch) and washed with an excess volume.
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Intracellular cytokine staining
For intracellular analysis of cytokines, cells were restimulated on d5 with PMA (5
ng/ml) and ionomycin (500 ng/ml) for 4 h with addition of brefeldin A (5 mg/ml;
all from Sigma-Aldrich) after 30 min. Following restimulation, cells were stained
with a LIVE/DEAD fixable dye (Invitrogen) and fixed in 2% formaldehyde (Merck).
Intracellular staining was performed in PBS/0.2% BSA containing 0.05% saponin
(Sigma-Aldrich) for permeabilization. Samples were stained with antibodies
(eBioscience) specific to CD4 (GK1.5), IFN-γ (XMG1.2), IL-4 (11B11), IL-10 (JES5-
16E3), IL-13 (38213.11, eBio13A), TNF-a (MP6-XT22) and IL-2 (JES6-5H4).
STAT staining
STAT protein amounts and phosphorylation of STAT proteins were analysed using
BD Phosflow buffers according to the manufacturer’s instructions (BD Bioscience).
Cells were fixed with prewarmed 1x BD Phosflow Lyse/Fix Buffer for 10 min
at 37◦C. Cells were permeabilized with ice-cold BD Phosflow Perm Buffer III
for 30 min on ice. Then, cells were stained for 30 min with anti-CD4 and either
PE-conjugated anti-pSTAT1 (4a) and Alexa-647-conjugated anti-STAT1 (1/Stat1)
or PE-conjugated anti-pSTAT6 (pY641) and Alexa-647-conjugated anti-STAT6
(23/STAT6) or PE-conjugated anti-pSTAT4 (38/p-Stat4; all from BD Biosciences)
and polyclonal rabbit anti-STAT4 (Zymed). Secondary antibody (Cy5-conjugated
donkey anti-rabbit; Jackson Immunoresearch) was added at a final concentration
of 0.2 mg/ml. Cells were washed and analysed by FACS. Geometric mean indices
were calculated by dividing the geometric mean of the analysed population by the
geometric mean of the respective isotype control-stained cells.
T-bet and GATA-3 staining
T-bet and GATA-3 protein amounts were analysed using FoxP3 staining buffer
set (eBioscience) according to the manufacturer’s instructions. Briefly, cells were
stained with anti-CD4 (GK1.5) and a LIVE/DEAD fixable dye (Invitrogen), fol-
lowed by fixation with 1x Fixation/Permeabilization buffer and intracellular stain-
ing with Pacific Blue-conjugated anti-T-bet (4B10) and Alexa-647-conjugated anti-
GATA-3 (TWAJ, both from eBioscience) in 1x Permeabilization buffer. Cells were
washed in 1x Permeabilization buffer and analysed by FACS. For T-bet/pSTAT4
and GATA-3/pSTAT6 co-stainings, the STAT staining protocol was used. Geomet-
ric mean indices were calculated by dividing the geometric mean of stained cells
by the geometric mean of the respective isotype control-stained cells.
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6.1.3 RNA
mRNA from Th cell differentiation kinetics was purified using the NucleoSpin
RNA II Kit (Macherey-Nagel) according to the manufacturers instructions. Illu-
mina mouse WG-6 gene arrays were prepared, and gene expression was analysed.
Differential gene expression was analysed using the EDGE software package248.
6.2 Computational methods
6.2.1 Data processing
The data was obtained by flow cytometry using the DIVA software (BD bios-
ciences), and the geometric mean of each population was computed with FlowJo
(Treestar) after appropriate gating. It was then processed the following way as
described below.
Cytokine concentrations
The concentrations [C]cyto of IFN-γ, IL-12 and IL-4 used for each condition i were
transformed the following way before fitting the linear regression models to the
relative pSTAT values:
Cicyto =
⎧⎪⎨⎪⎩
log10
(
([C]i+1cyto )
2
[C]i+2cyto
)
if [C]icyto = 0,
log10([C]
i
cyto) else.
This transformation approximates the 0 concentration by the next smallest
titration step. Furthermore, the [C]icyto were normalised to be between 0 and 1 by
dividing them by their minimal value before the log transformation, and again by
their maximal value after it.
Transcription factors
For each transcription factor (TF, i.e., T-bet. GATA-3, STAT1, STAT4, STAT6,
pSTAT1, pSTAT4 and pSTAT6) staining of condition i, the geometric mean (GM) of
the population was divided by the geometric mean of the corresponding isotope
control to correct for differences in cell size and autofluorescence, obtaining the
geometric mean index (GMI):
GMIiTF =
GMiTF
GMiiso
For each experiment e and transcription factor, this GMI value was further di-
vided by the maximal GMI value for the same TF in the experiment x to correct for
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differences in staining intensities and cytometer sensibility between independent
experiments:
GMIiTF, e =
GMIiTF, e
max
(
GMITF, e
)
For the analysis of the cytokine effects on the STAT phosphorylation, we
computed the relative GMI (rGMI) of each pSTAT (pSTAT1, pSTAT4 and pSTAT6)
by dividing the GMI of the pSTAT staining by the GMI of the corresponding total
STAT staining after removing the baseline of pSTAT expression:
rGMIipSTAT, x =
GMIipSTAT, x −min
(
GMIpSTAT, x
)
GMIiSTAT, x
Furthermore, in order to be able to compare the weights of the regressors of
the linear models, the data for each protein used as an explanatory variable in
the linear modelling was further normalised to have a mean of 0 and a standard
deviation of 1:
GMIiTF =
GMIiTF −mean
(
GMITF
)
stdev(GMITF)
6.2.2 Linear regression models
The linear modelling was done with Wolfram Mathematica 10. The LinearModelFit
function was used to fit the parameters to the data as well as to compute R2,
Akaike’s Information Criterion (AIC), the statistical significance of the parameters,
their confidence intervals, the residuals and Cook’s distance. Unless specified
otherwise, the models were fitted to the data generated by the IFN-γ, IL-12 and
IL-4 titrations performed in the presence and absence of the other cytokines with
Ifng-/- (IFN-γ and IL-12 titrations) or Il4-/- (IL-4 titrations) cells.
The linear regression models were compared using several statistics. The
coefficient of determination
R2 = 1− SSt
SSr
where SSt is the total sum of squares and SSr the residual sum of squares, informs
about the goodness of fit. The Akaike information criterion, in the case of linear
regression models,
AIC = 2k + n ln (SSr)
where k is the number of parameters and n the sample size penalises the com-
plexity of the model while rewarding goodness of fit, and the significance of the
parameters according to the F -statistic in ANOVA calculations182.
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pSTATs as functions of cytokine concentrations
The family of linear models explaining the pSTAT values in condition i as functions
of the cytokine concentrations was build as follows:
rGMIix = αx,0 +
3∑
j=1
αx,j · Cij
where x = {pSTAT1, pSTAT4, pSTAT6} and j = {IFN-γ, IL-12, IL-4}. For each
pSTAT on each day, seven models with different explanatory variables were fitted
to the relative pSTAT values: IFN-γ only, IL-12 only, IL-4 only, IFN-γ and IL-12,
IFN-γ and IL-4, IL-12 and IL-4 or all three cytokines were used as explanatory
variables. The models were compared using the R2, the AIC and the significance
of the parameters. The best model was the one having the lowest AICs and only
significant parameters.
Master transcription factors as functions of pSTATs and each other
The family of linear models explaining the expression of the transcription factors
T-bet and GATA-3 was built similarly to the previous family, but weighted sums
over time until day T of the active transcription factors (pSTAT1, pSTAT4, pSTAT6
and GATA-3 or T-bet, respectively) were used as explanatory variables for T-bet
and GATA-3 in each condition i on day T . The transcription factor modelled could
not be included in the explanatory variables due to the nature of linear regression
analysis.
GMIix(T ) = αx,0 +
5∑
j ̸=i,j=1
(
αx,j ·
T∑
t=1
e−λx·(T−t)GMIij(t)
)
where x = {T-bet, GATA-3}, j =
⎧⎨⎩{GATA-3, pSTAT1, pSTAT4, pSTAT6} x = T-bet,{T-bet, pSTAT1, pSTAT4, pSTAT6} x = GATA-3
and T = {1, 2, 3, 4, 5}. Similarly to the method used with the models explaining
STAT phosphorylation, fifteen models with all possible combinations of the four
explanatory variables were fitted to the GMIs of T-bet and GATA-3 independently
for each day. λ was determined first by comparing the R2 of the fitted model
including all explanatory variables for increasing λ values and choosing the λ
value leading to the highest R2. The models with fixed λ values were then fitted
again and compared using the AIC, R2 and the significance of the parameters. The
best model was the one having the lowest AIC and only significant parameters.
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STATs as functions of activated transcription factors
The family of linear models explaining the expression of the three STAT transcrip-
tion factors was build like the one explaining T-bet and GATA-3 expression, using
the sums over time until day T of the active transcription factors (T-bet, GATA-3,
pSTAT1, pSTAT4, pSTAT6) as explanatory variables for total STAT expression on
day T in each condition i.
GMIix(T ) = αx,0 +
5∑
j=1
(
αx,j ·
T∑
t=1
e−λx·(T−t)GMIij(t)
)
where T = {1, 2, 3, 4, 5}, x ={STAT1, STAT4, STAT6} and j ={T-bet, GATA-3,
pSTAT1, pSTAT4, pSTAT6}. Again, thirty-one models with all possible combina-
tions of the five explanatory variables were fitted to the GMIs of STAT1, STAT4 or
STAT6 independently for each day. λ was determined first by comparing the R2 of
the fitted model including all explanatory variables for increasing λ values and
choosing the λ value leading to the highest R2. The models with fixed λ values
were then fitted again and compared using the AIC, R2 and the significance of
the parameters. The best model was the one having the lowest AIC and only
significant parameters.
Cytokine producers as functions of T-bet and GATA-3
The percentage of cytokine producers during the recall response after five days of
differentiation was expressed as a function of the T-bet and GATA-3 GMIs on day
5 before TCR restimulation in each condition i. Linear functions were fitted to the
flow cytometry data of cytokine expression:
Pix = αx,0 +
2∑
j=1
αx,i ·GMIij
where P is the percentage of cytokine producers, x ={IFN-γ, IL-13, IL-4, TNF-α,
IL-2, IL-10}, and j ={T-bet, GATA-3}. Three different models were fitted for
each cytokine to the data of the IL-12/IL-4 cross-titration performed in wild-type
cells, taking both T-bet and GATA-3, only T-bet or only GATA-3 as explanatory
variables. The models were compared using the AIC, R2 and the significance of
the parameters. The best model was the one having the lowest AIC and only
significant parameters. These linear models were used as a basis to empirically
find better-fitting non-linear models using the NonLinearModelFit function.
The standardized residuals were examined for each model, as well as Cook’s
distance, both provided by the LinearModelFit function. Three data points were
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excluded after analysis of Cook’s distance because of biologically aberrant STAT4
or STAT1 GMI due to abnormally low isotope control stainings.
6.2.3 ODE model
Based on the network topology derived from the linear models, a system of or-
dinary differential equations was designed to describe the data. This system
was implemented in MATLAB (MathWorks) using the Data2Dynamics environ-
ment185,186.
Model development
The model used describes the phosphorylation of the STATs in response to po-
larising cytokines as well as the expression of transcriptions factors in function
of active transcription factors. The first part of the model is not ODE-based and
describes the kinetics of cytokine concentrations and the phosphorylation of the
STATs:
[IFN-γ] = CIFN-γ · (1− tanh(t− TIFN-γ))
[IL-12] = CIL-12 · (1− tanh(t− TIL-12))
[IL-4] = CIL-4 · (1− tanh(t− TIL-4))
pS1 = (α1[IFN-γ] + α2[IL-12] + α3[IL-4]) · S1
pS4 = (α4[IL-12] + α5[IL-4]) · S4
pS6 = (α5[IL-4]) · S6
Where Cs are the logarithm of the cytokine concentrations, t the time in days,
the T s the half-lives of the cytokine concentrations, and the αs the strength of
the cytokine effects on STAT phosphorylation. The T and α parameters were
fitted to the pSTAT intensities from the IFN-γ, IL-12 and IL-4 titrations, taking the
experimental values of the total STAT intensities as inputs.
The transcription factor expression was modeled by a system of five ordinary
differential equations, one for each protein. The pSTATs were assumed to act in
concert with antigen signalling, so that a linear equation describing the antigen
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stimulus was added to the system:
Ag = (1− e(−t)) · e(−l2·t)
S˙1 =
BS1 + β1 · T + β2 · pS1 · Ag
1 + β3 · pS4 · Ag − δS1 · S1
S˙4 =
BS4 + β4 · T
1 + β5 · pS4 · Ag + β6 ·G − δS4 · S4
S˙6 =
BS6 + β7 · pS6 · Ag
1 + β8 · pS1 · Ag − δS6 · S6
T˙ =
BT + β9 · pS1 · Ag + β10 · pS4 · Ag
1 + β11 ·G − δT · T
G˙ =
BG + β12 · pS6 · Ag
1 + β13 · pS1 · Ag + β14 · pS4 · Ag − δG ·G
S1, S4, S6, T and G represent STAT1, STAT4, STAT6, T-bet and GATA-3 protein
expression, respectively. Ag represents the antigen stimulus, which increases with
time constant 1 and decreases with time constant l2 (Figure 4.2). pS1, pS4 and pS6
represent the phosphorylated forms of SATA1, STAT4 and STAT6, respectively.
Each protein is produced with a basal rate Bi and degraded with a rate δi. In
addition to that, the positive and negative regulatory mechanisms described by
the linear regression analysis are added to the production rate with weights βi.
This model describes the positive effects of pSTAT1 on STAT1 and T-bet expres-
sion as well as its negative effects on GATA-3 and STAT6, the negative effects of
pSTAT4 on STAT1, STAT4 and GATA-3 and its positive effect on T-bet, the positive
effects of pSTAT6 on itself and GATA-3. Described are also the positive effects of
T-bet on STAT1 and STAT4 and the negative effects of GATA-3 on STAT4 and T-bet.
All 19 β parameters were fitted to the whole data of T-bet, GATA-3, STAT1, STAT4
and STAT6 expression from day to day 5 using only the cytokine concentrations
as input data.
Model fitting and testing
The model was fitted in two steps; first, the algebraic part of the model describing
STAT phosphorylation was fitted to the pSTAT data with the initial cytokine
concentrations and STAT values as inputs; then, using the best-fit parameters from
the first step, the non-linear part was fitted to the whole dataset using only the
initial cytokine concentrations as inputs.
The first part of the model was fitted with Wolfram Mathematica 10. The
NonLinearModelFit function was used to fit the parameters to the data as well as
to compute their confidence intervals. The ODE model was fitted and analysed
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using the Data2Dynamics software185,186. The parameter estimation procedure
was done with the lsqnonlin algorithm, a deterministic optimisation algorithm.
The confidence intervals and identifiability of the parameters were inferred by
calculating the profile likelihood188,189. Latin Hypercube Sampling187 of the initial
parameter values was used to verify that a global minimum was found. Alternative
models lacking a specific interaction were similarly fitted to the same data.
The accuracy of the model was tested by predicting the T-bet and GATA-3
values from the IL-12/IL-4 cross-titration experiment (which were not used for
the fit) consisting of 49 conditions on day 5 of culture using MATLAB and the best-
fit parameters. As only endogenous IFN-γ was present during this culture, the
concentration of this cytokine was approximated using the percent of producers
during the recall response, postulating that it was proportional to the production
during differentiation and that the highest production was sufficient to reach
saturation (i.e., CiIFN-γ =
PiIFN-γ
max(PIFN-γ)
). Using the values for the β parameters found
by fitting to the other dataset, the known IL-12 and IL-4 concentrations and the
extrapolated IFN-γ concentrations, the model was able to reproduce the levels of
T-bet and GATA-3 expression from the experimental data.
Different models were compared using the Akaike information criterion
AIC = 2k − 2 ln (Lˆ)
where Lˆ is the maximum likelihood estimator computed with the D2D framework.
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Figure 7.1: List of all the different culture conditions used during primary differentiation in the
main titration experiments. The cytokines IFN-γ, IL-12 and IL-4 were titrated during differentiation of
appropriate cytokine-deficient naive Th cells in presence or absence of one or both other cytokines.
7.1. Supplementary figures 147
a b
Th1
Th2
Th1/2Hybrid
1 2 3 4 5
0
500
1000
1500
2000
Day
Il12Rb2 Il4Ra
1 2 3 4 5
0
500
1000
1500
2000
Day
Figure 7.2: Kinetic RNA data of cytokine receptors during differentiation of naive wild-type Th cells.
RNA from wild-type Th1, Th2 and Hybrid Th1/2 cells was extracted and quantified by microarrays in a
kinetic manner during primary differentiation.
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Figure 7.3: Kinetic RNA data of transcription factors during differentiation of naive wild-type Th
cells. RNA from wild-type Th1, Th2 and Hybrid Th1/2 cells was extracted and quantified by microarrays
in a kinetic manner during primary differentiation.
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Figure 7.4: Diagnostics of the linear models for STAT phosphorylation. a Cook’s distance for each data
point. b Normal probability plots. c Residual for each data point.
7.1. Supplementary figures 149
20 40 60 80
Data point
-0.5
0.5
1.0
Distance GATA-3, Cook's distance
0.0 0.2 0.4 0.6 0.8 1.0
0.0
0.2
0.4
0.6
0.8
1.0
GATA-3, Probability Plot
20 40 60 80
Data point
Residual GATA-3, Residuals
-1.0
-0.5
0.5
1.0
1.5
20 40 60 80 Data point
-0.6
-0.2
0.2
0.6
Distance
T-bet, Cook's distance
0.0 0.2 0.4 0.6 0.8 1.0
0.0
0.2
0.4
0.6
0.8
1.0
T-bet, Probability Plot
20 40 60 80
Data point
Residual T-bet, Residuals
-1.0
-0.5
0.5
1.0
1.5
a
b
c
Figure 7.5: Diagnostics of the linear models for master transcription factor expression. a Cook’s
distance for each data point. b Normal probability plots. c Residual for each data point.
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Figure 7.6: Diagnostics of the linear models for STAT expression. a Cook’s distance for each data point.
b Normal probability plots. c Residual for each data point.
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Figure 7.8: Fits of the dynamical models converged to a global minimum. The dynamical model was
fitted 300 times with different initial values determined by Latin Hypercube Sampling and the resulting
logarithms of the likelihood values compared.
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Figure 7.9: IFN-γ reduces cell expansion, whereas IL-12 and IL-4 tend to augment it. a Cell expansion
in response to IFN-γ with IL-12 (full lines) or without IL-12 (dotted lines), in the presence of IL-4 (purple lines) or
anti-IL-4 (blue lines). b Cell expansion in response to IL-12 with IFN-γ (full lines) or without IFN-γ (dotted lines), in
the presence of IL-4 (purple lines) or anti-IL-4 (blue lines). c Cell expansion in response to IL-4 with IFN-γ (full lines)
or anti-IFN-γ (dotted lines), in the presence of IL-12 (purple lines) or without IL-12 (red lines). d Cell expansion in
response to GP6461−80 in the different conditions.
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